Section 56

EurekaMag PDF full texts Chapter 55,647


Wilkinson, C.P. 2011: Safety of vitrectomy for floaters--how safe is safe?. American Journal of Ophthalmology 151(6): 919-920.E1
Low, D.; Pettitt, J. 2012: Safety of vulnerable children could be put at risk. Bmj 345: E6210
Thomas, C.A.; Taylor, K.; Schamberger, M.S.; Rotta, A.T. 2014: Safety of warfarin dosing in the intensive care unit following the Fontan procedure. Congenital Heart Disease 9(4): 361-365
Galipienzo, J.; García de Tena, J.; Flores, J.; Alvarez, C.ón.; Alonso-Viteri, S.; Ruiz, A. 2010: Safety of withholding anticoagulant therapy in patients with suspected pulmonary embolism with a negative multislice computed tomography pulmonary angiography. European Journal of Internal Medicine 21(4): 283-288
Tanimoto, T.; Uchida, N.; Kodama, Y.; Teshima, T.; Taniguchi, S. 2011: Safety of workers at the Fukushima Daiichi nuclear power plant. Lancet 377(9776): 1489-1490
Bradley, D. 2007: Safety of young children in registered day care. Journal of Family Health Care 17(2): 41-42
Gaba, R.C.; Riaz, A.; Lewandowski, R.J.; Ibrahim, S.M.; Ryu, R.K.; Sato, K.T.; Omary, R.A.; Salem, R. 2010: Safety of yttrium-90 microsphere radioembolization in patients with biliary obstruction. Journal of Vascular and Interventional Radiology: Jvir 21(8): 1213-1218
Twaites, B.R.; Wilton, L.V.; Shakir, S.A.W. 2007: Safety of zafirlukast: results of a postmarketing surveillance study on 7976 patients in England. Drug Safety 30(5): 419-429
Coleman, R.; Woodward, E.; Brown, J.; Cameron, D.; Bell, R.; Dodwell, D.; Keane, M.; Gil, M.; Davies, C.; Burkinshaw, R.; Houston, S.J.; Grieve, R.J.; Barrett-Lee, P.J.; Thorpe, H. 2011: Safety of zoledronic acid and incidence of osteonecrosis of the jaw (ONJ) during adjuvant therapy in a randomised phase IIi trial (AZURE: BIG 01-04) for women with stage II/IIi breast cancer. Breast Cancer Research and Treatment 127(2): 429-438
Tseng, H.F.; Liu, A.; Sy, L.; Marcy, S.M.; Fireman, B.; Weintraub, E.; Baggs, J.; Weinmann, S.; Baxter, R.; Nordin, J.; Daley, M.F.; Jackson, L.; Jacobsen, S.J. 2012: Safety of zoster vaccine in adults from a large managed-care cohort: a Vaccine Safety Datalink study. Journal of Internal Medicine 271(5): 510-520
Ibrahim, M.; Maselli, D.J.; Hasan, R. 2013: Safety of β-blockers in the acute management of cocaine-associated chest pain. American Journal of Emergency Medicine 31(6): 987-988
Erdmann, E. 2012: Safety of β-blockers. Prejudices and reality. Der Internist 53(5): 630-634
Bousquet, J.; Bourdin, A.; Demoly, P. 2014: Safety of β2-agonists: a 50-year debate closed?. European Respiratory Journal 43(1): 6-9
Nahata, M.C. 2009: Safety of "inert" additives or excipients in paediatric medicines. Archives of Disease in Childhood. Fetal and Neonatal Edition 94(6): F392-F393
Saumier, N.; Lorne, E.; Dermigny, F.; Walkzak, K.; Daelman, F.; Jezraoui, P.; Mahjoub, Y.; Milazzo, S.; Dupont, H. 2010: Safety of "needle" regional anaesthesia for anterior segment surgery under antiplatelet agents and anticoagulants therapies. Annales Francaises d'Anesthesie et de Reanimation 29(12): 878-883
Van de Meent, H.; Oerlemans, M.; Bruggeman, A.; Klomp, F.; van Dongen, R.; Oostendorp, R.; Frölke, J.P. 2011: Safety of "pain exposure" physical therapy in patients with complex regional pain syndrome type 1. Pain 152(6): 1431-1438
Ofori-Adjei, D. 2007: Safety of "sachet water" and raw milk. Ghana Medical Journal 41(2): 37
Ogunsanya, T.J.; Durborow, R.M.; Myers, M.L.; Cole, H.P.; Thompson, S.L. 2011: Safety on North Carolina and Kentucky trout farms. Journal of Agricultural Safety and Health 17(1): 33-61
Shah, R.K.; Lander, L.; Forbes, P.; Jenkins, K.; Healy, G.B.; Roberson, D.W. 2009: Safety on an inpatient pediatric otolaryngology service: many small errors, few adverse events. Laryngoscope 119(5): 871-879
Okun, A. 2008: Safety on bicycles, skateboards, scooters, and skates. Pediatrics in Review 29(10): 366-367
Duffin, C. 2011: Safety on board. Nursing Standard: 1987) 26(3): 20-21
Bilger, K. 2013: Safety on ice. Occupational Health and Safety 82(12): 18 20
Foster, R.J.; Hotchkiss, J.; Buckley, J.G.; Elliott, D.B. 2014: Safety on stairs: influence of a tread edge highlighter and its position. Experimental gerontology 55: 152-158
McGowan, D.R. 2014: Safety on the streets. Jems: a Journal of Emergency Medical Services Suppl: 10-12
Kirkwood, S.; Myers, J.B. 2007: Safety or marketing? Why we decorate our vehicles the way that we do. Jems: a Journal of Emergency Medical Services 32(9): 46-48; 50-53
Vogus, T.J.; Cooil, B.; Sitterding, M.; Everett, L.Q. 2014: Safety organizing, emotional exhaustion, and turnover in hospital nursing units. Medical Care 52(10): 870-876
Greenberg, M.D.; Haviland, A.M.; Yu, H.; Farley, D.O. 2009: Safety outcomes in the United States: trends and challenges in measurement. Health Services Research 44(2 Part 2): 739-755
Sylaja, P.N.; Dong, W.; Grotta, J.C.; Miller, M.K.; Tomita, K.; Hamilton, S.; Semba, C.; Hill, M.D. 2007: Safety outcomes of Alteplase among acute ischemic stroke patients with special characteristics. Neurocritical Care 6(3): 181-185
West, D. 2009: Safety outcry is 'mandate' for quality. Health Service Journal 119(6185): 4-5
Faulkner, M.A. 2014: Safety overview of FDA-approved medications for the treatment of the motor symptoms of Parkinson's disease. Expert Opinion on Drug Safety 13(8): 1055-1069
Wang, Y.G.; Swick, T.J.; Carter, L.P.; Thorpy, M.J.; Benowitz, N.L. 2009: Safety overview of postmarketing and clinical experience of sodium oxybate (Xyrem): abuse, misuse, dependence, and diversion. Journal of Clinical Sleep Medicine: Jcsm: Official Publication of the American Academy of Sleep Medicine 5(4): 365-371
Stephenson, E.; Ogilvie, C.M.; Patel, H.; Cornwell, G.; Jacquet, L.; Kadeva, N.; Braude, P.; Ilic, D. 2010: Safety paradigm: genetic evaluation of therapeutic grade human embryonic stem cells. Journal of the Royal Society Interface 7(Suppl 6): S677-S688
Grisanti, S.; Altvater, A.; Peters, S. 2008: Safety parameters for indocyanine green in vitreoretinal surgery. Developments in Ophthalmology 42: 43-68
Casado Verdejo, I.és.; Postigo Mota, S.; Iglesias Guerra, J.é A.; Galán Andrés, M.I.; Durán Gómez, N.; Muñoz Bermejo, L. 2011: Safety patient in medication use and administration. Revista de Enfermeria 34(3): 48-51
Luria, G.; Yagil, D. 2010: Safety perception referents of permanent and temporary employees: safety climate boundaries in the industrial workplace. Accident; Analysis and Prevention 42(5): 1423-1430
Chen, H.; Zhou, H.; Zhao, J.; Hsu, P. 2011: Safety performance evaluation of left-side off-ramps at freeway diverge areas. Accident; Analysis and Prevention 43(3): 605-612
Venkataraman, N. 2008: Safety performance factor. International Journal of Occupational Safety and Ergonomics: Jose 14(3): 327-331
Barbosa, H.; Cunto, Fávio.; Bezerra, Bárbara.; Nodari, C.; Jacques, M.Alice. 2014: Safety performance models for urban intersections in Brazil. Accident; Analysis and Prevention 70: 258-266
Snyder, L.A.; Krauss, A.D.; Chen, P.Y.; Finlinson, S.; Huang, Y.-H. 2011: Safety performance: the mediating role of safety control. Work 40(1): 99-111
Sazani, P.; Weller, D.L.; Shrewsbury, S.B. 2010: Safety pharmacology and genotoxicity evaluation of AVI-4658. International Journal of Toxicology 29(2): 143-156
Himmel, H.M. 2008: Safety pharmacology assessment of central nervous system function in juvenile and adult rats: effects of pharmacological reference compounds. Journal of Pharmacological and Toxicological Methods 58(2): 129-146
Pugsley, M.K.; Dalton, J.A.; Authier, S.; Curtis, M.J. 2014: Safety pharmacology in 2014: new focus on non-cardiac methods and models. Journal of Pharmacological and Toxicological Methods 70(2): 170-174
Pihl, T.H.; Jørgensen, C.S.; Santoni-Rugiu, E.; Leifsson, P.ál.S.úl.; Hansen, E.W.; Laursen, I.; Houen, G. 2010: Safety pharmacology, toxicology and pharmacokinetic assessment of human Gc globulin (vitamin D binding protein). Basic and Clinical Pharmacology and Toxicology 107(5): 853-860
Hamdam, J.; Sethu, S.; Smith, T.; Alfirevic, A.; Alhaidari, M.; Atkinson, J.; Ayala, M.; Box, H.; Cross, M.; Delaunois, A.; Dermody, A.; Govindappa, K.; Guillon, J-Michel.; Jenkins, R.; Kenna, G.; Lemmer, Börn.; Meecham, K.; Olayanju, A.; Pestel, S.; Rothfuss, A.; Sidaway, J.; Sison-Young, R.; Smith, E.; Stebbings, R.; Tingle, Y.; Valentin, J-Pierre.; Williams, A.; Williams, D.; Park, K.; Goldring, C. 2013: Safety pharmacology--current and emerging concepts. Toxicology and Applied Pharmacology 273(2): 229-241
Dasgupta, K.S.; Lanjewar, K.Y.; Joshi, S.V. 2006: Safety pin - the UNSAFE foreign body of air passage. Indian Journal of Otolaryngology and Head and Neck Surgery: Official Publication of the Association of Otolaryngologists of India 58(4): 387-388
Kuehn, B.M. 2010: Safety plan for opioids meets resistance: opioid-linked deaths continue to soar. JAMA 303(6): 495-497
Hemingway, M.; Kilfoyle, M. 2013: Safety planning for intraoperative magnetic resonance imaging. AORN Journal 98(5): 508-524
Mkandawire-Valhmu, L.; Stevens, P.E.; Kako, P.M.; Dressel, A. 2013: Safety planning in focus groups of Malawian women living with HIV: helping each other deal with violence and abuse. Violence Against Women 19(11): 1331-1349
Chanmugam, A.; Hall, K. 2012: Safety planning with children and adolescents in domestic violence shelters. Violence and Victims 27(6): 831-848
Coon, R. 1949: Safety practices for county hospitals and institutions. Monthly Bulletin. Indiana State Board of Health 52(9): 195-207
Muragaki, Y.; Maruyama, T.; Tanaka, M.; Iseki, H.; Okada, Y. 2010: Safety precaution of awake craniotomy. No Shinkei Geka. Neurological Surgery 38(5): 427-435
Brathwaite, D.; Aziz, F.; Eakins, C.; Charles, A.J.; Cristian, A. 2012: Safety precautions in the rehabilitation medicine prescription. Physical Medicine and Rehabilitation Clinics of North America 23(2): 231-239
Sugino, M.; Todo, H.; Suzuki, T.; Nakada, K.; Tsuji, K.; Tokunaga, H.; Jinno, H.; Sugibayashi, K. 2014: Safety prediction of topically exposed biocides using permeability coefficients and the desquamation rate at the stratum corneum. Journal of Toxicological Sciences 39(3): 475-485
Saadat, S.; Naseripour, M.; Rahimi, B. 2009: Safety preparedness of urban community for New Year fireworks in Tehran. Burns: Journal of the International Society for Burn Injuries 35(5): 719-722
Tutenges, S.éb. 2009: Safety problems among heavy-drinking youth at a Bulgarian nightlife resort. International Journal on Drug Policy 20(5): 444-446
Yang, Y.-X.; Yong, M.-C. 2009: Safety problems and countermeasures of electroacupuncture instruments. Zhongguo Zhen Jiu 29(4): 339-341
Fariña-López, E. 2011: Safety problems associated with using physical restraint devices on the elderly. Revista Espanola de Geriatria y Gerontologia 46(1): 36-42
Pal'tsev, I.P.; Kravchenko, O.K.; Levina, A.V. 2007: Safety problems of modern laser medical equipment. Meditsina Truda i Promyshlennaia Ekologiia 12: 12-16
Jorquera, J.I. 2007: Safety procedures of coagulation factors. Haemophilia: the Official Journal of the World Federation of Hemophilia 13(Suppl 5): 41-46
Rossi, D.; Alessandroni, P.; Catalano, V.; Giordani, P.; Fedeli, S.L.; Fedeli, A.; Baldelli, A.M.; Casadei, V.; Ceccolini, M.; Catalano, G. 2007: Safety profile and activity of lower capecitabine dose in patients with metastatic breast cancer. Clinical Breast Cancer 7(11): 857-860
May, C.H.; Lincoff, A.M. 2012: Safety profile and bleeding risk of ticagrelor compared with clopidogrel. Expert Opinion on Drug Safety 11(6): 959-967
Zhou, Q.; Dergunov, S.A.; Zhang, Y.; Li, X.; Mu, Q.; Zhang, Q.; Jiang, G.; Pinkhassik, E.; Yan, B. 2011: Safety profile and cellular uptake of biotemplated nanocapsules with nanometre-thin walls. Nanoscale 3(6): 2576-2582
Parker, J.M.; Oh, C.K.; LaForce, C.; Miller, S.D.; Pearlman, D.S.; Le, C.; Robbie, G.J.; White, W.I.; White, B.; Molfino, N.A.; Boulet, L.-P.; Fogarty, C.; Gauvreau, G.; Kaiser, H.; Lemiere, C.; Brazinsky, S.; Nayak, A.; Korenblat, P. 2011: Safety profile and clinical activity of multiple subcutaneous doses of MEDI-528, a humanized anti-interleukin-9 monoclonal antibody, in two randomized phase 2a studies in subjects with asthma. Bmc Pulmonary Medicine 11: 14
Merrill, J.T.; Wallace, D.J.; Petri, M.; Kirou, K.A.; Yao, Y.; White, W.I.; Robbie, G.; Levin, R.; Berney, S.M.; Chindalore, V.; Olsen, N.; Richman, L.; Le, C.; Jallal, B.; White, B. 2011: Safety profile and clinical activity of sifalimumab, a fully human anti-interferon α monoclonal antibody, in systemic lupus erythematosus: a phase I, multicentre, double-blind randomised study. Annals of the Rheumatic Diseases 70(11): 1905-1913
Adkins, D.; Ratanatharathorn, V.; Yang, H.; White, B. 2009: Safety profile and clinical outcomes in a phase I, placebo-controlled study of siplizumab in acute graft-versus-host disease. Transplantation 88(2): 198-202
Ateba, S.B.; Simo, R.V.ès.; Mbanya, J.C.; Krenn, L.; Njamen, D.é 2014: Safety profile and gender specific differences of a methanol extract of Eriosema laurentii (Leguminosae) in acute and subchronic (28 days) oral toxicity studies in Wistar rats. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association 65: 27-32
Ribas, A.; Chesney, J.A.; Gordon, M.S.; Abernethy, A.P.; Logan, T.F.; Lawson, D.H.; Chmielowksi, B.; Glaspy, J.A.; Lewis, K.; Huang, B.; Wang, E.; Hsyu, P.-H.; Gomez-Navarro, J.; Gerhardt, D.; Marshall, M.A.; Gonzalez, R. 2012: Safety profile and pharmacokinetic analyses of the anti-CTLA4 antibody tremelimumab administered as a one hour infusion. Journal of Translational Medicine 10: 236
Rossi, C.; Reginelli, A.; D'Amora, M.; Di Grezia, G.; Mandato, Y.; D'Andrea, A.; Brunese, L.; Grassi, R.; Rotondi, A. 2014: Safety profile and protocol prevention of adverse reactions to uroangiographic contrast media in diagnostic imaging. Journal of Biological Regulators and Homeostatic Agents 28(1): 155-165
Gadgeel, S.M. 2012: Safety profile and tolerability of antiangiogenic agents in non-small-cell lung cancer. Clinical Lung Cancer 13(2): 96-106
Verzoni, E.; Pusceddu, S.; Buzzoni, R.; Garanzini, E.; Damato, A.; Biondani, P.; Testa, I.; Grassi, P.; Bajetta, E.; de Braud, F.; DeBraud, F.; Procopio, G. 2014: Safety profile and treatment response of everolimus in different solid tumors: an observational study. Future Oncology 10(9): 1611-1617
Bucolo, C.; Longo, L.; Camillieri, G.; Drago, F.; Salomone, S. 2012: Safety profile assessment of buflomedil: an overview of adverse reactions between 1975 and 2011. Pharmacoepidemiology and Drug Safety 21(11): 1190-1196
Vatlach, S.; Arand, J.; Engel, C.; Poets, C.F. 2014: Safety profile comparison between extemporaneous and a licensed preparation of caffeine citrate in preterm infants with apnea of prematurity. Neonatology 105(2): 108-111
Thome, J.; Doppler, E. 2012: Safety profile of Cerebrolysin: clinical experience from dementia and stroke trials. Drugs of Today 48 Suppl A: 63-69
Falade, C.; Manyando, C. 2009: Safety profile of Coartem: the evidence base. Malaria Journal 8(Suppl 1): S6
Bigliardi, S.; Morselli, M.; Potenza, L.; Coluccio, V.; Maccaferri, M.; Paolini, A.; Colaci, E.; Fantuzzi, V.; Faglioni, L.; Soci, F.; Nasillo, V.; Messerotti, A.; Pedrazzi, P.; Marietta, M.; Luppi, M.; Forghieri, F. 2015: Safety profile of Erwinia asparaginase treatment in adults with newly diagnosed acute lymphoblastic leukemia: a retrospective monocenter study. Leukemia and Lymphoma 56(3): 770-773
Lalezari, J.; Latiff, G.H.; Brinson, C.; Echevarria, J.; Treviño-Pérez, S.; Bogner, J.R.; Stock, D.; Joshi, S.R.; Hanna, G.J.; Lataillade, M. 2014: Safety profile of HIV-1 attachment inhibitor prodrug BMS-663068 in antiretroviral-experienced subjects: week 24 analysis. Journal of the International Aids Society 17(4 Suppl 3: 19530
Dent, M.P.; Wolterbeek, A.P.M.; Russell, P.J.; Bradford, R. 2012: Safety profile of Hoodia gordonii extract: mouse prenatal developmental toxicity study. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association 50(Suppl 1): S20-S25
Dent, M.P.; Wolterbeek, A.P.M.; Russell, P.J.; Bradford, R. 2012: Safety profile of Hoodia gordonii extract: rabbit prenatal developmental toxicity study. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association 50(Suppl 1): S26-S33
Afif, W.; Loftus, E.V. 2010: Safety profile of IBD therapeutics: infectious risks. Medical Clinics of North America 94(1): 115-133
Bewtra, M.; Lewis, J.D. 2009: Safety profile of IBD: lymphoma risks. Gastroenterology Clinics of North America 38(4): 669-689
Yeo, T.W.; Lampah, D.A.; Gitawati, R.; Tjitra, E.; Kenangalem, E.; Granger, D.L.; Weinberg, J.B.; Lopansri, B.K.; Price, R.N.; Celermajer, D.S.; Duffull, S.B.; Anstey, N.M. 2008: Safety profile of L-arginine infusion in moderately severe falciparum malaria. Plos one 3(6): E2347
Young, S.H.Y.; Zhao, Y.; Koh, A.; Singh, R.; Chan, B.P.L.; Chang, H.Meng.; Venketasubramanian, N.; Chen, C.; Young, S.H.Y.; Chan, B.P.L.; Sharma, V.Kumar.; Teoh, H.Luen.; Seet, R.; Venketasubramanian, N.; Chang, H.Meng.; de Silva, D.; Singh, R. 2010: Safety profile of MLC601 (Neuroaid) in acute ischemic stroke patients: A Singaporean substudy of the Chinese medicine neuroaid efficacy on stroke recovery study. Cerebrovascular Diseases 30(1): 1-6
Swain, S.M.; Im, Y.-H.; Im, S.-A.; Chan, V.; Miles, D.; Knott, A.; Clark, E.; Ross, G.; Baselga, J.é 2014: Safety profile of Pertuzumab with Trastuzumab and Docetaxel in patients from Asia with human epidermal growth factor receptor 2-positive metastatic breast cancer: results from the phase IIi trial CLEOPATRA. Oncologist 19(7): 693-701
Barros, S.A.; Gollob, J.A. 2012: Safety profile of RNAi nanomedicines. Advanced Drug Delivery Reviews 64(15): 1730-1737
Iaffaldano, P.; D'Onghia, M.; Trojano, M. 2009: Safety profile of Tysabri: international risk management plan. Neurological Sciences: Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 30 Suppl. 2: S159-S162
Song, H.; Shi, H.; Zhang, X.; Wang, J.; Yu, Y.; Chen, W.; Zhou, H. 2015: Safety profile of a divided dose of propranolol for heart rate in children with infantile haemangioma during 16 weeks of treatment. British Journal of Dermatology 172(2): 444-449
Khraishi, M.; Russell, A.; Olszynski, W.P. 2010: Safety profile of abatacept in rheumatoid arthritis: a review. Clinical Therapeutics 32(11): 1855-1870
Trivedi, D.; Denniston, A.K.O.; Murray, P.I. 2011: Safety profile of anterior chamber paracentesis performed at the slit lamp. Clinical and Experimental Ophthalmology 39(8): 725-728
Stamp, L.K. 2014: Safety profile of anti-gout agents: an update. Current Opinion in Rheumatology 26(2): 162-168
Hori, S. 2011: Safety profile of antimicrobial agents. Yakugaku Zasshi: Journal of the Pharmaceutical Society of Japan 131(10): 1423-1428
Barańska-Rybak, W.; Pikula, M.ł; Dawgul, M.łg.; Kamysz, W.; Trzonkowski, P.; Roszkiewicz, J. 2013: Safety profile of antimicrobial peptides: camel, citropin, protegrin, temporin a and lipopeptide on HaCaT keratinocytes. Acta Poloniae Pharmaceutica 70(5): 795-801
Plourde, P.V.; Jeha, S.; Hijiya, N.; Keller, F.G.; Silverman, L.B.; Rheingold, S.R.; Dreyer, Z.E.; Dahl, G.V.; Mercedes, T.; Lai, C.; Corn, T. 2014: Safety profile of asparaginase Erwinia chrysanthemi in a large compassionate-use trial. Pediatric Blood and Cancer 61(7): 1232-1238
Yoeruek, E.; Spitzer, M.S.; Tatar, O.; Aisenbrey, S.; Bartz-Schmidt, K.U.; Szurman, P. 2007: Safety profile of bevacizumab on cultured human corneal cells. Cornea 26(8): 977-982
Scaglione, F. 2012: Safety profile of bilastine: 2nd generation H1-antihistamines. European Review for Medical and Pharmacological Sciences 16(14): 1999-2005
Cole, B.J.; Provencher, M.T. 2007: Safety profile of bioabsorbable shoulder anchors. Arthroscopy: the Journal of Arthroscopic and Related Surgery: Official Publication of the Arthroscopy Association of North America and the International Arthroscopy Association 23(8): 912
Corominas, H.èc.; Sánchez-Eslava, L.; García, G.; Padró, I.; Aimarich, C.; Gonzàlez, J.; Franco, M.; Mur, E.; Sanchez, S.; Roldán, G.òr.; Iniesta, S.; Sesma, M.; Martín, J.; Rodriguez, M.C.; Capellan, M.R.; Gosálvez, C.; Garcia-Diaz, S.; Sáez, E.ón.; Luna, Y.; Plana, P. 2013: Safety profile of biological intravenous therapy in a rheumatoid arthritis patients cohort. Clinical nursing monitoring (Sebiol study). Reumatologia Clinica 9(2): 80-84
Cutroneo, P.M.; Isgrò, V.; Russo, A.; Ientile, V.; Sottosanti, L.; Pimpinella, G.; Conforti, A.; Moretti, U.; Caputi, A.P.; Trifirò, G. 2014: Safety profile of biological medicines as compared with non-biologicals: an analysis of the italian spontaneous reporting system database. Drug Safety 37(11): 961-970
Gordon, S.C.; Muir, A.J.; Lim, J.K.; Pearlman, B.; Argo, C.K.; Ramani, A.; Maliakkal, B.; Alam, I.; Stewart, T.G.; Vainorius, M.; Peter, J.; Nelson, D.R.; Fried, M.W.; Reddy, K.R. 2015: Safety profile of boceprevir and telaprevir in chronic hepatitis C: real world experience from HCV-TARGET. Journal of Hepatology 62(2): 286-293
Sabel, M.; Giese, A. 2008: Safety profile of carmustine wafers in malignant glioma: a review of controlled trials and a decade of clinical experience. Current Medical Research and Opinion 24(11): 3239-3257
Granizo, J.J.; Aguilar, L.; Gimenez, M.J.; Coronel, P.; Gimeno, M.; Prieto, J. 2009: Safety profile of cefditoren. a pooled analysis of data from clinical trials in community-acquired respiratory tract infections. Revista Espanola de Quimioterapia: Publicacion Oficial de la Sociedad Espanola de Quimioterapia 22(2): 57-61
Ptaszynska, A.; Johnsson, K.M.; Parikh, S.J.; de Bruin, T.W.A.; Apanovitch, A.Marie.; List, J.F. 2014: Safety profile of dapagliflozin for type 2 diabetes: pooled analysis of clinical studies for overall safety and rare events. Drug Safety 37(10): 815-829
Peura, D.A.; Metz, D.C.; Dabholkar, A.H.; Paris, M.M.; Yu, P.; Atkinson, S.N. 2009: Safety profile of dexlansoprazole MR, a proton pump inhibitor with a novel dual delayed release formulation: global clinical trial experience. Alimentary Pharmacology and Therapeutics 30(10): 1010-1021
Yeo, W.W.Y.; Hosseinkhani, H.; Rahman, S.A.; Rosli, R.; Domb, A.J.; Abdullah, S. 2014: Safety profile of dextran-spermine gene delivery vector in mouse lungs. Journal of Nanoscience and Nanotechnology 14(5): 3328-3336
Varenna, M.; Bertoldo, F.; Di Monaco, M.; Giusti, A.; Martini, G.; Rossini, M. 2013: Safety profile of drugs used in the treatment of osteoporosis: a systematical review of the literature. Reumatismo 65(4): 143-166
Caillet, C.él.; Chauvelot-Moachon, L.; Montastruc, J.-L.; Bagheri, H. 2012: Safety profile of enantiomers vs. racemic mixtures: it's the same?. British Journal of Clinical Pharmacology 74(5): 886-889
Petrov, I.; Grozdinski, L.; Kaninski, G.; Iliev, N.; Iloska, M.; Radev, A. 2011: Safety profile of endovascular treatment for chronic cerebrospinal venous insufficiency in patients with multiple sclerosis. Journal of Endovascular Therapy: An Official Journal of the International Society of Endovascular Specialists 18(3): 314-323
Gridelli, C.; Maione, P.; Galetta, D.; Rossi, A. 2007: Safety profile of erlotinib in patients with advanced non-small cell lung cancer with chronic renal failure. Journal of Thoracic Oncology: Official Publication of the International Association for the Study of Lung Cancer 2(1): 96-98
Davies, M.; Wilton, L.V.; Shakir, S.A.W. 2008: Safety profile of esomeprazole: results of a prescription-event monitoring study of 11 595 patients in England. Drug Safety 31(4): 313-323
Anderson, T.J.; Boden, W.E.; Desvigne-Nickens, P.; Fleg, J.L.; Kashyap, M.L.; McBride, R.; Probstfield, J.L. 2014: Safety profile of extended-release niacin in the AIM-HIGH trial. New England Journal of Medicine 371(3): 288-290
Akhtar, M.I.; Hamid, M.; Minai, F.; Wali, A.R.; Anwar-Ul-Haq; Aman-Ullah, M.; Ahsan, K. 2014: Safety profile of fast-track extubation in pediatric congenital heart disease surgery patients in a tertiary care hospital of a developing country: An observational prospective study. Journal of Anaesthesiology Clinical Pharmacology 30(3): 355-359
Muhammad, A.K.M.G.; Xiong, W.; Puntel, M.; Farrokhi, C.; Kroeger, K.M.; Salem, A.; Lacayo, L.; Pechnick, R.N.; Kelson, K.R.; Palmer, D.; Ng, P.; Liu, C.; Lowenstein, P.R.; Castro, M.G. 2012: Safety profile of gutless adenovirus vectors delivered into the normal brain parenchyma: implications for a glioma phase 1 clinical trial. Human Gene Therapy Methods 23(4): 271-284
Manocha, D.; Bansal, N.; Gumaste, P.; Brangman, S. 2013: Safety profile of high-dose statin therapy in geriatric patients with stroke. Southern Medical Journal 106(12): 658-664
Gatzioufas, Z.; Richoz, O.; Brugnoli, E.; Hafezi, F. 2013: Safety profile of high-fluence corneal collagen cross-linking for progressive keratoconus: preliminary results from a prospective cohort study. Journal of Refractive Surgery 29(12): 846-848
Spoerl, D.; Bircher, A.J.; Scherer, K. 2011: Safety profile of hymenoptera venom immunotherapy (VIT) in monosensitized patients: lack of new sensitization to nontreated insect venom. Journal of Investigational Allergology and Clinical Immunology 21(1): 22-27
Dargani, N.V.; Malhotra, A.K. 2014: Safety profile of iloperidone in the treatment of schizophrenia. Expert Opinion on Drug Safety 13(2): 241-246
Langley, R.G.; Papp, K.; Bissonnette, R.; Toth, D.; Matheson, R.; Hultquist, M.; White, B. 2010: Safety profile of intravenous and subcutaneous siplizumab, an anti-CD2 monoclonal antibody, for the treatment of plaque psoriasis: results of two randomized, double-blind, placebo-controlled studies. International Journal of Dermatology 49(7): 818-828
Sousa, A.M.; de Santana Neto, J.é; Guimaraes, G.M.N.; Cascudo, G.M.; Neto, J.é O.B.; Ashmawi, H.A. 2014: Safety profile of intravenous patient-controlled analgesia for breakthrough pain in cancer patients: a case series study. Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer 22(3): 795-801
Goulleret, N.; Mauvisseau, E.; Essevaz-Roulet, Mélanie.; Quinlivan, M.; Breuer, J. 2010: Safety profile of live varicella virus vaccine (Oka/Merck): five-year results of the European Varicella Zoster Virus Identification Program (EU VZVIP). Vaccine 28(36): 5878-5882
Kramer, K.; Smith, M.; Souweidane, M.M. 2014: Safety profile of long-term intraventricular access devices in pediatric patients receiving radioimmunotherapy for central nervous system malignancies. Pediatric Blood and Cancer 61(9): 1590-1592
Lazzarin, A.; Than, S.; Valluri, S.R.; Heera, J.; Mukwaya, G. 2012: Safety profile of maraviroc in patients coinfected with HIV-1 and hepatitis B or C included in the maraviroc expanded access program. HIV Clinical Trials 13(2): 83-89
Linden, P. 2007: Safety profile of meropenem: an updated review of over 6,000 patients treated with meropenem. Drug Safety 30(8): 657-668
Davies, M.; Wilton, L.; Shakir, S. 2013: Safety profile of modafinil across a range of prescribing indications, including off-label use, in a primary care setting in England: results of a modified prescription-event monitoring study. Drug Safety 36(4): 237-246
Kolaski, K.; Ajizian, S.J.; Passmore, L.; Pasutharnchat, N.; Koman, L.A.; Smith, B.P. 2008: Safety profile of multilevel chemical denervation procedures using phenol or botulinum toxin or both in a pediatric population. American Journal of Physical Medicine and Rehabilitation 87(7): 556-566
Mansi, L.; Thiery-Vuillemin, A.; Nguyen, T.; Bazan, F.; Calcagno, F.; Rocquain, J.; Demarchi, M.; Villanueva, C.; Maurina, T.; Pivot, X. 2010: Safety profile of new anticancer drugs. Expert Opinion on Drug Safety 9(2): 301-317
Donner, B.; Bader-Weder, S.; Schwarz, R.; Peng, M.M.; Smith, J.R.; Niranjan, V. 2011: Safety profile of oseltamivir during the 2009 influenza pandemic. Pharmacoepidemiology and Drug Safety 20(5): 532-543
Buggy, Y.; Layton, D.; Fogg, C.; Shakir, S.A.W. 2010: Safety profile of oxcarbazepine: results from a prescription-event monitoring study. Epilepsia 51(5): 818-829
Skalova, S.; Rejtar, P. 2010: Safety profile of paediatric percutaneous ultrasonography-guided renal biopsies. Singapore Medical Journal 51(6): 481-483
Rheims, S. 2011: Safety profile of phenobarbital: can meta-analyses tell us the truth?. Epileptic Disorders: International Epilepsy Journal with Videotape 13(4): 366-367
Wirth, T.; Hedman, M.; Mäkinen, K.; Manninen, H.; Immonen, A.; Vapalahti, M.; Ylä-Herttuala, S. 2006: Safety profile of plasmid/liposomes and virus vectors in clinical gene therapy. Current Drug Safety 1(3): 253-257
Destefano, F.; Pfeifer, D.; Nohynek, H. 2008: Safety profile of pneumococcal conjugate vaccines: systematic review of pre- and post-licensure data. Bulletin of the World Health Organization 86(5): 373-380
Gupta, A.; Kekunnaya, R.; Ramappa, M.; Vaddavalli, P.K. 2011: Safety profile of primary intraocular lens implantation in children below 2 years of age. British journal of ophthalmology 95(4): 477-480
Salgado, E.; Maneiro, J.R.; Carmona, L.; Gomez-Reino, J.J. 2014: Safety profile of protein kinase inhibitors in rheumatoid arthritis: systematic review and meta-analysis. Annals of the Rheumatic Diseases 73(5): 871-882
López Cortés, L.F.; Martínez, E.; von Wichmann, M.Án. 2013: Safety profile of rilpivirine: general and neuropsychiatric tolerability, safety in patients with hepatitis B or C viruses, and lipid profile. Enfermedades Infecciosas y Microbiologia Clinica 31(Suppl 2): 6-11
Agarwal, P.K.; Sammon, J.; Bhandari, A.; Dabaja, A.; Diaz, M.; Dusik-Fenton, S.; Satyanarayana, R.; Simone, A.; Trinh, Q-Dien.; Baize, B.; Menon, M. 2011: Safety profile of robot-assisted radical prostatectomy: a standardized report of complications in 3317 patients. European Urology 59(5): 684-698
Henley, D.B.; Sundell, K.L.; Sethuraman, G.; Dowsett, S.A.; May, P.C. 2014: Safety profile of semagacestat, a gamma-secretase inhibitor: IDENTITY trial findings. Current Medical Research and Opinion 30(10): 2021-2032
Malagari, K.; Pomoni, M.; Spyridopoulos, T.N.; Moschouris, H.; Kelekis, A.; Dourakis, S.; Alexopoulou, E.; Koskinas, J.; Angelopoulos, M.; Kornezos, J.; Pomoni, A.; Tandeles, S.; Marinis, A.; Rizos, S.; Kelekis, D. 2011: Safety profile of sequential transcatheter chemoembolization with DC Bead™: results of 237 hepatocellular carcinoma (HCC) patients. Cardiovascular and Interventional Radiology 34(4): 774-785
Eren, M.; Yıldırım, S.H.; Sivrikoz, I.A. 2010: Safety profile of six months lansoprozole treatment in children. Indian Journal of Gastroenterology: Official Journal of the Indian Society of Gastroenterology 29(6): 247-248
Marcellin, P.; Roberts, S.K.; Reddy, K.R.; Harrison, S.A.; Jensen, D.M.; Hadziyannis, S.; Diago, M.; Weltman, M.; Messinger, D.; Tatsch, F.; Rizzetto, M. 2012: Safety profile of standard- vs. high-dose peginterferon alfa-2a plus standard-dose ribavirin in HCV genotype 1/4 patients: pooled analysis from 5 randomized studies. Expert Opinion on Drug Safety 11(6): 901-909
Toth, P.P.; Morrone, D.; Weintraub, W.S.; Hanson, M.E.; Lowe, R.S.; Lin, J.; Shah, A.K.; Tershakovec, A.M. 2012: Safety profile of statins alone or combined with ezetimibe: a pooled analysis of 27 studies including over 22,000 patients treated for 6-24 weeks. International Journal of Clinical Practice 66(8): 800-812
Ellapparadja, P.; Husami, Y.; McLeod, I. 2014: Safety profile of sural nerve in posterolateral approach to the ankle joint: MRI study. European Journal of Orthopaedic Surgery and Traumatology: Orthopedie Traumatologie 24(4): 615-619
Akimoto, K.; Kusunoki, Y.; Nishio, S.; Takagi, K.; Kawai, S. 2008: Safety profile of tacrolimus in patients with rheumatoid arthritis. Clinical Rheumatology 27(11): 1393-1397
Schuller, E.; Klingler, A.; Dubischar-Kastner, K.; Dewasthaly, S.; Müller, Z. 2011: Safety profile of the Vero cell-derived Japanese encephalitis virus (JEV) vaccine IXIARO(®). Vaccine 29(47): 8669-8676
Lapi, F.; Tuccori, M.; Motola, D.; Pugi, A.; Vietri, M.; Montanaro, N.; Vaccheri, A.; Leoni, O.; Cocci, A.; Leone, R.; Conforti, A.; Moretti, U.; Sessa, E.; Mazzaglia, G.; Mugelli, A.; Mazzei, T.; Vannacci, A. 2010: Safety profile of the fluoroquinolones: analysis of adverse drug reactions in relation to prescription data using four regional pharmacovigilance databases in Italy. Drug Safety 33(9): 789-799
Liu, H.H. 2010: Safety profile of the fluoroquinolones: focus on levofloxacin. Drug Safety 33(5): 353-369
Van Bambeke, F.ço.; Tulkens, P.M. 2009: Safety profile of the respiratory fluoroquinolone moxifloxacin: comparison with other fluoroquinolones and other antibacterial classes. Drug Safety 32(5): 359-378
Cottin, P.; Niedrig, M.; Domingo, C. 2013: Safety profile of the yellow fever vaccine Stamaril®: a 17-year review. Expert Review of Vaccines 12(11): 1351-1368
Leizorovicz, A.; Siguret, V.; Mottier, D.; Leizorovicz, A.; Siguret, V.; Mottier, D.; Clonier, F.; Janas, M.; Stinson, J.; Townshend, G.; Maddalena, M.; Leizorovicz, A.; Siguret, V.; Mottier, D.; Bauersachs, R.; Ribera Casado, J.é-M.; Maksimovic, Z.; Gutowski, P.; Fiessinger, J.N.ël.; Girard, P.; Parent, F.; Boddaert, J.; Bost, V.; Steg, G.; Baumelou, A.; Bounameaux, H.; Torres, F.; Matthes, B.K.; Tørnqvist, K.; Pedersen, T.F.; Rasmussen, I.; Clonier, F.; Janas, M.; Stinson, J. 2011: Safety profile of tinzaparin versus subcutaneous unfractionated heparin in elderly patients with impaired renal function treated for acute deep vein thrombosis: the Innohep® in Renal Insufficiency Study (IRIS). Thrombosis Research 128(1): 27-34
Bock, F.; Onderka, J.; Rummelt, C.; Dietrich, T.; Bachmann, B.ör.; Kruse, F.E.; Schlötzer-Schrehardt, U.; Cursiefen, C. 2009: Safety profile of topical VEGF neutralization at the cornea. Investigative Ophthalmology and Visual Science 50(5): 2095-2102
Taylor, R.S.; Fotopoulos, G.; Maibach, H. 2011: Safety profile of topical diclofenac: a meta-analysis of blinded, randomized, controlled trials in musculoskeletal conditions. Current Medical Research and Opinion 27(3): 605-622
González Martín, A. 2011: Safety profile of trabectedin in combination with liposomal pegylated doxorrubicin in relapsed ovarian carcinoma: considerations for optimal management. International Journal of Gynecological Cancer: Official Journal of the International Gynecological Cancer Society 21(Suppl 1): S6-S8
Lapchak, P.A.; Han, M.-K.; Salgado, K.F.; Streeter, J.; Zivin, J.A. 2008: Safety profile of transcranial near-infrared laser therapy administered in combination with thrombolytic therapy to embolized rabbits. Stroke 39(11): 3073-3078
Robinson-Papp, J.; Simpson, D.M. 2007: Safety profile of treatment in diabetic peripheral neuropathic pain. Pain Medicine 8(Suppl 2): S43-S49
Passerotti, C.C.; Begg, N.; Penna, F.J.; Passerotti, A.M.A.M.S.; Leite, K.R.M.; Antunes, A.A.; Srougi, M.; Retik, A.B.; Nguyen, H.T. 2009: Safety profile of trocar and insufflation needle access systems in laparoscopic surgery. Journal of the American College of Surgeons 209(2): 222-232
Faulkner, M.A.; Burke, R.A. 2013: Safety profile of two novel antiepileptic agents approved for the treatment of refractory partial seizures: ezogabine (retigabine) and perampanel. Expert Opinion on Drug Safety 12(6): 847-855
Thurston, T.E.; Andrades, P.; Phillips, R.A.; Ray, P.D.; Grant, J.H. 2009: Safety profile of wire osteosynthesis in craniosynostosis surgery. Journal of Craniofacial Surgery 20(4): 1154-1158
Goni, V.G.; Chhabra, R.; Gupta, A.; Marwaha, N.; Dhillon, M.S.; Pebam, S.; Gopinathan, N.R.; Bangalore Kantharajanna, S. 2014: Safety profile, feasibility and early clinical outcome of cotransplantation of olfactory mucosa and bone marrow stem cells in chronic spinal cord injury patients. Asian Spine Journal 8(4): 484-490
Busse, W.W.; Katial, R.; Gossage, D.; Sari, S.; Wang, B.; Kolbeck, R.; Coyle, A.J.; Koike, M.; Spitalny, G.L.; Kiener, P.A.; Geba, G.P.; Molfino, N.A. 2010: Safety profile, pharmacokinetics, and biologic activity of MEDI-563, an anti-IL-5 receptor alpha antibody, in a phase i study of subjects with mild asthma. Journal of Allergy and Clinical Immunology 125(6): 1237-1244.E2
Pruett, T.L.; McGory, R.W.; Wright, F.H.; Pescovitz, M.D.; Yang, H.; McClain, J.B. 2009: Safety profile, pharmacokinetics, and pharmacodynamics of siplizumab, a humanized anti-CD2 monoclonal antibody, in renal allograft recipients. Transplantation Proceedings 41(9): 3655-3661
Jung, S.-J.; Kasala, D.; Choi, J.-W.; Lee, S.-H.; Hwang, J.K.; Kim, S.W.; Yun, C.-O. 2015: Safety profiles and antitumor efficacy of oncolytic adenovirus coated with bioreducible polymer in the treatment of a CAR negative tumor model. Biomacromolecules 16(1): 87-96
Mendes, D.; Alves, C.; Batel-Marques, F. 2014: Safety profiles of adalimumab, etanercept and infliximab: a pharmacovigilance study using a measure of disproportionality in a database of spontaneously reported adverse events. Journal of Clinical Pharmacy and Therapeutics 39(3): 307-313
Malik, D.; Tarek, M.; Caceres del Carpio, J.; Ramirez, C.; Boyer, D.; Kenney, M.C.; Kuppermann, B.D. 2014: Safety profiles of anti-VEGF drugs: bevacizumab, ranibizumab, aflibercept and ziv-aflibercept on human retinal pigment epithelium cells in culture. British Journal of Ophthalmology 98(Suppl 1): I11-I16
Yamamoto, Y.; Iwase, H. 2008: Safety profiles of aromatase inhibitors and selective estrogen-receptor modulators in the treatment of early breast cancer. International Journal of Clinical Oncology 13(5): 384-394
Fuloria, J. 2012: Safety profiles of current antiangiogenic therapies for metastatic colorectal cancer. Oncotargets and Therapy 5: 133-142
Hotta, K.; Kiura, K. 2011: Safety profiles of erlotinib therapy in patients with advanced non-small-cell lung cancer. Expert Review of Anticancer Therapy 11(7): 991-997
Ishii, M.; Nagaoka, S.; Tatsumi, M.; Kitagawa, N.; Taketsuna, M.; Okubo, S.; Maeda, K.; Takeuchi, K. 2011: Safety profiles of gemcitabine hydrochloride(GEMZAR®)in Japanese clinical studies. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 38(13): 2607-2616
Tinsley, S.M. 2010: Safety profiles of second-line tyrosine kinase inhibitors in patients with chronic myeloid leukaemia. Journal of Clinical Nursing 19(9-10): 1207-1218
Perez, E.A. 2007: Safety profiles of tamoxifen and the aromatase inhibitors in adjuvant therapy of hormone-responsive early breast cancer. Annals of Oncology: Official Journal of the European Society for Medical Oncology 18(Suppl 8): Viii 26-Viii 35
Hassanein, A.A.G.; Hanna, R.S. 2007: Safety programmes in the Egyptian construction industry. International Journal of Injury Control and Safety Promotion 14(4): 251-257
Schorr, J.P.; Hamdar, S.H. 2014: Safety propensity index for signalized and unsignalized intersections: exploration and assessment. Accident; Analysis and Prevention 71: 93-105
Dick, T. 2008: Safety questions. Are you providing what your crews need to stay safe?. Ems Magazine 37(3): 52
Kingman, M.S.; Chin, K. 2013: Safety recommendations for administering intravenous prostacyclins in the hospital. Critical Care Nurse 33(5): 32-39
Hirayama, Y. 2010: Safety regulation for medicines and foodstuffs. Asian Pacific Journal of Cancer Prevention: Apjcp 11(1): 22-23
Cho, W.-K. 2009: Safety regulation for the design approval of special form radioactive sources. Applied Radiation and Isotopes: Including Data Instrumentation and Methods for use in Agriculture Industry and Medicine 67(7-8): 1304-1306
Hamada, N.; Ogino, H.; Fujimichi, Y. 2012: Safety regulations of food and water implemented in the first year following the Fukushima nuclear accident. Journal of Radiation Research 53(5): 641-671
Chenot, J.-F.ço.; Hua, T.D.; Abu Abed, M.; Schneider-Rudt, H.; Friede, T.; Schneider, S.; Vormfelde, S.V. 2014: Safety relevant knowledge of orally anticoagulated patients without self-monitoring: a baseline survey in primary care. Bmc Family Practice 15: 104
Rajadhyaksha, V. 2012: Safety reporting - Making it safely effective or effectively safe?. Perspectives in Clinical Research 3(3): 85-86
Watanabe, N.; Omori, I.M.; Nakagawa, A.; Cipriani, A.; Barbui, C.; McGuire, H.; Churchill, R.; Furukawa, T.A. 2010: Safety reporting and adverse-event profile of mirtazapine described in randomized controlled trials in comparison with other classes of antidepressants in the acute-phase treatment of adults with depression: systematic review and meta-analysis. Cns Drugs 24(1): 35-53
Yazici, Y. 2009: Safety reporting in randomized clinical trials - a need for improvement. Bulletin of the Nyu Hospital for Joint Diseases 67(2): 209-210
Pak, J.; Chang, J-Jin.; Lee, J.Hun.; Lee, S.Hee. 2013: Safety reporting on implantation of autologous adipose tissue-derived stem cells with platelet-rich plasma into human articular joints. Bmc Musculoskeletal Disorders 14: 337
Mascherek, A.; Kobler, I.; Bezzola, P. 2014: Safety requires good communication. Krankenpflege. Soins Infirmiers 107(6): 68-70
Ternov, S. 2009: Safety requires hard work and harsh imposition from the authorities. Lakartidningen 106(30-31): 1920
Tong, Y.; Yang, J.; Li, C.; He, W. 2011: Safety research in Chinese medicines based on application of data mining. Zhongguo Zhong Yao Za Zhi 36(21): 3047-3050
Aitken, M.E.; Bowman, S.M.; Card-Higginson, P.; Carson, J.E.; Lin, T.M.; Thompson, J.W.; Zhao, Y. 2008: Safety restraint use linked to hospital use and charges in Arkansas. Journal of the Arkansas Medical Society 104(7): 161-164
Konstantinova, M.; Loizeau, V.; Pilorget, V.; Cali, A.; Danne, T. 2014: Safety results from OCAPI: a European Observational Cohort Study of insulin glulisine-treated children aged 6-12 years with type 1 diabetes. Experimental and Clinical Endocrinology and Diabetes: Official Journal German Society of Endocrinology and German Diabetes Association 122(9): 523-527
Farnier, M. 2011: Safety review of combination drugs for hyperlipidemia. Expert Opinion on Drug Safety 10(3): 363-371
Ludlam, W.H.; Anthony, L. 2011: Safety review: dose optimization of somatostatin analogs in patients with acromegaly and neuroendocrine tumors. Advances in Therapy 28(10): 825-841
Montana, M.; Verhaeghe, P.; Ducros, C.; Terme, T.; Vanelle, P.; Rathelot, P. 2010: Safety review: squalene and thimerosal in vaccines. Therapie 65(6): 533-541
Woratanarat, P.; Ingsathit, A.; Chatchaipan, P.; Suriyawongpaisal, P. 2013: Safety riding program and motorcycle-related injuries in Thailand. Accident; Analysis and Prevention 58: 115-121
López-Arquillos, A.; Rubio-Romero, J.C.; Gibb, A.G.F.; Gambatese, J.A. 2014: Safety risk assessment for vertical concrete formwork activities in civil engineering construction. Work 49(2): 183-192
Aminbakhsh, S.; Gunduz, M.; Sonmez, R. 2013: Safety risk assessment using analytic hierarchy process (AHP) during planning and budgeting of construction projects. Journal of Safety Research 46: 99-105
Jenke, D. 2015: Safety risk categorization of organic extractables associated with polymers used in packaging, delivery and manufacturing systems for parenteral drug products. Pharmaceutical Research 32(3): 1105-1127
Romano, M. 2007: Safety risk? Members seek info on residents' hours. Modern healthcare 37(18): 34
Morales, D.R.; Lipworth, B.J.; Guthrie, B.; Jackson, C.; Donnan, P.T.; Santiago, V.H. 2014: Safety risks for patients with aspirin-exacerbated respiratory disease after acute exposure to selective nonsteroidal anti-inflammatory drugs and COX-2 inhibitors: Meta-analysis of controlled clinical trials. Journal of Allergy and Clinical Immunology 134(1): 40-45
Herman, R.A.; Song, P.; Zhuang, M. 2011: Safety risks of cryptic reading frames and gene disruption due to crop transgenesis: what are the odds?. Gm Crops 2(1): 4-6
Marzella, L.; Blank, M.; Gelperin, K.; Johann-Liang, R. 2007: Safety risks with gadolinium-based contrast agents. Journal of magnetic resonance imaging: JMRI 26(3): 816; author reply 817
Dressler, R.; Consiglio-Ward, L.; Moore, C.; Savoy, M.; Aboff, B.; Salam, T.; Jordan, J.; Collier, V.U. 2014: Safety science as second nature: training residents to use best practices instinctively to keep patients safe. Physician executive 40(3): 66-69
Wagner, D.P.; Sparks, H.V.; Fink, G. 2010: Safety science meets basic science in problem-based learning. Medical Education 44(11): 1125-1126
Kawasaki, Y.; Hirano, T.; Miyatake, K.; Fujii, K.; Takeda, Y. 2014: Safety screw fixation technique in a case of coracoid base fracture with acromioclavicular dislocation and coracoid base cross-sectional size data from a computed axial tomography study. Archives of Orthopaedic and Trauma Surgery 134(7): 913-918
Toriizuka, K.; Tsutani, K. 2008: Safety securing and safety monitoring of herbal medicines, finished herbal products and supplements. Yakugaku Zasshi: Journal of the Pharmaceutical Society of Japan 128(6): 835-836
Katz-Navon, T.; Naveh, E.; Stern, Z. 2007: Safety self-efficacy and safety performance: potential antecedents and the moderation effect of standardization. International Journal of Health Care Quality Assurance 20(7): 572-584
Swift, L. 2010: Safety sets sail in San Diego. Occupational Health and Safety 79(9): 46
Pontes, H.; Clément, M.; Rollason, V. 2014: Safety signal detection: the relevance of literature review. Drug Safety 37(7): 471-479
Fernando, A.B.P.; Urcelay, G.P.; Mar, A.C.; Dickinson, A.; Robbins, T.W. 2014: Safety signals as instrumental reinforcers during free-operant avoidance. Learning and Memory 21(9): 488-497
Genud-Gabai, R.; Klavir, O.; Paz, R. 2013: Safety signals in the primate amygdala. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 33(46): 17986-17994
Christianson, J.P.; Jennings, J.H.; Ragole, T.; Flyer, J.G.N.; Benison, A.M.; Barth, D.S.; Watkins, L.R.; Maier, S.F. 2011: Safety signals mitigate the consequences of uncontrollable stress via a circuit involving the sensory insular cortex and bed nucleus of the stria terminalis. Biological Psychiatry 70(5): 458-464
Calda, P. 2009: Safety signals of 17-OHP-C use in pregnancy and efficacy in the prevention of preterm birth. Journal of Maternal-Fetal and Neonatal Medicine: the Official Journal of the European Association of Perinatal Medicine the Federation of Asia and Oceania Perinatal Societies the International Society of Perinatal Obstetricians 22(6): 540-542
Macpherson, A.K.; Jones, J.; Rothman, L.; Macarthur, C.; Howard, A.W. 2010: Safety standards and socioeconomic disparities in school playground injuries: a retrospective cohort study. Bmc Public Health 10: 542
Levin, S.A. 1988: Safety standards for the environmental release of genetically engineered organisms. Trends in Ecology and Evolution 3(4): S47-S49
Waldman, S.V.; Grancelli, H.; Yaman, B.; Cohen Arazi, H. 2011: Safety standards for the use of magnetic resonance in patients with cardiovascular devices. Medicina 71(1): 78-82
Bier, D.M. 2012: Safety standards in infant nutrition: a United States perspective. Annals of Nutrition and Metabolism 60(3): 192-195
Cole, H.P.; Piercy, L.R.; Heinz, K.L.; Westneat, S.C.; Arrowsmith, H.E.; Raymond, K.M. 2009: Safety status of farm tractors that operate on public highways in four rural Kentucky counties. Journal of Agricultural Safety and Health 15(3): 207-223
Guédon, A.C.P.; Wauben, L.S.G.L.; Overvelde, M.; Blok, J.H.; van der Elst, M.; Dankelman, J.; van den Dobbelsteen, J.J. 2014: Safety status system for operating room devices. Technology and Health Care: Official Journal of the European Society for Engineering and Medicine 22(6): 795-803
Shokida, M.F.; Gabriel, J.; Sanchez, C. 2007: Safety stitch: a modification to postoperatively adjustable suture strabismus surgery of the inferior rectus muscle. Binocular Vision and Strabismus Quarterly 22(4): 210-215
Terezakis, S.A.; Pronovost, P.; Harris, K.; Deweese, T.; Ford, E. 2011: Safety strategies in an academic radiation oncology department and recommendations for action. Joint Commission Journal on Quality and Patient Safety 37(7): 291-299
Galloway, S.M. 2013: Safety strategy: what great leaders do well. Occupational Health and Safety 82(11): 62
Williams, L.D.; Burdock, G.A.; Shin, E.; Kim, S.; Jo, T.H.; Jones, K.N.; Matulka, R.A. 2010: Safety studies conducted on a proprietary high-purity aloe vera inner leaf fillet preparation, Qmatrix. Regulatory Toxicology and Pharmacology: Rtp 57(1): 90-98
Williams, L.D.; Burdock, G.A.; Edwards, J.A.; Beck, M.; Bausch, J. 2009: Safety studies conducted on high-purity trans-resveratrol in experimental animals. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association 47(9): 2170-2182
Mburu, N.; Obiero, J.A.; Waititu, K.; Mwaura, B.N.; Orawo, J.O.; Farah, I.O.; Mwethera, P.G. 2009: Safety studies of a recently developed microbicidal contraceptive gel (UniPron) in female baboons (Papio anubis). African Journal of Reproductive Health 13(4): 95-104
Abe, Y. 2011: Safety studies of nanomaterials about intracellular distribution and genotoxicity. Yakugaku Zasshi: Journal of the Pharmaceutical Society of Japan 131(2): 215-219
Traul, K.A.; Romero, J.B.; Brayton, C.; DeTolla, L.; Forbes-McBean, N.; Halquist, M.S.; Karnes, H.T.; Sarabia-Estrada, R.; Tomlinson, M.J.; Tyler, B.M.; Ye, X.; Zadnik, P.; Guarnieri, M. 2015: Safety studies of post-surgical buprenorphine therapy for mice. Laboratory Animals 49(2): 100-110
Kaur, S.; Prabha, V.; Kaur, K. 2011: Safety studies of sperm agglutinating factor produced by Staphylococcus aureus as a vaginal contraceptive: in vivo studies. Gynecological endocrinology: the official journal of the International Society of Gynecological Endocrinology 27(11): 956-960
Knowles, M.K.; Nadin-Davis, S.A.; Sheen, M.; Rosatte, R.; Mueller, R.; Beresford, A. 2009: Safety studies on an adenovirus recombinant vaccine for rabies (AdRG1.3-ONRAB) in target and non-target species. Vaccine 27(47): 6619-6626
Jenks, N.; Myers, R.; Greiner, S.M.; Thompson, J.; Mader, E.K.; Greenslade, A.; Griesmann, G.E.; Federspiel, M.J.; Rakela, J.; Borad, M.J.; Vile, R.G.; Barber, G.N.; Meier, T.R.; Blanco, M.C.; Carlson, S.K.; Russell, S.J.; Peng, K.-W. 2010: Safety studies on intrahepatic or intratumoral injection of oncolytic vesicular stomatitis virus expressing interferon-beta in rodents and nonhuman primates. Human Gene Therapy 21(4): 451-462
LeBlanc, A.K.; Naik, S.; Galyon, G.D.; Jenks, N.; Steele, M.; Peng, K.-W.; Federspiel, M.J.; Donnell, R.; Russell, S.J. 2013: Safety studies on intravenous administration of oncolytic recombinant vesicular stomatitis virus in purpose-bred beagle dogs. Human Gene Therapy. Clinical Development 24(4): 174-181
Heimbach, J.T.; Marone, P.A.; Hunter, J.M.; Nemzer, B.V.; Stanley, S.M.; Kennepohl, E. 2010: Safety studies on products from whole coffee fruit. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association 48(8-9): 2517-2525
Hasler, P.W.; Bloch, S.B.; Villumsen, J.ør.; Fuchs, J.; Lund-Andersen, H.; Larsen, M. 2015: Safety study of 38,503 intravitreal ranibizumab injections performed mainly by physicians in training and nurses in a hospital setting. Acta Ophthalmologica 93(2): 122-125
Benninger, D.H.; Lomarev, M.; Wassermann, E.M.; Lopez, G.; Houdayer, E.; Fasano, R.E.; Dang, N.; Hallett, M. 2009: Safety study of 50 Hz repetitive transcranial magnetic stimulation in patients with Parkinson's disease. Clinical Neurophysiology: Official Journal of the International Federation of Clinical Neurophysiology 120(4): 809-815
Li, W.-j.; Dai, Y.; Han, Y.; Qiu, Z.-f.; Xie, J.; Zuo, L.-y.; Li, Y.-l.; Li, T.-s. 2011: Safety study of 52-week highly active antiretroviral therapy in 198 HIV/AIDS Chinese patients. Zhonghua Yi Xue Za Zhi 91(19): 1318-1322
Salegio, E.A.; Samaranch, L.; Jenkins, R.W.; Clarke, C.J.; Lamarre, C.; Beyer, J.; Kells, A.P.; Bringas, J.; Sebastian, W.S.; Richardson, R.M.; Rosenbluth, K.H.; Hannun, Y.A.; Bankiewicz, K.S.; Forsayeth, J. 2012: Safety study of adeno-associated virus serotype 2-mediated human acid sphingomyelinase expression in the nonhuman primate brain. Human Gene Therapy 23(8): 891-902
Dover, S.E.; Aroutcheva, A.A.; Faro, S.; Chikindas, M.L. 2007: Safety study of an antimicrobial peptide lactocin 160, produced by the vaginal Lactobacillus rhamnosus. Infectious Diseases in Obstetrics and Gynecology 2007: 78248
Wilkie, D.A.; Stone Hoy, S.; Gemensky-Metzler, A.; Colitz, C.M.H. 2015: Safety study of capsular tension ring use in canine phacoemulsification and IOL implantation. Veterinary Ophthalmology 18(5): 409-415
Motoi, M.; Ohno, N. 2012: Safety study of culinary-medicinal Royal Sun Agaricus, Agaricus brasiliensis S. Wasser et al. KA21 (higher Basidiomycetes) assessed by prokaryotic as well as eukaryotic systems. International Journal of Medicinal Mushrooms 14(2): 135-148
Mao, Z.-H.; Jin, J.; Li, J.-W.; Deng, Y.-X.; Wang, M.-L.; Lu, A.-G.; Hu, W.-G.; Zheng, M.-H. 2009: Safety study of laparoscopic surgery for colorectal cancer in elderly patients. Zhonghua Wei Chang Wai Ke Za Zhi 12(3): 244-248
Ley, M.; Vivanco, R.; Massot, A.; Jiménez, J.; Roquer, J.; Rocamora, R. 2014: Safety study of long-term video-electroencephalogram monitoring. Neurologia 29(1): 21-26
Higashihara, E.; Nutahara, K.; Okegawa, T.; Tanbo, M.; Mori, H.; Miyazaki, I.; Nitatori, T.; Kobayashi, K. 2015: Safety study of somatostatin analogue octreotide for autosomal dominant polycystic kidney disease in Japan. Clinical and Experimental Nephrology 19(4): 746-752
Chan, N.P.Y.; Shek, S.Y.N.; Yu, C.S.; Ho, S.G.Y.; Yeung, C.K.; Chan, H.H.L. 2011: Safety study of transcutaneous focused ultrasound for non-invasive skin tightening in Asians. Lasers in Surgery and Medicine 43(5): 366-375
Sirriyeh, R.; Lawton, R.; Armitage, G.; Gardner, P.; Ferguson, S. 2012: Safety subcultures in health-care organizations and managing medical error. Health Services Management Research 25(1): 16-23
Pater, R. 2014: Safety super vision. Occupational Health and Safety 83(6): 82
Izumi, T. 2007: Safety support for medical device: 2. Concrete contents of revision and points to be considered. Nihon Hoshasen Gijutsu Gakkai Zasshi 63(8): 930-932
Izumi, T. 2007: Safety support for medical device: 3. Business: what we should do for control. Nihon Hoshasen Gijutsu Gakkai Zasshi 63(9): 1119-1120
Izumi, T. 2007: Safety support for medical device: an outline revision and highlights of the medical law. Nihon Hoshasen Gijutsu Gakkai zasshi 63(7): 823-824
Ichikawa, T. 2012: Safety surgery is priority for anesthesiologists--the introduction of WHO SSSL checklist and surgical Apgar score. Masui. Japanese Journal of Anesthesiology 61 Suppl: S189-S195
Sacks, G.S. 2012: Safety surrounding parenteral nutrition systems. JPEN. Journal of Parenteral and Enteral Nutrition 36(2 Suppl): 20s-22s
van der Maas, N.A.T.; David, S.; Kemmeren, J.M.; Vermeer-de Bondt, P.E. 2007: Safety surveillance in the National Vaccination Programme; fewer adverse events with the DTP-IPV-Hib vaccine after the transition to an acellular pertussis component in 2005. Nederlands Tijdschrift Voor Geneeskunde 151(49): 2732-2737
Caillet, Céline.; Durrieu, G.; Jacquet, A.; Faucher, A.; Ouaret, S.; Perrault-Pochat, M-Christine.; Kreft-Jaïs, C.; Castot, A.; Montastruc, J-Louis.; Autret-Leca, E.; Baldin B, B.; Bavoux, F.; Bénard-Laribière, A.; Biour, M.; Beyens, M.N.; Colin, F.; Cocquerel, A.; Crepin, S.; Décréau-Gaillon, G.; Dos Santos, S.; Eftekhari, P.; Favrelière, S.; Gautier, S.; Gras-Champel, V.; Javot, L.; Jean-Pastor, M.J.; Le Beller, C.; Lebrun-Vignes, B.; Millaret, A.; Perrazi, A.; Pinzani, V.; Riché, C.; Schir, E.; Sgro, C.; Tebacher-Alt, M.; Trenque, T.; Valnet-Rabier, M.B.; Veyrac, G. 2011: Safety surveillance of influenza A(H1N1)v monovalent vaccines during the 2009-2010 mass vaccination campaign in France. European journal of clinical pharmacology 67(6): 649-651
Carcione, D.; Blyth, C.C.; Richmond, P.C.; Mak, D.B.; Effler, P.V. 2013: Safety surveillance of influenza vaccine in pregnant women. Australian and New Zealand Journal of Obstetrics and Gynaecology 53(1): 98-99
Schuemie, M.J. 2012: Safety surveillance of longitudinal databases: further methodological considerations. Pharmacoepidemiology and Drug Safety 21(6): 670
Norén, G.N.; Hopstadius, J.; Bate, A.; Edwards, I.R. 2011: Safety surveillance of longitudinal databases: methodological considerations. Pharmacoepidemiology and Drug Safety 20(7): 714-717
Mischley, L.K.; Vespignani, M.F.; Finnell, J.S. 2013: Safety survey of intranasal glutathione. Journal of Alternative and Complementary Medicine 19(5): 459-463
Klein, I. 1946: Safety switch for short-wave machine. New York State Journal of Medicine 46: 746
Sibbitt, W.L.; Band, P.A.; Kettwich, L.G.; Sibbitt, C.R.; Sibbitt, L.J.; Bankhurst, A.D. 2011: Safety syringes and anti-needlestick devices in orthopaedic surgery. Journal of Bone and Joint Surgery. American Volume 93(17): 1641-1649
Sivasankar, S.; Karmegam, K.; Bahri, M.T.Shamsul.; Naeini, H.Sadeghi.; Kulanthayan, S. 2014: Safety system for child pillion riders of underbone motorcycles in Malaysia. Traffic Injury Prevention 15(6): 564-571
Adnadjevic, D.; Lorrain, T.; Graven-Nielsen, T. 2013: Safety system for moving coil pressure algometer. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference 2013: 5356-5359
Reed, R.K.; Bell, J.C. 2013: Safety systems and access control in the National Ignition Facility. Health Physics 104(6): 563-570
Imamura, T.; Sakamoto, R.; Sasaki, T.; Kokumai, N.; Ohgitani, T.; Sawata, A.; Lin, Z.; Sakaguchi, M. 2010: Safety test and field study of an inactivated oil-adjuvanted H5N1 avian influenza vaccine. Journal of Veterinary Medical Science 72(11): 1455-1463
Post, P.L. 2010: Safety testing and use of insect cells for recombinant protein production. Pda Journal of Pharmaceutical Science and Technology 64(5): 396-418
Giansanti, F.; Schiavone, N.; Papucci, L.; Bitossi, A.; Andreucci, E.; Pontenani, F.; Cutrì, M.; Menchini, U. 2014: Safety testing of blue vital dyes using cell culture models. Journal of Ocular Pharmacology and Therapeutics: the Official Journal of the Association for Ocular Pharmacology and Therapeutics 30(5): 406-412
Montag, T.; Spreitzer, I.; Löschner, B.; Unkelbach, U.; Flory, E.; Sanzenbacher, R.; Schwanig, M.; Schneider, C.K. 2007: Safety testing of cell-based medicinal products: opportunities for the monocyte activation test for pyrogens. Altex 24(2): 81-89
Petrarca, R.; Richardson, M.; Douiri, A.; Nau, J.; McHugh, D.; Stangos, A.N.; Jackson, T.L. 2013: Safety testing of epimacular brachytherapy with microperimetry and indocyanine green angiography: 12-month results. Retina 33(6): 1232-1240
Hillenkamp, J.; Dydykina, S.; Klettner, A.; Treumer, F.; Vasold, R.; Bäumler, W.; Roider, J. 2010: Safety testing of indocyanine green with different surgical light sources and the protective effect of optical filters. Retina 30(10): 1685-1691
Backes, J. 2007: Safety testing of medical devices: IEC 62353 explained. Medical Device Technology 18(7): 46-47
Pang, K.S. 2009: Safety testing of metabolites: Expectations and outcomes. Chemico-Biological Interactions 179(1): 45-59
Birnbaum, L.S.; Stokes, W.S. 2010: Safety testing: moving toward alternative methods. Environmental Health Perspectives 118(1): A12-A13
Larsson, L.-G.ör. 2008: Safety thinking in surgery. Lakartidningen 105(11): 832
Jeffs, L.; Kitto, S.; Merkley, J.; Lyons, R.F.; Bell, C.M. 2012: Safety threats and opportunities to improve interfacility care transitions: insights from patients and family members. Patient Preference and Adherence 6: 711-718
Nishida, K.; Kamei, M.; Du, Z.-j.; Xie, P.; Yamamoto, T.; Suzuki, M.; Sakaguchi, H.; Nishida, K. 2011: Safety threshold of intravitreal activated protein-C. Graefe's Archive for Clinical and Experimental Ophthalmology 249(6): 833-838
Powell, A.G.M.T.; Paterson-Brown, S. 2011: Safety through education. FY1 doctors still poor in prescribing intravenous fluids. Bmj 342: D2741
Toft, B. 2011: Safety through education. Human factors for all?. Bmj 342: D3025
Thompson, M.J. 2011: Safety through education. Prevention is better than the law. Bmj 342: D3028
Staines, R. 2009: Safety through equality. Nursing Times 105(6): 8-10
Ong, M.-S.; Coiera, E. 2010: Safety through redundancy: a case study of in-hospital patient transfers. Quality and Safety in Health Care 19(5): E32
Woo, E.; Virani, J. 2012: Safety tips for intense pulsed light therapy. Nursing 42(2): 20
Mulhern, B.; Lentz, T.J. 2010: Safety tips for roadway work zones. Occupational Health and Safety 79(1): 18-20
Anonymous 2008: Safety tips for the nursery and around the house. Child Health Alert 26: 5
Koukopoulos, P. 2007: Safety training: we're lovin' it. Occupational Health and Safety 76(6): 73-75
Ujam, A.; Awad, Z.; Wong, G.; Tatla, T.; Farrell, R. 2012: Safety trial of Floseal(®) haemostatic agent in head and neck surgery. Annals of the Royal College of Surgeons of England 94(5): 336-339
Sofuni, A.; Moriyasu, F.; Sano, T.; Itokawa, F.; Tsuchiya, T.; Kurihara, T.; Ishii, K.; Tsuji, S.; Ikeuchi, N.; Tanaka, R.; Umeda, J.; Tonozuka, R.; Honjo, M.; Mukai, S.; Fujita, M.; Itoi, T. 2014: Safety trial of high-intensity focused ultrasound therapy for pancreatic cancer. World Journal of Gastroenterology 20(28): 9570-9577
Friedlander, J. 2014: Safety under the sun. Occupational Health and Safety 83(6): 20
Gascón, P. 2008: Safety update on erythropoiesis-stimulating agents: trials within and outside the accepted indications. Oncologist 13 Suppl. 3: 4-10
Abshire, T. 2008: Safety update on recombinant factor VIIa in the treatment of congenital and acquired hemophilia. Seminars in Hematology 45(2 Suppl. 1): S3-S6
Pedersen, M. 2007: Safety update on the possible causal relationship between gadolinium-containing MRI agents and nephrogenic systemic fibrosis. Journal of Magnetic Resonance Imaging: Jmri 25(5): 881-883
Abshire, T.; Kenet, G. 2008: Safety update on the use of recombinant factor VIIa and the treatment of congenital and acquired deficiency of factor VIII or IX with inhibitors. Haemophilia: the Official Journal of the World Federation of Hemophilia 14(5): 898-902
Moltenis, Mélanie.; Valnet-Rabier, M-Blanche.; Leroy, Jël.; Kantelip, J-Pierre. 2012: Safety update on vaccination during pregnancy. Therapie 67(5): 457-463
Blaiss, M.S. 2011: Safety update regarding intranasal corticosteroids for the treatment of allergic rhinitis. Allergy and Asthma Proceedings 32(6): 413-418
Zheng, B.-H.; Luo, J.-H.; Fu, Q.; Qin, Y.-W.; Hu, L.-L. 2012: Safety value of contaminant in water pollution accident based on human health risk. Huan Jing Ke Xue= Huanjing Kexue 33(2): 337-341
Hayashi, E.; Imai, T.; Niimi, H. 2011: Safety verification for reuse of PET and glass bottles. Shokuhin Eiseigaku Zasshi. Journal of the Food Hygienic Society of Japan 52(2): 112-116
Kato, S.; Andoh, H.; Gamoh, M.; Yamaguchi, T.; Murakawa, Y.; Shimodaira, H.; Takahashi, S.; Mori, T.; Ohori, H.; Maeda, S.-i.; Suzuki, T.; Kato, S.; Akiyama, S.; Sasaki, Y.; Yoshioka, T.; Ishioka, C. 2012: Safety verification trials of mFOLFIRi and sequential IRIS + bevacizumab as first- or second-line therapies for metastatic colorectal cancer in Japanese patients. Oncology 83(2): 101-107
Scotland, G.S.; McNamee, P.; Peddie, V.L.; Bhattacharya, S. 2007: Safety versus success in elective single embryo transfer: women's preferences for outcomes of in vitro fertilisation. Bjog: An International Journal of Obstetrics and Gynaecology 114(8): 977-983
Melander-Wikman, A.; Fältholm, Y.; Gard, G. 2008: Safety vs. privacy: elderly persons' experiences of a mobile safety alarm. Health and Social Care in the Community 16(4): 337-346
Braun, M. 2013: Safety vs. safety. Biomedical Instrumentation and Technology 47(5): 440
Mikkelsen, K.L.; Spangenberg, S.; Kines, P. 2010: Safety walkarounds predict injury risk and reduce injury rates in the construction industry. American Journal of Industrial Medicine 53(6): 601-607
Nonyelum, S.C.; Nkem, N.; Ifeyinwa, C.-N.; Orisakwe, O.E. 2010: Safety warnings and first aid instructions on consumer and pharmaceutical products in Nigeria: has there been an improvement?. JPMA. Journal of the Pakistan Medical Association 60(10): 801-804
Wray, K.; Rajab-Ali, R. 2014: Safety watch: reducing constant observation through nurse empowerment and accountability. Journal of Nursing Administration 44(4): 237-243
O'Dowd, A. 2009: Safety watchdog warns of high dosage errors among children and young people. Bmj 338: B2500
Luettel, D.; Bischler, A. 2010: Safety when giving insulin in hospital. Nursing Times 106(39): 12-13
Emery, P.; Rigby, W.; Tak, P.P.; Dörner, T.; Olech, E.; Martin, C.; Millar, L.; Travers, H.; Fisheleva, E. 2014: Safety with ocrelizumab in rheumatoid arthritis: results from the ocrelizumab phase III program. Plos one 9(2): E87379
Carlson, J. 2013: Safety woes. FDA finds deficiencies at 31 compounding factories. Modern Healthcare 43(15): 4
Winkel, N.C. 1946: Safety work in the Netherlands during the war. Industrial Safety Survey . 22(4): 121-125
Ludwick, R.; Meehan, A.; Zeller, R.; O'Toole, R. 2008: Safety work: initiating, maintaining, and terminating restraints. Clinical Nurse Specialist Cns 22(2): 81-87
Saxton, J.W.; Finkelstein, M.M. 2011: Safety works: getting past the very thought of change. Journal of Medical Practice Management: Mpm 26(6): 377-381
Aliber, J. 2012: Safety zone. Health Facilities Management 25(9): 25-30
Saber, A.A.; Helbling, B.; Khaghany, K.; Nirmit, G.; Pimental, R.; McLeod, M.K. 2007: Safety zone for splenic hilar control during splenectomy: a computed tomography scan mapping of the tail of the pancreas in relation to the splenic hilum. American Surgeon 73(9): 890-894
Saber, A.A.; Miller, L.; Helbling, B.; Nirmit, G.; Martinez, R.L.; Elgamal, M.; Khaghany, K.; Khater, U.M. 2008: Safety zones for colorectal dissection: a CT scan mapping of the ureters relative to the colon and rectum. American Surgeon 74(11): 1114-1115
Byrnes, J. 2013: Safety's impact on the value equation. Healthcare Financial Management: Journal of the Healthcare Financial Management Association 67(12): 114-116
Neuman, M.R. 2013: Safety, BME style. IEEE pulse 4(2): 4-5
Horowitz, N.S.; Penson, R.T.; Duda, D.G.; di Tomaso, E.; Boucher, Y.; Ancukiewicz, M.; Cohen, K.S.; Berlin, S.; Krasner, C.N.; Moses, M.A.; Jain, R.K. 2011: Safety, Efficacy, and Biomarker Exploration in a Phase Ii Study of Bevacizumab, Oxaliplatin, and Gemcitabine in Recurrent Müllerian Carcinoma. Clinical Ovarian Cancer and other Gynecologic Malignancies 4(1): 26-33
Eren, O.Onder.; Ozturk, M.Akif.; Sonmez, O.Uysal.; Oyan, B. 2016: Safety, Feasibility, and Efficacy of Capecitabine Maintenance in Patients With Advanced Gastric Cancer: A Retrospective Study. American Journal of Therapeutics 23(6): E1493-E1497
Bongers, K.T.; Schoon, Y.; Graauwmans, M.J.; Hoogsteen-Ossewaarde, M.E.; Olde Rikkert, M.G.M. 2015: Safety, Feasibility, and Reliability of the Maximal Step Length, Gait Speed, and Chair Test Measured by Seniors Themselves: The Senior Step Study. Journal of Aging and Physical Activity 23(3): 438-443
Steele, A.D.; Madhi, S.A.; Louw, C.E.; Bos, P.; Tumbo, J.M.; Werner, C.M.; Bicer, C.; De Vos, B.; Delem, A.; Han, H.H. 2011: Safety, Reactogenicity, and Immunogenicity of Human Rotavirus Vaccine RIX4414 in Human Immunodeficiency Virus-positive Infants in South Africa. Pediatric Infectious Disease Journal 30(2): 125-130
Kumarasamy, N.; Venkatesh, K.K.; Devaleenal, B.; Poongulali, S.; Yepthomi, T.; Solomon, S.; Flanigan, T.P.; Mayer, K.H. 2011: Safety, Tolerability, and Efficacy of Second-Line Generic Protease Inhibitor Containing HAART after First-Line Failure among South Indian HIV-Infected Patients. Journal of the International Association of Physicians in Aids Care 10(2): 71-75
Basford, J.R.; Oh, J.K.; Allison, T.G.; Sheffield, C.G.; Manahan, B.G.; Hodge, D.O.; Tajik, A.Jamil.; Rodeheffer, R.J.; Tei, C. 2009: Safety, acceptance, and physiologic effects of sauna bathing in people with chronic heart failure: a pilot report. Archives of Physical Medicine and Rehabilitation 90(1): 173-177
Topalian, S.L.; Hodi, F.Stephen.; Brahmer, J.R.; Gettinger, S.N.; Smith, D.C.; McDermott, D.F.; Powderly, J.D.; Carvajal, R.D.; Sosman, J.A.; Atkins, M.B.; Leming, P.D.; Spigel, D.R.; Antonia, S.J.; Horn, L.; Drake, C.G.; Pardoll, D.M.; Chen, L.; Sharfman, W.H.; Anders, R.A.; Taube, J.M.; McMiller, T.L.; Xu, H.; Korman, A.J.; Jure-Kunkel, M.; Agrawal, S.; McDonald, D.; Kollia, G.D.; Gupta, A.; Wigginton, J.M.; Sznol, M. 2012: Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. New England Journal of Medicine 366(26): 2443-2454
Kibengo, F.M.; Ruzagira, E.; Katende, D.; Bwanika, A.N.; Bahemuka, U.; Haberer, J.E.; Bangsberg, D.R.; Barin, B.; Rooney, J.F.; Mark, D.; Chetty, P.; Fast, P.; Kamali, A.; Priddy, F.H. 2013: Safety, adherence and acceptability of intermittent tenofovir/emtricitabine as HIV pre-exposure prophylaxis (PrEP) among HIV-uninfected Ugandan volunteers living in HIV-serodiscordant relationships: a randomized, clinical trial. Plos one 8(9): E74314
Regev-Shoshani, G.; Vimalanathan, S.; Prema, D.; Church, J.S.; Reudink, M.W.; Nation, N.; Miller, C.C. 2014: Safety, bioavailability and mechanism of action of nitric oxide to control Bovine Respiratory Disease Complex in calves entering a feedlot. Research in Veterinary Science 96(2): 328-337
Du, Y.-r.; Li, F.; Wang, X.-b.; Tang, Z.-g.; Tian, J.; Ba, J.-t.; Long, M.-q.; Zhang, J.-b. 2007: Safety, biodistribution, and dosimetry of myocardial imaging agent 99Tc(m)N-NOET in healthy volunteers. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae 29(4): 517-521
Boulware, D.R. 2010: Safety, censoring, and intent-to-treat analysis: dangers to generalizability. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 51(8): 985
Mathias, J.M. 2013: Safety, cost savings, simplicity back broader use of bloodless surgery. Or Manager 29(5): 1; 6 8-9
Rahman, K.M.; Arifeen, S.E.; Zaman, K.; Rahman, M.; Raqib, R.; Yunus, M.; Begum, N.; Islam, M.S.; Sohel, B.M.; Rahman, M.; Venkatesan, M.; Hale, T.L.; Isenbarger, D.W.; Sansonetti, P.J.; Black, R.E.; Baqui, A.H. 2011: Safety, dose, immunogenicity, and transmissibility of an oral live attenuated Shigella flexneri 2a vaccine candidate (SC602) among healthy adults and school children in Matlab, Bangladesh. Vaccine 29(6): 1347-1354
Feldblum, P.J.; Odoyo-June, E.; Obiero, W.; Bailey, R.C.; Combes, S.; Hart, C.; Jou Lai, J.; Fischer, S.; Cherutich, P. 2014: Safety, effectiveness and acceptability of the PrePex device for adult male circumcision in Kenya. Plos one 9(5): E95357
Blencowe, H.; Kerac, M.; Molyneux, E. 2009: Safety, effectiveness and barriers to follow-up using an 'early discharge' Kangaroo Care policy in a resource poor setting. Journal of Tropical Pediatrics 55(4): 244-248
Terhaer, F.K.; Bock, M.; Fartasch, M.é; Gabard, B.; Elsner, P.; Kleesz, P.; Landeck, L.; Pohrt, U.; Seyfarth, F.; Schliemann, S.; Diepgen, T.L.; Zagrodnik, F.; John, S.M. 2010: Safety, effectiveness and comparability of professional skin cleansers. Journal der Deutschen Dermatologischen Gesellschaft 8(10): 806-810
Patel, S.; Hee, S.W.; Sandhu, H.; Yang, Y.; Underwood, M. 2014: Safety, effectiveness, and cost effectiveness of decision aids still unclear. Bmj 349: G6578
Tricco, A.C.; Ashoor, H.M.; Antony, J.; Beyene, J.; Veroniki, A.A.; Isaranuwatchai, W.; Harrington, A.; Wilson, C.; Tsouros, S.; Soobiah, C.; Yu, C.H.; Hutton, B.; Hoch, J.S.; Hemmelgarn, B.R.; Moher, D.; Majumdar, S.R.; Straus, S.E. 2014: Safety, effectiveness, and cost effectiveness of long acting versus intermediate acting insulin for patients with type 1 diabetes: systematic review and network meta-analysis. Bmj 349: G5459
Villamizar, N.; Pryor, A.D. 2011: Safety, effectiveness, and cost effectiveness of metabolic surgery in the treatment of type 2 diabetes mellitus. Journal of Obesity 2011: 790683
Tricco, A.C.; Ashoor, H.M.; Soobiah, C.; Hemmelgarn, B.; Moher, D.; Hutton, B.; Yu, C.H.; Majumdar, S.R.; Straus, S.E. 2013: Safety, effectiveness, and cost of long-acting versus intermediate-acting insulin for type 1 diabetes: protocol for a systematic review and network meta-analysis. Systematic Reviews 2: 73
Kingsbury, D.J.; Bader-Meunier, B.; Patel, G.; Arora, V.; Kalabic, J.; Kupper, H. 2014: Safety, effectiveness, and pharmacokinetics of adalimumab in children with polyarticular juvenile idiopathic arthritis aged 2 to 4 years. Clinical Rheumatology 33(10): 1433-1441
Mathews, M.S.; Sharma, J.; Snyder, K.V.; Natarajan, S.K.; Siddiqui, A.H.; Hopkins, L.N.; Levy, E.I. 2009: Safety, effectiveness, and practicality of endovascular therapy within the first 3 hours of acute ischemic stroke onset. Neurosurgery 65(5): 860
Yoelin, S.; Walt, J.G.; Earl, M. 2010: Safety, effectiveness, and subjective experience with topical bimatoprost 0.03% for eyelash growth. Dermatologic Surgery: Official Publication for American Society for Dermatologic Surgery 36(5): 638-649
Diamantis, M.L.; Bartlett, B.L.; Tyring, S.K. 2009: Safety, efficacy and recurrence rates of imiquimod cream 5% for treatment of anogenital warts. Skin Therapy Letter 14(5): 1-3; 5
Aisien, A.O.; Enosolease, M.E. 2010: Safety, efficacy and acceptability of implanon a single rod implantable contraceptive (etonogestrel) in University of Benin Teaching Hospital. Nigerian journal of clinical practice 13(3): 331-335
Konstan, M.W.; Flume, P.A.; Kappler, M.; Chiron, R.ël.; Higgins, M.; Brockhaus, F.; Zhang, J.; Angyalosi, G.; He, E.; Geller, D.E. 2011: Safety, efficacy and convenience of tobramycin inhalation powder in cystic fibrosis patients: the EAGER trial. Journal of Cystic Fibrosis: Official Journal of the European Cystic Fibrosis Society 10(1): 54-61
Lee, M.W. 2009: Safety, efficacy and ethical issues regarding weight-loss medications. Expert Review of Clinical Pharmacology 2(2): 111-113
Elmi, A.; Kajbafzadeh, A.-M.; Tourchi, A.; Talab, S.S.; Esfahani, S.A. 2011: Safety, efficacy and health related quality of life of autologous myoblast transplantation for treatment of urinary incontinence in children with bladder exstrophy-epispadias complex. Journal of Urology 186(5): 2021-2026
Cremonesi, A.; Gieowarsingh, S.; Spagnolo, B.; Manetti, R.; Liso, A.; Furgieri, A.; Barattoni, M.C.; Ghetti, L.; Tavazzi, L.; Castriota, F. 2009: Safety, efficacy and long-term durability of endovascular therapy for carotid artery disease: the tailored-Carotid Artery Stenting Experience of a single high-volume centre (tailored-CASE Registry). Eurointervention: Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 5(5): 589-598
Carranza-Lira, S.án. 2009: Safety, efficacy and patient acceptability of drospirenone and estradiol in the treatment of menopausal vasomotor symptoms: a review. Clinical Interventions in Aging 4: 59-62
Graziottin, A. 2008: Safety, efficacy and patient acceptability of the combined estrogen and progestin transdermal contraceptive patch: a review. Patient Preference and Adherence 2: 357-367
Bednarek, P.H.; Jensen, J.T. 2010: Safety, efficacy and patient acceptability of the contraceptive and non-contraceptive uses of the LNG-IUS. International Journal of Women's Health 1: 45-58
Benagiano, G.; Carrara, S.; Filippi, V. 2009: Safety, efficacy and patient satisfaction with continuous daily administration of levonorgestrel/ethinylestradiol oral contraceptives. Patient Preference and Adherence 3: 131-143
Tomiyama, N.; Hidaka, M.; Hidaka, H.; Kawano, Y.; Hanada, N.; Kawaguchi, H.; Arimori, K.; Nakamura, C. 2010: Safety, efficacy and pharmacokinetics of S-1 in a hemodialysis patient with advanced gastric cancer. Cancer ChemoTherapy and Pharmacology 65(4): 807-809
Wasserman, R.L.; Church, J.A.; Stein, M.; Moy, J.; White, M.; Strausbaugh, S.; Schroeder, H.; Ballow, M.; Harris, J.; Melamed, I.; Elkayam, D.; Lumry, W.; Suez, D.; Rehman, S.M. 2012: Safety, efficacy and pharmacokinetics of a new 10% liquid intravenous immunoglobulin (IVIG) in patients with primary immunodeficiency. Journal of Clinical Immunology 32(4): 663-669
Strumberg, D.; Schultheis, B.; Scheulen, M.E.; Hilger, R.A.; Krauss, J.; Marschner, N.; Lordick, F.; Bach, F.; Reuter, D.; Edler, L.; Mross, K. 2010: Safety, efficacy and pharmacokinetics of nimotuzumab, a humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody, in patients with locally advanced or metastatic pancreatic cancer. International Journal of Clinical Pharmacology and Therapeutics 48(7): 473-475
Valecha, N.; Srivastava, B.; Dubhashi, N.G.; Rao, B.H.K.; Kumar, A.; Ghosh, S.K.; Singh, J.P.N.; Kiechel, J.R.; Sharma, B.; Jullien, V.; Dash, A.P.; Taylor, W.R.J.; Anvikar, A.R. 2013: Safety, efficacy and population pharmacokinetics of fixed-dose combination of artesunate-mefloquine in the treatment of acute uncomplicated Plasmodium falciparum malaria in India. Journal of Vector Borne Diseases 50(4): 258-264
Conrozier, T.; Couris, C.M.; Mathieu, P.; Merle-Vincent, F.; Piperno, M.; Coury, F.; Belin, V.; Tebib, J.; Vignon, E. 2009: Safety, efficacy and predictive factors of efficacy of a single intra-articular injection of non-animal-stabilized-hyaluronic-acid in the hip joint: results of a standardized follow-up of patients treated for hip osteoarthritis in daily practice. Archives of Orthopaedic and Trauma Surgery 129(6): 843-848
Neunhoeffer, F.; Renk, H.; Hofbeck, M.; Grenz, C.; Haller, C.; Heimberg, E.; Gerbig, I.; Schlensak, C.; Kumpf, M. 2015: Safety, efficacy and response to a hydrocortisone rescue therapy protocol in children with refractory hypotension after cardiopulmonal bypass. Pediatric Cardiology 36(3): 640-645
Thong, K.Y.; Jose, B.; Sukumar, N.; Cull, M.L.; Mills, A.P.; Sathyapalan, T.; Shafiq, W.; Rigby, A.S.; Walton, C.; Ryder, R.E.J.; Eliwe, M..H.; Chuni, P.; Hay, C.; Narayan, S.; Krishnan, S.; McGrane, D.; Sainsbury, C.; Fisher, M.; Eliot, G.; Shaikh, S.; Jones, S..L.; Milles, J..J.; Griffiths, U.; Colloby, M.; Harold, C.; Rangan, S.; Morrison, J.; Fisher, M.; McGrane, D.; Govindan, J.; Price, P.; Ahmed, S.; Gardner, A.; Brackenbridge, A.; Reid, A.; Piper-Smith, J.; Preston, J.; Field, B..C..T.; Dornhorst, A.; Hammond, P.; Thirumurugan, E.; John, R.; Patel, M.; Ulnaf, S.; Begum, S.; Edwards, M.; Doolittle, H.; Currie, A.; O'Sullivan, S.; Lillystone, R.; Mathews, A..A.; Walton, C.; Ng, B.; Kumar, B..K.; Bosomworth, A.; Srinath, A.; Parkin 2011: Safety, efficacy and tolerability of exenatide in combination with insulin in the Association of British Clinical Diabetologists nationwide exenatide audit*. Diabetes Obesity and Metabolism 13(8): 703-710
Swaroop, A.; Bagchi, M.; Kumar, P.; Preuss, H.G.; Tiwari, K.; Marone, P.A.; Bagchi, D. 2014: Safety, efficacy and toxicological evaluation of a novel, patented anti-diabetic extract of Trigonella Foenum-Graecum seed extract (Fenfuro). Toxicology Mechanisms and Methods 24(7): 495-503
Heise, T.; Morrow, L.; Hompesch, M.; Häring, H.-U.; Kapitza, C.; Abt, M.; Ramsauer, M.; Magnone, M.-C.; Fuerst-Recktenwald, S. 2014: Safety, efficacy and weight effect of two 11β-HSD1 inhibitors in metformin-treated patients with type 2 diabetes. Diabetes Obesity and Metabolism 16(11): 1070-1077
Breech, L.L.; Braverman, P.K. 2010: Safety, efficacy, actions, and patient acceptability of drospirenone/ethinyl estradiol contraceptive pills in the treatment of premenstrual dysphoric disorder. International Journal of Women's Health 1: 85-95
Lannfelt, L.; Blennow, K.; Zetterberg, H.; Batsman, S.; Ames, D.; Harrison, J.; Masters, C.L.; Targum, S.; Bush, A.I.; Murdoch, R.; Wilson, J.; Ritchie, C.W.; Lannfelt, L.; Nilsson, C.; Eriksson, S.; Pilenvik, E.; Minthon, L.; Are, K.; Haglund, A.; Båtsman, S.; Boundy, K.; Ames, D.; Brodaty, H.; Woodward, M.; Kurrle, S.; Drysdale, P.; Macfarlane, S. 2008: Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial. LANCET. Neurology 7(9): 779-786
Weber, J.S.; Kudchadkar, R.R.; Yu, B.; Gallenstein, D.; Horak, C.E.; Inzunza, H.D.; Zhao, X.; Martinez, A.J.; Wang, W.; Gibney, G.; Kroeger, J.; Eysmans, C.; Sarnaik, A.A.; Chen, Y.A. 2013: Safety, efficacy, and biomarkers of nivolumab with vaccine in ipilimumab-refractory or -naive melanoma. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 31(34): 4311-4318
Olesen, A.S.; Lohse, L.; Dalgaard, M.D.; Woźniakowski, G.; Belsham, G.J.; Bøtner, A.; Rasmussen, T.B. 2018: Complete genome sequence of an African swine fever virus (ASFV POL/2015/Podlaskie) determined directly from pig erythrocyte-associated nucleic acid. Journal of Virological Methods 261: 14-16
Hardesty, D.A.; Thind, H.; Zabramski, J.M.; Spetzler, R.F.; Nakaji, P. 2014: Safety, efficacy, and cost of intraoperative indocyanine green angiography compared to intraoperative catheter angiography in cerebral aneurysm surgery. Journal of Clinical Neuroscience: Official Journal of the Neurosurgical Society of Australasia 21(8): 1377-1382
McCullough, M.; Weber, C.; Leong, C.; Sharma, J. 2013: Safety, efficacy, and cost savings of single parathyroid hormone measurement for risk stratification after total thyroidectomy. American Surgeon 79(8): 768-774
Tiwari, M.M.; Reynoso, J.F.; High, R.; Tsang, A.W.; Oleynikov, D. 2011: Safety, efficacy, and cost-effectiveness of common laparoscopic procedures. Surgical Endoscopy 25(4): 1127-1135
Hamilton, D.Kojo.; Smith, J.S.; Reames, D.L.; Williams, B.J.; Chernavvsky, D.R.; Shaffrey, C.I. 2011: Safety, efficacy, and dosing of recombinant human bone morphogenetic protein-2 for posterior cervical and cervicothoracic instrumented fusion with a minimum 2-year follow-up. Neurosurgery 69(1): 103-11; Discussion 111
Kiser, T.H.; Burch, J.C.; Klem, P.M.; Hassell, K.L. 2008: Safety, efficacy, and dosing requirements of bivalirudin in patients with heparin-induced thrombocytopenia. PharmacoTherapy 28(9): 1115-1124
Ray, J.B.; Ray, S. 2011: Safety, efficacy, and durability of laparoscopic adjustable gastric banding in a single surgeon U.S. community practice. Surgery for Obesity and Related Diseases: Official Journal of the American Society for Bariatric Surgery 7(2): 140-144
Qasem, Q.; Dooley, I.J.; D'Arcy, F.; O'Keefe, M. 2012: Safety, efficacy, and effect of foldable phakic iris-claw intraocular lenses on higher-order aberrations: Two-year follow-up. Journal of Cataract and Refractive Surgery 38(11): 2053-2054
Adiga, S.; Athreya, S. 2014: Safety, efficacy, and feasibility of an ultra-low dose radiation protocol for CT-guided percutaneous needle biopsy of pulmonary lesions: initial experience. Clinical Radiology 69(7): 709-714
Mahmoud, A.F.; Massa, S.T.; Douberly, S.L.; Montes, M.L.; Ruckenstein, M.J. 2014: Safety, efficacy, and hearing preservation using an integrated electro-acoustic stimulation hearing system. Otology and Neurotology: Official Publication of the American Otological Society American Neurotology Society and European Academy of Otology and Neurotology 35(8): 1421-1425
Jackson, L.A.; Gaglani, M.J.; Keyserling, H.L.; Balser, J.; Bouveret, N.; Fries, L.; Treanor, J.J. 2010: Safety, efficacy, and immunogenicity of an inactivated influenza vaccine in healthy adults: a randomized, placebo-controlled trial over two influenza seasons. Bmc Infectious Diseases 10: 71
Mahabadi, A.A.; Achenbach, S.; Burgstahler, C.; Dill, T.; Fischbach, R.; Knez, A.; Moshage, W.; Richartz, B.M.; Ropers, D.; Schröder, S.; Silber, S.; Möhlenkamp, S. 2010: Safety, efficacy, and indications of beta-adrenergic receptor blockade to reduce heart rate prior to coronary CT angiography. Radiology 257(3): 614-623
Modi, S.S.; Davison, J.A.; Walters, T. 2011: Safety, efficacy, and intraoperative characteristics of DisCoVisc and Healon ophthalmic viscosurgical devices for cataract surgery. Clinical Ophthalmology 5: 1381-1389
Guo, K.; Sun, J.; Qiao, Q.; Guo, N.; Guo, L. 2012: Safety, efficacy, and modifications of the dermal bra technique for reduction mammaplasty and ptosis correction: a 10-year retrospective study. Plastic and Reconstructive Surgery 129(6): 1237-1245
Sauer, R.-S.; Krug, S.M.; Hackel, D.; Staat, C.; Konasin, N.; Yang, S.; Niedermirtl, B.; Bosten, J.; Günther, R.; Dabrowski, S.; Doppler, K.; Sommer, C.; Blasig, I.E.; Brack, A.; Rittner, H.L. 2014: Safety, efficacy, and molecular mechanism of claudin-1-specific peptides to enhance blood-nerve-barrier permeability. Journal of Controlled Release: Official Journal of the Controlled Release Society 185: 88-98
Caperton, C.; Berman, B. 2011: Safety, efficacy, and patient acceptability of imiquimod for topical treatment of actinic keratoses. Clinical Cosmetic and Investigational Dermatology 4: 35-40
Page, M.A.; Fraunfelder, F.W. 2009: Safety, efficacy, and patient acceptability of lidocaine hydrochloride ophthalmic gel as a topical ocular anesthetic for use in ophthalmic procedures. Clinical Ophthalmology 3: 601-609
Kimer, N.; Krag, A.; Gluud, L.L. 2014: Safety, efficacy, and patient acceptability of rifaximin for hepatic encephalopathy. Patient Preference and Adherence 8: 331-338
Celio, L.; Ricchini, F.; De Braud, F. 2013: Safety, efficacy, and patient acceptability of single-dose fosaprepitant regimen for the prevention of chemotherapy-induced nausea and vomiting. Patient Preference and Adherence 7: 391-400
Hasan, R.; Ghanbari, H.; Feldman, D.; Menesses, D.; Rivas, D.; Zakhem, N.C.; Duarte, C.; Machado, C. 2011: Safety, efficacy, and performance of implanted recycled cardiac rhythm management (CRM) devices in underprivileged patients. Pacing and Clinical Electrophysiology: Pace 34(6): 653-658
Blanco, Jé.Ramón.; Caro-Murillo, A.María.; Castaño, M.Angel.; Olalla, Ján.; Domingo, P.; Arazo, P.; Gómez-Sirvent, J.Luis.; Riera, M.; Pulido, F.; Vera, F.; Romero-Palacios, A.; Aguirrebengoa, K.; Portilla, Jín.; Ferrer, P.; Pedrol, E. 2013: Safety, efficacy, and persistence of emtricitabine/tenofovir versus other nucleoside analogues in naive subjects aged 50 years or older in Spain: the TRIP study. HIV clinical trials 14(5): 204-215
Wrishko, R.; Sorsaburu, S.; Wong, D.; Strawbridge, A.; McGill, J. 2009: Safety, efficacy, and pharmacokinetic overview of low-dose daily administration of tadalafil. Journal of Sexual Medicine 6(7): 2039-2048
Lalezari, J.; Gathe, J.; Brinson, C.; Thompson, M.; Cohen, C.; Dejesus, E.; Galindez, J.; Ernst, J.A.; Martin, D.E.; Palleja, S.M. 2011: Safety, efficacy, and pharmacokinetics of TBR-652, a CCR5/CCR2 antagonist, in HIV-1-infected, treatment-experienced, CCR5 antagonist-naive subjects. Journal of Acquired Immune Deficiency Syndromes 57(2): 118-125
Jonas, M.M.; Kelly, D.; Pollack, H.; Mizerski, J.; Sorbel, J.; Frederick, D.; Mondou, E.; Rousseau, F.; Sokal, E. 2008: Safety, efficacy, and pharmacokinetics of adefovir dipivoxil in children and adolescents (age 2 to <18 years) with chronic hepatitis B. Hepatology 47(6): 1863-1871
Quiros, J.A.; Heyman, M.B.; Pohl, J.F.; Attard, T.M.; Pieniaszek, H.J.; Bortey, E.; Walker, K.; Forbes, W.P. 2009: Safety, efficacy, and pharmacokinetics of balsalazide in pediatric patients with mild-to-moderate active ulcerative colitis: results of a randomized, double-blind study. Journal of Pediatric Gastroenterology and Nutrition 49(5): 571-579
Wall, D.A.; Chan, K.W.; Nieder, M.L.; Hayashi, R.J.; Yeager, A.M.; Kadota, R.; Przepiorka, D.; Mezzi, K.; Kletzel, M. 2010: Safety, efficacy, and pharmacokinetics of intravenous busulfan in children undergoing allogeneic hematopoietic stem cell transplantation. Pediatric Blood and Cancer 54(2): 291-298
Ford, N.; Lee, J.; Andrieux-Meyer, I.; Calmy, A. 2011: Safety, efficacy, and pharmacokinetics of rilpivirine: systematic review with an emphasis on resource-limited settings. Hiv/Aids 3: 35-44
Wells, T.G.; Portman, R.; Norman, P.; Haertter, S.; Davidai, G.; Fei Wang 2010: Safety, efficacy, and pharmacokinetics of telmisartan in pediatric patients with hypertension. Clinical Pediatrics 49(10): 938-946
Berkowitz, J.L.; Janik, J.E.; Stewart, D.M.; Jaffe, E.S.; Stetler-Stevenson, M.; Shih, J.H.; Fleisher, T.A.; Turner, M.; Urquhart, N.E.; Wharfe, G.H.; Figg, W.D.; Peer, C.J.; Goldman, C.K.; Waldmann, T.A.; Morris, J.C. 2014: Safety, efficacy, and pharmacokinetics/pharmacodynamics of daclizumab (anti-CD25) in patients with adult T-cell leukemia/lymphoma. Clinical Immunology 155(2): 176-187
Tomita, M.; Watabe, M.; Yukawa, S.; Nakamura, N.; Nakamura, T.; Magnago, T. 2014: Safety, efficacy, and predictability of laser in situ keratomileusis to correct myopia or myopic astigmatism with a 750 Hz scanning-spot laser system. Journal of Cataract and Refractive Surgery 40(2): 251-258
Nasser, F.; Cavalcante, R.N.; Affonso, B.B.; Messina, M.L.; Carnevale, F.C.; de Gregorio, M.A. 2014: Safety, efficacy, and prognostic factors in endovascular treatment of pelvic congestion syndrome. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 125(1): 65-68
Matsuo, T.; Uchida, T.; Takarabe, K. 2009: Safety, efficacy, and quality control of a photoelectric dye-based retinal prosthesis (Okayama University-type retinal prosthesis) as a medical device. Journal of Artificial Organs: the Official Journal of the Japanese Society for Artificial Organs 12(4): 213-225
Mason, J.O.; Neimkin, M.G.; Mason, J.O.; Friedman, D.A.; Feist, R.M.; Thomley, M.L.; Albert, M.A. 2014: Safety, efficacy, and quality of life following sutureless vitrectomy for symptomatic vitreous floaters. Retina 34(6): 1055-1061
Basnet, S.; Mander, G.; Andoh, J.; Klaska, H.; Verhulst, S.; Koirala, J. 2012: Safety, efficacy, and tolerability of early initiation of noninvasive positive pressure ventilation in pediatric patients admitted with status asthmaticus: a pilot study. Pediatric Critical Care Medicine: a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies 13(4): 393-398
Sclafani, A.P. 2011: Safety, efficacy, and utility of platelet-rich fibrin matrix in facial plastic surgery. Archives of Facial Plastic Surgery 13(4): 247-251
Vaishampayan, U.N.; Burger, A.M.; Sausville, E.A.; Heilbrun, L.K.; Li, J.; Horiba, M.N.; Egorin, M.J.; Ivy, P.; Pacey, S.; Lorusso, P.M. 2010: Safety, efficacy, pharmacokinetics, and pharmacodynamics of the combination of sorafenib and tanespimycin. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 16(14): 3795-3804
Khoramnia, R.; Salgado, J.P.; Wuellner, C.; Donitzky, C.; Lohmann, C.P.; Winkler von Mohrenfels, C. 2012: Safety, efficacy, predictability and stability of laser in situ keratomileusis (LASIK) with a 1000-Hz scanning spot excimer laser. Acta Ophthalmologica 90(6): 508-513
Mirski, M.A.; Pandian, V.; Bhatti, N.; Haut, E.; Feller-Kopman, D.; Morad, A.; Haider, A.; Schiavi, A.; Efron, D.; Ulatowski, J.; Yarmus, L.; Stevens, K.A.; Miller, C.A.; Papangelou, A.; Vaswani, R.; Kalmar, C.; Gupta, S.; Intihar, P.; Mack, S.; Rushing, A.P.; Chi, A.; Roberts, V.J. 2012: Safety, efficiency, and cost-effectiveness of a multidisciplinary percutaneous tracheostomy program. Critical Care Medicine 40(6): 1827-1834
Lippa, C.F. 2008: Safety, end-of-life issues, and dealing with sexually inappropriate behavior in dementia patients. American Journal of Alzheimer's Disease and other Dementias 23(4): 311-312
Highsmith, M.Jason.; Kahle, J.T.; Bongiorni, D.R.; Sutton, B.S.; Groer, S.; Kaufman, K.R. 2010: Safety, energy efficiency, and cost efficacy of the C-Leg for transfemoral amputees: A review of the literature. Prosthetics and Orthotics International 34(4): 362-377
Rossi, S.; Hallett, M.; Rossini, P.M.; Pascual-Leone, A. 2009: Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clinical Neurophysiology: Official Journal of the International Federation of Clinical Neurophysiology 120(12): 2008-2039
Fox, A.; Berrick, J.D.; Frasch, K. 2008: Safety, family, permanency, and child well-being: what we can learn from children. Child Welfare 87(1): 63-90
Thudium, M.O.; von Lehe, M.; Wessling, C.; Schoene-Bake, J-Christoph.; Soehle, M. 2014: Safety, feasibility and complications during resective pediatric epilepsy surgery: a retrospective analysis. Bmc Anesthesiology 14: 71
Black, S.; Zulliger, R.; Myer, L.; Marcus, R.; Jeneker, S.; Taliep, R.; Pienaar, D.; Wood, R.; Bekker, L-Gail. 2013: Safety, feasibility and efficacy of a rapid ART initiation in pregnancy pilot programme in Cape Town, South Africa. South African Medical Journal 103(8): 557-562
Devière, J.; Ojeda Valdes, G.; Cuevas Herrera, L.; Closset, J.; Le Moine, O.; Eisendrath, P.; Moreno, C.; Dugardeyn, S.; Barea, M.; de la Torre, R.; Edmundowicz, S.; Scott, S. 2008: Safety, feasibility and weight loss after transoral gastroplasty: first human multicenter study. Surgical Endoscopy 22(3): 589-598
Phongsavan, K.; Phengsavanh, A.; Wahlström, R.; Marions, L. 2011: Safety, feasibility, and acceptability of visual inspection with acetic acid and immediate treatment with cryotherapy in rural Laos. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 114(3): 268-272
Lin, E.; Snell, G.I.; Levvey, B.J.; Mifsud, N.; Paul, M.; Buckland, M.R.; Gooi, J.; Marasco, S.; Sharland, A.F.; Myles, P.S. 2014: Safety, feasibility, and effect of remote ischemic conditioning in patients undergoing lung transplantation. Journal of Heart and Lung Transplantation: the Official Publication of the International Society for Heart Transplantation 33(11): 1139-1148
Matheny, K.E.; Carter, K.B.; Tseng, E.Y.; Fong, K.J. 2014: Safety, feasibility, and efficacy of placement of steroid-eluting bioabsorbable sinus implants in the office setting: a prospective case series. International Forum of Allergy and Rhinology 4(10): 808-815
Havel, C.; Berzlanovich, A.; Sterz, F.; Domanovits, H.; Herkner, H.; Zeiner, A.; Behringer, W.; Laggner, A.N. 2008: Safety, feasibility, and hemodynamic and blood flow effects of active compression-decompression of thorax and abdomen in patients with cardiac arrest. Critical Care Medicine 36(6): 1832-1837
Zhu, Y.-Q.; Gu, B.-X.; Li, M.-H.; Wang, W.; Cheng, Y.-S.; Tan, H.-Q.; Wang, J.-B.; Zhang, P.-L.; Ma, L.-T. 2010: Safety, feasibility, and mid-term follow-up of Willis stent graft placement in the treatment of symptomatic complicated intra- or extra-cranial aneurysms: a multicenter experience. Minimally Invasive Therapy and Allied Technologies: Mitat: Official Journal of the Society for Minimally Invasive Therapy 19(6): 320-328
Dankiewicz, J.; Schmidbauer, S.; Nielsen, N.; Kern, K.B.; Mooney, M.R.; Stammet, P.; Riker, R.R.; Rubertsson, S.; Seder, D.; Smid, O.; Sunde, K.; Søreide, E.; Unger, B.T.; Friberg, H. 2014: Safety, feasibility, and outcomes of induced hypothermia therapy following in-hospital cardiac arrest-evaluation of a large prospective registry*. Critical Care Medicine 42(12): 2537-2545
Soop, M.; Larson, D.W.; Malireddy, K.; Cima, R.R.; Young-Fadok, T.M.; Dozois, E.J. 2009: Safety, feasibility, and short-term outcomes of laparoscopically assisted primary ileocolic resection for Crohn's disease. Surgical Endoscopy 23(8): 1876-1881
Gianotti, L.; Nespoli, L.; Torselli, L.; Panelli, M.; Nespoli, A. 2011: Safety, feasibility, and tolerance of early oral feeding after colorectal resection outside an enhanced recovery after surgery (ERAS) program. International Journal of Colorectal Disease 26(6): 747-753
Morinville, V.ér.D.; Paquin, S.C.; Sahai, A.V. 2010: Safety, feasibility, and usefulness of rectal endoscopic ultrasonography for pediatric anal and perianal complaints. Journal of Pediatric Gastroenterology and Nutrition 51(1): 93-95
Torres, N.ás.I.; Noll, K.S.; Xu, S.; Li, J.; Huang, Q.; Sinko, P.J.; Wachsman, M.ón.B.; Chikindas, M.L. 2013: Safety, formulation, and in vitro antiviral activity of the antimicrobial peptide subtilosin against herpes simplex virus type 1. Probiotics and Antimicrobial Proteins 5(1): 26-35
Matern, U.; Koneczny, S. 2007: Safety, hazards and ergonomics in the operating room. Surgical Endoscopy 21(11): 1965-1969
Jean-Baptiste, E.; Blanchemain, N.; Martel, B.; Neut, C.; Hildebrand, H.F.; Haulon, S. 2012: Safety, healing, and efficacy of vascular prostheses coated with hydroxypropyl-β-cyclodextrin polymer: experimental in vitro and animal studies. European Journal of Vascular and Endovascular Surgery: the Official Journal of the European Society for Vascular Surgery 43(2): 188-197
Bodner, T.; Kraner, M.; Bradford, B.; Hammer, L.; Truxillo, D. 2014: Safety, health, and well-being of municipal utility and construction workers. Journal of Occupational and Environmental Medicine 56(7): 771-778
Rolland, J. 2014: Safety, hope, and healing: a unique perspective. AORN Journal 99(1): 160-165
Chotpitayasunondh, T.; Thisyakorn, U.; Pancharoen, C.; Pepin, S.; Nougarede, N. 2008: Safety, humoral and cell mediated immune responses to two formulations of an inactivated, split-virion influenza A/H5N1 vaccine in children. Plos one 3(12): E4028
Hata, A.; Inoue, F.; Yamasaki, M.; Fujikawa, J.; Kawasaki, Y.; Hamamoto, Y.; Honjo, S.; Moriishi, E.; Mori, Y.; Koshiyama, H. 2013: Safety, humoral and cell-mediated immune responses to herpes zoster vaccine in subjects with diabetes mellitus. Journal of Infection 67(3): 215-219
Chen, G.L.; Lamirande, E.W.; Jin, H.; Kemble, G.; Subbarao, K. 2010: Safety, immunogencity, and efficacy of a cold-adapted A/Ann Arbor/6/60 (H2N2) vaccine in mice and ferrets. Virology 398(1): 109-114
Van Damme, P.; Kafeja, F.; Anemona, A.; Basile, V.; Hilbert, A.K.; De Coster, I.; Rondini, S.; Micoli, F.; Qasim Khan, R.M.; Marchetti, E.; Di Cioccio, V.; Saul, A.; Martin, L.B.; Podda, A. 2011: Safety, immunogenicity and dose ranging of a new Vi-CRM₁₉₇ conjugate vaccine against typhoid fever: randomized clinical testing in healthy adults. Plos one 6(9): E25398
Aziz-Boaron, O.; Leibovitz, K.; Gelman, B.; Kedmi, M.; Klement, E. 2013: Safety, immunogenicity and duration of immunity elicited by an inactivated bovine ephemeral fever vaccine. Plos one 8(12): E82217
Aide, P.; Aponte, J.J.; Renom, M.; Nhampossa, T.; Sacarlal, J.; Mandomando, I.; Bassat, Q.; Manaca, M.N.él.; Leach, A.; Lievens, M.; Vekemans, J.; Dubois, M.-C.; Loucq, C.; Ballou, W.R.; Cohen, J.; Alonso, P.L. 2010: Safety, immunogenicity and duration of protection of the RTS,S/AS02(D) malaria vaccine: one year follow-up of a randomized controlled phase I/IIb trial. Plos one 5(11): E13838
Boffito, M.; Fox, J.; Bowman, C.; Fisher, M.; Orkin, C.; Wilkins, E.; Jackson, A.; Pleguezuelos, O.; Robinson, S.; Stoloff, G.A.; Caparrós-Wanderley, W. 2013: Safety, immunogenicity and efficacy assessment of HIV immunotherapy in a multi-centre, double-blind, randomised, Placebo-controlled Phase Ib human trial. Vaccine 31(48): 5680-5686
Da Costa, V.G.; Marques-Silva, A.C.; Floriano, V.G.; Moreli, M.L. 2014: Safety, immunogenicity and efficacy of a recombinant tetravalent dengue vaccine: a meta-analysis of randomized trials. Vaccine 32(39): 4885-4892
De Rose, R.; Mason, R.D.; Loh, L.; Peut, V.; Smith, M.Z.; Fernandez, C.S.; Alcantara, S.; Amarasena, T.; Reece, J.; Seddiki, N.; Kelleher, A.D.; Zaunders, J.; Kent, S.J. 2008: Safety, immunogenicity and efficacy of peptide-pulsed cellular immunotherapy in macaques. Journal of Medical Primatology 37(Suppl 2): 69-78
Nunes, M.C.; Madhi, S.A. 2012: Safety, immunogenicity and efficacy of pneumococcal conjugate vaccine in HIV-infected individuals. Human Vaccines and Immunotherapeutics 8(2): 161-173
Haag-Weber, M.; Eckardt, K.-U.; Hörl, W.H.; Roger, S.D.; Vetter, A.; Roth, K. 2012: Safety, immunogenicity and efficacy of subcutaneous biosimilar epoetin-α (HX575) in non-dialysis patients with renal anemia: a multi-center, randomized, double-blind study. Clinical Nephrology 77(1): 8-17
Knuf, M.; Zepp, F.; Meyer, C.U.; Habermehl, P.; Maurer, L.; Burow, H.-M.; Behre, U.; Janssens, M.; Willems, P.; Bisanz, H.; Vetter, V.; Schmidt-Ott, R. 2010: Safety, immunogenicity and immediate pain of intramuscular versus subcutaneous administration of a measles-mumps-rubella-varicella vaccine to children aged 11-21 months. European Journal of Pediatrics 169(8): 925-933
Liakou, C.D.; Askiti, V.; Mitsioni, A.; Stefanidis, C.J.; Theodoridou, M.C.; Spoulou, V.I. 2011: Safety, immunogenicity and kinetics of immune response to 7-valent pneumococcal conjugate vaccine in children with idiopathic nephrotic syndrome. Vaccine 29(40): 6834-6837
Berglund, J.; Vink, P.; Tavares Da Silva, F.; Lestrate, P.; Boutriau, D. 2014: Safety, immunogenicity, and antibody persistence following an investigational Streptococcus pneumoniae and Haemophilus influenzae triple-protein vaccine in a phase 1 randomized controlled study in healthy adults. Clinical and Vaccine Immunology: Cvi 21(1): 56-65
Muñoz, N.; Manalastas, R.; Pitisuttithum, P.; Tresukosol, D.; Monsonego, J.; Ault, K.; Clavel, C.; Luna, J.; Myers, E.; Hood, S.; Bautista, O.; Bryan, J.; Taddeo, F.J.; Esser, M.T.; Vuocolo, S.; Haupt, R.M.; Barr, E.; Saah, A. 2009: Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial. Lancet 373(9679): 1949-1957
Lukashevich, I.S.; Carrion, R.; Salvato, M.S.; Mansfield, K.; Brasky, K.; Zapata, J.; Cairo, C.; Goicochea, M.; Hoosien, G.E.; Ticer, A.; Bryant, J.; Davis, H.; Hammamieh, R.; Mayda, M.; Jett, M.; Patterson, J. 2008: Safety, immunogenicity, and efficacy of the ML29 reassortant vaccine for Lassa fever in small non-human primates. Vaccine 26(41): 5246-5254
Araujo, E.C.; Clemens, S.A.C.; Oliveira, C.S.; Justino, M.C.A.; Rubio, P.; Gabbay, Y.B.; da Silva, V.B.; Mascarenhas, J.D.P.; Noronha, V.ân.L.; Clemens, R.; Gusmão, R.H.P.; Sanchez, N.; Monteiro, T.A.ôn.F.; Linhares, A.C. 2007: Safety, immunogenicity, and protective efficacy of two doses of RIX4414 live attenuated human rotavirus vaccine in healthy infants. Jornal de Pediatria 83(3): 217-224
Greenberg, R.N.; Overton, E.T.; Haas, D.W.; Frank, I.; Goldman, M.; von Krempelhuber, A.; Virgin, G.; Bädeker, N.; Vollmar, J.; Chaplin, P. 2013: Safety, immunogenicity, and surrogate markers of clinical efficacy for modified vaccinia Ankara as a smallpox vaccine in HIV-infected subjects. Journal of Infectious Diseases 207(5): 749-758
Richmond, P.C.; Marshall, H.S.; Nissen, M.D.; Jiang, Q.; Jansen, K.U.; Garcés-Sánchez, M.; Martinón-Torres, F.; Beeslaar, J.; Szenborn, L.; Wysocki, J.; Eiden, J.; Harris, S.L.; Jones, T.R.; Perez, J.L.; Nolan, T.; Nissen, M.; Richmond, P.; Marshall, H.; Szenborn, L.; Szymanski, H.; Pejcz, J.; Tetiurka, B.; Dziduch, J.; Hasiec, B.; Czajka, H.; Jackowska, T.; Brzostek, J.; Bieganskiego, W.; Majda-Stanislawska, E.; Witor, A.; Kopinska, E.; Konior, R.; Wysocki, J.; Blanco, O.; Rojo, P.; Amador, J.T.R.; Arimany, J.L.; Infante, P.; Martinón, F.; Sanz, A.B. 2012: Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: a randomised, single-blind, placebo-controlled, phase 2 trial. LANCET. Infectious Diseases 12(8): 597-607
Scheifele, D.W.; McNeil, S.A.; Ward, B.J.; Dionne, M.; Cooper, C.; Coleman, B.; Loeb, M.; Rubinstein, E.; McElhaney, J.; Hatchette, T.; Li, Y.; Montomoli, E.; Schneeberg, A.; Bettinger, J.A.; Halperin, S.A.; Langley, J.; Smith, B.; Quach, C.; Papenburg, J.; Beauchesne, A.é; Gilca, V.; De Serres, G.; McGeer, A.; Hammond, G.; Aoki, F.; Stiver, G.; Yu, S.; Bastien, N.; Lapini, G.; Sbragi, S. 2013: Safety, immunogenicity, and tolerability of three influenza vaccines in older adults: results of a randomized, controlled comparison. Human Vaccines and Immunotherapeutics 9(11): 2460-2473
Anonymous 2007: Safety, in their own words. How ambulance manufacturers are helping you stay safe. Ems Magazine 36(6): 91-95
Edeki, T.; Kujacic, M.; Broadhurst, H.; Li, J.; Sunzel, M. 2014: Safety, local tolerability and pharmacokinetics of ceftaroline fosamil administered in a reduced infusion volume. British Journal of Clinical Pharmacology 78(6): 1291-1297
Weld, L.R.; Nwoye, U.O.; Knight, R.B.; Baumgartner, T.S.; Ebertowski, J.S.; Stringer, M.T.; Kasprenski, M.C.; Weld, K.J. 2014: Safety, minimization, and awareness radiation training reduces fluoroscopy time during unilateral ureteroscopy. Urology 84(3): 520-525
Kremenchutzky, M. 2011: Safety, not only efficacy still to be proven for controversial new MS treatment. Canadian Journal of Neurological Sciences. le Journal Canadien des Sciences Neurologiques 38(5): 667-668
Mathus-Vliegen, E.M.H.; van der Vliet, K. 2013: Safety, patient's tolerance, and efficacy of a 2-liter vitamin C-enriched macrogol bowel preparation: a randomized, endoscopist-blinded prospective comparison with a 4-liter macrogol solution. Diseases of the Colon and Rectum 56(8): 1002-1012
Mallon, G.P. 2010: Safety, permanency, and well-being revisited. Child Welfare 89(3): 5-8
Boulet, L.-P.; Lemière, C.; Gauvreau, G.; Olivenstein, R.; Lougheed, D.; Paradis, B.; O'Byrne, P.; Pageau, R.é; Renzi, P.M. 2009: Safety, pharmacodynamics and pharmacokinetics of TPi 1020 in smokers with asthma. Respiratory Medicine 103(8): 1159-1166
Chen, H.; Qiao, J.; Li, Q.; Deng, J.; Tan, Z.; Guo, T.; Li, W. 2009: Safety, pharmacokinetic and pharmacodynamic studies of batifiban injection following single- and multiple-dose administration to healthy Chinese subjects. Journal of Huazhong University of Science and Technology. Medical Sciences 29(1): 12-18
Thuita, J.K.; Wolf, K.K.; Murilla, G.A.; Liu, Q.; Mutuku, J.N.; Chen, Y.; Bridges, A.S.; Mdachi, R.E.; Ismail, M.A.; Ching, S.; Boykin, D.W.; Hall, J.E.; Tidwell, R.R.; Paine, M.F.; Brun, R.; Wang, M.Z. 2013: Safety, pharmacokinetic, and efficacy studies of oral DB868 in a first stage vervet monkey model of human African trypanosomiasis. Plos Neglected Tropical Diseases 7(6): E2230
Meininger, V.; Pradat, P.-F.ço.; Corse, A.; Al-Sarraj, S.; Rix Brooks, B.; Caress, J.B.; Cudkowicz, M.; Kolb, S.J.; Lange, D.; Leigh, P.N.; Meyer, T.; Milleri, S.; Morrison, K.E.; Orrell, R.W.; Peters, G.; Rothstein, J.D.; Shefner, J.; Lavrov, A.; Williams, N.; Overend, P.; Price, J.; Bates, S.; Bullman, J.; Krull, D.; Berges, A.; Abila, B.; Meno-Tetang, G.; Wurthner, J. 2014: Safety, pharmacokinetic, and functional effects of the nogo-a monoclonal antibody in amyotrophic lateral sclerosis: a randomized, first-in-human clinical trial. Plos one 9(5): E97803
Kovalchin, J.; Krieger, J.; Collins, K.; Genova, M.; Augustyniak, M.; Masci, A.; Avril, T.; Gandon, G.; Patat, A.; Fauchoux, N.; Toutin, C.; Lacoste, E.; Patel, U.; Mascioli, E.; Zanelli, E. 2011: Safety, pharmacokinetic, and pharmacodynamic evaluations of PI-2301, a potent immunomodulator, in a first-in-human, single-ascending-dose study in healthy volunteers. Journal of Clinical Pharmacology 51(5): 649-660
Infante, J.R.; Camidge, D.Ross.; Mileshkin, L.R.; Chen, E.X.; Hicks, R.J.; Rischin, D.; Fingert, H.; Pierce, K.J.; Xu, H.; Roberts, W.Gregory.; Shreeve, S.Martin.; Burris, H.A.; Siu, L.L. 2012: Safety, pharmacokinetic, and pharmacodynamic phase I dose-escalation trial of PF-00562271, an inhibitor of focal adhesion kinase, in advanced solid tumors. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 30(13): 1527-1533
Schwartz, S.L.; Akinlade, B.; Klasen, S.; Kowalski, D.; Zhang, W.; Wilpshaar, W. 2011: Safety, pharmacokinetic, and pharmacodynamic profiles of ipragliflozin (ASP1941), a novel and selective inhibitor of sodium-dependent glucose co-transporter 2, in patients with type 2 diabetes mellitus. Diabetes Technology and Therapeutics 13(12): 1219-1227
Zheng, M.; Appel, L.; Luo, F.; Lane, R.; Burt, D.; Risinger, R.; Antoni, G.; Cahir, M.; Keswani, S.; Hayes, W.; Bhagwagar, Z. 2015: Safety, pharmacokinetic, and positron emission tomography evaluation of serotonin and dopamine transporter occupancy following multiple-dose administration of the triple monoamine reuptake inhibitor BMS-820836. Psychopharmacology 232(3): 529-540
Ballow, C.; Leh, A.; Slentz-Kesler, K.; Yan, J.; Haughey, D.; Bernton, E. 2013: Safety, pharmacokinetic, immunogenicity, and pharmacodynamic responses in healthy volunteers following a single intravenous injection of purified staphylococcal protein a. Journal of Clinical Pharmacology 53(9): 909-918
Erhardt, A.; Deterding, K.; Benhamou, Y.; Reiser, M.; Forns, X.; Pol, S.; Calleja, J.é L.; Ross, S.; Spangenberg, H.C.; Garcia-Samaniego, J.; Fuchs, M.; Enríquez, J.; Wiegand, J.; Stern, J.; Wu, K.; Kukolj, G.; Marquis, M.; Beaulieu, P.; Nehmiz, G.; Steffgen, J.ür. 2009: Safety, pharmacokinetics and antiviral effect of BILB 1941, a novel hepatitis C virus RNA polymerase inhibitor, after 5 days oral treatment. Antiviral Therapy 14(1): 23-32
Devalapally, H.; Rajan, K.Subramanian.; Akkinepally, R.Rao.; Devarakonda, R.Krishna. 2008: Safety, pharmacokinetics and biodistribution studies of a beta-galactoside prodrug of doxorubicin for improvement of tumor selective chemotherapy. Drug Development and Industrial Pharmacy 34(8): 789-795
Ades, V. 2011: Safety, pharmacokinetics and efficacy of artemisinins in pregnancy. Infectious Disease Reports 3(1): E8
Spira, J.; Plyushch, O.; Zozulya, N.; Yatuv, R.; Dayan, I.; Bleicher, A.; Robinson, M.; Baru, M. 2010: Safety, pharmacokinetics and efficacy of factor VIIa formulated with PEGylated liposomes in haemophilia a patients with inhibitors to factor VIII--an open label, exploratory, cross-over, phase I/Ii study. Haemophilia: the Official Journal of the World Federation of Hemophilia 16(6): 910-918
Vicari, A.P.; Schmalbach, T.; Lekstrom-Himes, J.; Morris, M.L.; Al-Adhami, M.J.; Laframboise, C.; Leese, P.; Krieg, A.M.; Efler, S.M.; Davis, H.L. 2007: Safety, pharmacokinetics and immune effects in normal volunteers of CPG 10101 (ACTILON), an investigational synthetic toll-like receptor 9 agonist. Antiviral Therapy 12(5): 741-751
Lopatin, U.; Wolfgang, G.; Tumas, D.; Frey, C.R.; Ohmstede, C.; Hesselgesser, J.; Kearney, B.; Moorehead, L.; Subramanian, G.M.; McHutchison, J.G. 2013: Safety, pharmacokinetics and pharmacodynamics of GS-9620, an oral Toll-like receptor 7 agonist. Antiviral Therapy 18(3): 409-418
Schmitt, C.; Charoin-Pannier, A.; McIntyre, C.; Zandt, H.; Ciorciaro, C.; Winters, K.; Pepper, T. 2012: Safety, pharmacokinetics and pharmacodynamics of multiple ascending doses of R1663, an oral factor Xa inhibitor, in healthy young subjects coupled with exploration of influence of gender and age. Thrombosis and Haemostasis 108(1): 54-64
Jiang, J.; Hu, Y.; Zhang, J.; Yang, J.; Mueck, W.; Kubitza, D.; Bauer, R.J.; Meng, L.; Hu, P. 2010: Safety, pharmacokinetics and pharmacodynamics of single doses of rivaroxaban - an oral, direct factor Xa inhibitor - in elderly Chinese subjects. Thrombosis and Haemostasis 103(1): 234-241
Zhao, X.; Sun, P.; Zhou, Y.; Liu, Y.; Zhang, H.; Mueck, W.; Kubitza, D.; Bauer, R.J.; Zhang, H.; Cui, Y. 2009: Safety, pharmacokinetics and pharmacodynamics of single/multiple doses of the oral, direct Factor Xa inhibitor rivaroxaban in healthy Chinese subjects. British Journal of Clinical Pharmacology 68(1): 77-88
Lawitz, E.; Gruener, D.; Marbury, T.; Hill, J.; Webster, L.; Hassman, D.; Nguyen, A.-H.; Pflanz, S.; Mogalian, E.; Gaggar, A.; Massetto, B.; Subramanian, G.M.; McHutchison, J.G.; Jacobson, I.M.; Freilich, B.; Rodriguez-Torres, M. 2015: Safety, pharmacokinetics and pharmacodynamics of the oral toll-like receptor 7 agonist GS-9620 in treatment-naive patients with chronic hepatitis C. Antiviral Therapy 20(7): 699-708
Sardh, E.; Rejkjaer, L.; Andersson, D.E.H.; Harper, P. 2007: Safety, pharmacokinetics and pharmocodynamics of recombinant human porphobilinogen deaminase in healthy subjects and asymptomatic carriers of the acute intermittent porphyria gene who have increased porphyrin precursor excretion. Clinical Pharmacokinetics 46(4): 335-349
Yamada, I.; Suzuki, F.; Kamiya, N.; Aoki, K.; Sakurai, Y.; Kano, M.; Matsui, H.; Kumada, H. 2012: Safety, pharmacokinetics and resistant variants of telaprevir alone for 12 weeks in hepatitis C virus genotype 1b infection. Journal of Viral Hepatitis 19(2): E112-E119
Hickman, M.A.; Cox, S.R.; Mahabir, S.; Miskell, C.; Lin, J.; Bunger, A.; McCall, R.B. 2008: Safety, pharmacokinetics and use of the novel NK-1 receptor antagonist maropitant (Cerenia) for the prevention of emesis and motion sickness in cats. Journal of Veterinary Pharmacology and Therapeutics 31(3): 220-229
Kurzrock, R.; Goel, S.; Wheler, J.; Hong, D.; Fu, S.; Rezai, K.; Morgan-Linnell, S.K.; Urien, S.; Mani, S.; Chaudhary, I.; Ghalib, M.H.; Buchbinder, A.; Lokiec, F.ço.; Mulcahy, M. 2012: Safety, pharmacokinetics, and activity of EZN-2208, a novel conjugate of polyethylene glycol and SN38, in patients with advanced malignancies. Cancer 118(24): 6144-6151
Kurzrock, R.; Gabrail, N.; Chandhasin, C.; Moulder, S.; Smith, C.; Brenner, A.; Sankhala, K.; Mita, A.; Elian, K.; Bouchard, D.; Sarantopoulos, J. 2012: Safety, pharmacokinetics, and activity of GRN1005, a novel conjugate of angiopep-2, a peptide facilitating brain penetration, and paclitaxel, in patients with advanced solid tumors. Molecular Cancer Therapeutics 11(2): 308-316
Jacobson, J.M.; Kuritzkes, D.R.; Godofsky, E.; DeJesus, E.; Larson, J.A.; Weinheimer, S.P.; Lewis, S.T. 2009: Safety, pharmacokinetics, and antiretroviral activity of multiple doses of ibalizumab (formerly TNX-355), an anti-CD4 monoclonal antibody, in human immunodeficiency virus type 1-infected adults. Antimicrobial Agents and ChemoTherapy 53(2): 450-457
Herbst, R.S.; Hong, D.; Chap, L.; Kurzrock, R.; Jackson, E.; Silverman, J.M.; Rasmussen, E.; Sun, Y.-N.; Zhong, D.; Hwang, Y.C.; Evelhoch, J.L.; Oliner, J.D.; Le, N.; Rosen, L.S. 2009: Safety, pharmacokinetics, and antitumor activity of AMG 386, a selective angiopoietin inhibitor, in adult patients with advanced solid tumors. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 27(21): 3557-3565
Lawitz, E.; Godofsky, E.; Rouzier, R.; Marbury, T.; Nguyen, T.; Ke, J.; Huang, M.; Praestgaard, J.; Serra, D.; Evans, T.G. 2011: Safety, pharmacokinetics, and antiviral activity of the cyclophilin inhibitor NIM811 alone or in combination with pegylated interferon in HCV-infected patients receiving 14 days of therapy. Antiviral Research 89(3): 238-245
Emu, B.; Luca, D.; Offutt, C.; Grogan, J.L.; Rojkovich, B.; Williams, M.B.; Tang, M.T.; Xiao, J.; Lee, J.H.; Davis, J.C. 2012: Safety, pharmacokinetics, and biologic activity of pateclizumab, a novel monoclonal antibody targeting lymphotoxin α: results of a phase i randomized, placebo-controlled trial. Arthritis Research and Therapy 14(1): R6
Rosen, L.S.; Kurzrock, R.; Mulay, M.; Van Vugt, A.; Purdom, M.; Ng, C.; Silverman, J.; Koutsoukos, A.; Sun, Y.-N.; Bass, M.B.; Xu, R.Y.; Polverino, A.; Wiezorek, J.S.; Chang, D.D.; Benjamin, R.; Herbst, R.S. 2007: Safety, pharmacokinetics, and efficacy of AMG 706, an oral multikinase inhibitor, in patients with advanced solid tumors. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 25(17): 2369-2376
Batist, G.; Gelmon, K.A.; Chi, K.N.; Miller, W.H.; Chia, S.K.L.; Mayer, L.D.; Swenson, C.E.; Janoff, A.S.; Louie, A.C. 2009: Safety, pharmacokinetics, and efficacy of CPX-1 liposome injection in patients with advanced solid tumors. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 15(2): 692-700
Berg, S.L.; Cairo, M.S.; Russell, H.; Ayello, J.; Ingle, A.Mark.; Lau, H.; Chen, N.; Adamson, P.C.; Blaney, S.M. 2011: Safety, pharmacokinetics, and immunomodulatory effects of lenalidomide in children and adolescents with relapsed/refractory solid tumors or myelodysplastic syndrome: a Children's Oncology Group Phase I Consortium report. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 29(3): 316-323
Gordon, M.S.; Sweeney, C.S.; Mendelson, D.S.; Eckhardt, S.G.; Anderson, A.; Beaupre, D.M.; Branstetter, D.; Burgess, T.L.; Coxon, A.; Deng, H.; Kaplan-Lefko, P.; Leitch, I.M.; Oliner, K.S.; Yan, L.; Zhu, M.; Gore, L. 2010: Safety, pharmacokinetics, and pharmacodynamics of AMG 102, a fully human hepatocyte growth factor-neutralizing monoclonal antibody, in a first-in-human study of patients with advanced solid tumors. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 16(2): 699-710
Cramer, S.C.; Abila, B.; Scott, N.E.; Simeoni, M.; Enney, L.A. 2013: Safety, pharmacokinetics, and pharmacodynamics of escalating repeat doses of GSK249320 in patients with stroke. Stroke 44(5): 1337-1342
Sasaki, T.; Seino, Y.; Fukatsu, A.; Sakai, S.; Samukawa, Y. 2014: Safety, pharmacokinetics, and pharmacodynamics of single and multiple luseogliflozin dosing in healthy Japanese males: a randomized, single-blind, placebo-controlled trial. Advances in Therapy 31(3): 345-361
Katz, A.; Udata, C.; Ott, E.; Hickey, L.; Burczynski, M.E.; Burghart, P.; Vesterqvist, O.; Meng, X. 2009: Safety, pharmacokinetics, and pharmacodynamics of single doses of LXR-623, a novel liver X-receptor agonist, in healthy participants. Journal of Clinical Pharmacology 49(6): 643-649
Karp, D.D.; Pollak, M.N.; Cohen, R.B.; Eisenberg, P.D.; Haluska, P.; Yin, D.; Lipton, A.; Demers, L.; Leitzel, K.; Hixon, M.L.; Terstappen, L.W.; Garland, L.; Paz-Ares, L.G.; Cardenal, F.; Langer, C.J.; Gualberto, A. 2009: Safety, pharmacokinetics, and pharmacodynamics of the insulin-like growth factor type 1 receptor inhibitor figitumumab (CP-751,871) in combination with paclitaxel and carboplatin. Journal of Thoracic Oncology: Official Publication of the International Association for the Study of Lung Cancer 4(11): 1397-1403
Olmos, D.; Postel-Vinay, S.; Molife, L.R.; Okuno, S.H.; Schuetze, S.M.; Paccagnella, M.L.; Batzel, G.N.; Yin, D.; Pritchard-Jones, K.; Judson, I.; Worden, F.P.; Gualberto, A.; Scurr, M.; de Bono, J.S.; Haluska, P. 2010: Safety, pharmacokinetics, and preliminary activity of the anti-IGF-1R antibody figitumumab (CP-751,871) in patients with sarcoma and Ewing's sarcoma: a phase 1 expansion cohort study. LANCET. Oncology 11(2): 129-135
Strumberg, D.; Clark, J.W.; Awada, A.; Moore, M.J.; Richly, H.; Hendlisz, A.; Hirte, H.W.; Eder, J.P.; Lenz, H.-J.; Schwartz, B. 2007: Safety, pharmacokinetics, and preliminary antitumor activity of sorafenib: a review of four phase i trials in patients with advanced refractory solid tumors. Oncologist 12(4): 426-437
Khwaja, O.S.; Ho, E.; Barnes, K.V.; O'Leary, H.M.; Pereira, L.M.; Finkelstein, Y.; Nelson, C.A.; Vogel-Farley, V.; DeGregorio, G.; Holm, I.A.; Khatwa, U.; Kapur, K.; Alexander, M.E.; Finnegan, D.M.; Cantwell, N.G.; Walco, A.C.; Rappaport, L.; Gregas, M.; Fichorova, R.N.; Shannon, M.W.; Sur, M.; Kaufmann, W.E. 2014: Safety, pharmacokinetics, and preliminary assessment of efficacy of mecasermin (recombinant human IGF-1) for the treatment of Rett syndrome. Proceedings of the National Academy of Sciences of the United States of America 111(12): 4596-4601
Advani, A.; Coiffier, B.; Czuczman, M.S.; Dreyling, M.; Foran, J.; Gine, E.; Gisselbrecht, C.; Ketterer, N.; Nasta, S.; Rohatiner, A.; Schmidt-Wolf, I.G.H.; Schuler, M.; Sierra, J.; Smith, M.R.; Verhoef, G.; Winter, J.N.; Boni, J.; Vandendries, E.; Shapiro, M.; Fayad, L. 2010: Safety, pharmacokinetics, and preliminary clinical activity of inotuzumab ozogamicin, a novel immunoconjugate for the treatment of B-cell non-Hodgkin's lymphoma: results of a phase i study. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 28(12): 2085-2093
Bendell, J.C.; Gordon, M.S.; Hurwitz, H.I.; Jones, S.F.; Mendelson, D.S.; Blobe, G.C.; Agarwal, N.; Condon, C.H.; Wilson, D.; Pearsall, A.E.; Yang, Y.; McClure, T.; Attie, K.M.; Sherman, M.L.; Sharma, S. 2014: Safety, pharmacokinetics, pharmacodynamics, and antitumor activity of dalantercept, an activin receptor-like kinase-1 ligand trap, in patients with advanced cancer. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 20(2): 480-489
Westerberg, G.; Chiesa, J.A.; Andersen, C.A.; Diamanti, D.; Magnoni, L.; Pollio, G.; Darpo, B.; Zhou, M. 2015: Safety, pharmacokinetics, pharmacogenomics and QT concentration-effect modelling of the SirT1 inhibitor selisistat in healthy volunteers. British Journal of Clinical Pharmacology 79(3): 477-491
Melissas, J. 2009: Safety, quality and excellence in bariatric surgery. Minerva Chirurgica 64(3): 239-252
Grose, A. 2014: Safety, quality, compassion… and cost. American Journal of Orthopedics 43(7): 300-301
El Sahly, H.M.; Atmar, R.L.; Patel, S.M.; Wells, J.M.; Cate, T.; Ho, M.; Guo, K.; Pasetti, M.F.; Lewis, D.E.; Sztein, M.B.; Keitel, W.A. 2009: Safety, reactogenicity and immunogenicity of Francisella tularensis live vaccine strain in humans. Vaccine 27(36): 4905-4911
Dicko, A.; Santara, G.; Mahamar, A.; Sidibe, Y.; Barry, A.; Dicko, Y.; Diallo, A.; Dolo, A.; Doumbo, O.; Shafi, F.; François, N.; Strezova, A.; Borys, D.; Schuerman, L. 2013: Safety, reactogenicity and immunogenicity of a booster dose of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Malian children. Human Vaccines and Immunotherapeutics 9(2): 382-388
Leroux-Roels, G.; Maes, C.; De Boever, F.; Traskine, M.; Rüggeberg, J.U.; Borys, D. 2014: Safety, reactogenicity and immunogenicity of a novel pneumococcal protein-based vaccine in adults: a phase I/Ii randomized clinical study. Vaccine 32(50): 6838-6846
Campbell, J.D.; Clement, K.H.L.; Wasserman, S.S.; Donegan, S.; Chrisley, L.; Kotloff, K.L. 2007: Safety, reactogenicity and immunogenicity of a recombinant protective antigen anthrax vaccine given to healthy adults. Human Vaccines 3(5): 205-211
Omenaca, F.; Sarlangue, J.; Szenborn, L.; Nogueira, M.; Suryakiran, P.V.; Smolenov, I.V.; Han, H.H.; Tejedor, J.C.; Castro, J.; Arístegui, J.; Centeno, F.; Merino, J.é M.; Moreno-Pérez, D.; Díez-Delgado, J.; Ruiz-Contreras, J.ús.; Carbonell, X.; Román, E.; Pajek, B.; Slaskie, S.; Wysocki, J.; Czajka, H.; Barroso, R.; Fonseca, F.; Areias, A.; Dinis, M.J.úl. 2012: Safety, reactogenicity and immunogenicity of the human rotavirus vaccine in preterm European Infants: a randomized phase IIIb study. Pediatric Infectious Disease Journal 31(5): 487-493
Lim, F.S.; Han, H.H.; Bock, H.L. 2007: Safety, reactogenicity and immunogenicity of the live attenuated combined measles, mumps and rubella vaccine containing the RIT 4385 mumps strain in healthy Singaporean children. Annals of the Academy of Medicine Singapore 36(12): 969-973
Postgate, A.J.; Burling, D.; Gupta, A.; Fitzpatrick, A.; Fraser, C. 2008: Safety, reliability and limitations of the given patency capsule in patients at risk of capsule retention: a 3-year technical review. Digestive Diseases and Sciences 53(10): 2732-2738
Gridelli, C.; de Marinis, F.; Pujol, J.-L.; Reck, M.; Ramlau, R.; Parente, B.; Pieters, T.; Middleton, G.; Corral, J.; Winfree, K.; Melemed, S.; Zimmermann, A.; John, W.; Beyrer, J.; Chouaki, N.; Visseren-Grul, C.; Paz-Ares, L.G. 2012: Safety, resource use, and quality of life in paramount: a phase IIi study of maintenance pemetrexed versus placebo after induction pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancer. Journal of Thoracic Oncology: Official Publication of the International Association for the Study of Lung Cancer 7(11): 1713-1721
Macpherson, J.A.E. 2008: Safety, risk acceptability, and morality. Science and Engineering Ethics 14(3): 377-390
Smith-Merry, J.; Caple, A. 2014: Safety, risk and mental health: decision-making processes prescribed by Australian mental health legislation. Journal of Law and Medicine 21(3): 661-681
Cavanagh, H.Dwight.; Holden, B. 2007: Safety, safety, safety. Eye and Contact Lens 33(6 Part 2): 341
Arcury, T.A.; Weir, M.M.; Summers, P.; Chen, H.; Bailey, M.; Wiggins, M.F.; Bischoff, W.E.; Quandt, S.A. 2012: Safety, security, hygiene and privacy in migrant farmworker housing. New solutions: a journal of environmental and occupational health policy: NS 22(2): 153-173
Sommavilla, B.; Jørgensen, C.; Jensen, K. 2008: Safety, simplicity and convenience of a modified prefilled insulin pen. Expert Opinion on PharmacoTherapy 9(13): 2223-2232
Taschuk, R.; Marciniuk, K.; Määttänen, P.; Madampage, C.; Hedlin, P.; Potter, A.; Lee, J.; Cashman, N.R.; Griebel, P.J.; Napper, S. 2014: Safety, specificity and immunogenicity of a PrP(Sc)-specific prion vaccine based on the YYR disease specific epitope. Prion 8(1): 51-59
Kesselheim, A. 2011: Safety, supply, and suits--litigation and the vaccine industry. New England Journal of Medicine 364(16): 1485-1487
Asma, S.; Boga, C.; Ozdogu, H. 2009: Safety, therapeutic effectiveness, and cost of parenteral iron therapy. International Journal of Hematology 90(1): 24-27
Benbow, M. 2014: Safety, tolerability and acceptability of KTwo. Journal of Wound Care 23(4 Suppl): S4-19
Loriot, Y.; Fizazi, K.; Jones, R.J.; Van den Brande, J.; Molife, R.L.; Omlin, A.; James, N.D.; Baskin-Bey, E.; Heeringa, M.; Baron, B.; Holtkamp, G.M.; Ouatas, T.; De Bono, J.S. 2014: Safety, tolerability and anti-tumour activity of the androgen biosynthesis inhibitor ASP9521 in patients with metastatic castration-resistant prostate cancer: multi-centre phase I/Ii study. Investigational new Drugs 32(5): 995-1004
Noberasco, C.; Spitaleri, G.; Mancuso, P.; Zorzino, L.; Radice, D.; Milani, A.; Rocca, A.; Bertolini, F.; Sandri, M.T.; Curigliano, G.; de Pas, T.; Jemos, C.; Omodeo Salè, E.; Boselli, S.; de Braud, F. 2009: Safety, tolerability and biological effects of long-term metronomic administration of non-cytotoxic anti-angiogenic agents. Oncology 77(6): 358-365
Li, H.-C.; Cheng, Y.-P.; Yang, C.-J. 2014: Safety, tolerability and effectiveness of HIV non-occupational prophylaxis in Taiwan. Journal of the International Aids Society 17(4 Suppl 3: 19736
Sherrod, C.; Johnson, D.; Chester, B. 2014: Safety, tolerability and effectiveness of an ergonomic intervention with chiropractic care for knowledge workers with upper-extremity musculoskeletal disorders: a prospective case series. Work 49(4): 641-651
Kumarasamy, N.; Venkatesh, K.K.; Devaleenol, B.; Poongulali, S.; Mothi, S.N.; Solomon, S. 2009: Safety, tolerability and effectiveness of generic HAART in HIV-infected children in South India. Journal of Tropical Pediatrics 55(3): 155-159
Witthöft, T.; Möller, B.; Wiedmann, K.H.; Mauss, S.; Link, R.; Lohmeyer, J.; Lafrenz, M.; Gelbmann, C.M.; Hüppe, D.; Niederau, C.; Alshuth, U. 2007: Safety, tolerability and efficacy of peginterferon alpha-2a and ribavirin in chronic hepatitis C in clinical practice: the German Open Safety Trial. Journal of Viral Hepatitis 14(11): 788-796
Passali, D.; Mösges, R.; Passali, G.C.; Passali, F.M.; Ayoko, G.; Bellussi, L. 2010: Safety, tolerability and efficacy of sublingual allergoid immunotherapy with three different shortened up-dosing administration schedules. Acta Otorhinolaryngologica Italica: Organo Ufficiale Della Societa Italiana di Otorinolaringologia e Chirurgia Cervico-Facciale 30(3): 131-137
Gaggar, A.; Coeshott, C.; Apelian, D.; Rodell, T.; Armstrong, B.R.; Shen, G.; Subramanian, G.M.; McHutchison, J.G. 2014: Safety, tolerability and immunogenicity of GS-4774, a hepatitis B virus-specific therapeutic vaccine, in healthy subjects: a randomized study. Vaccine 32(39): 4925-4931
Van Damme, P.; Minervini, G.; Liss, C.L.; McCarson, B.; Vesikari, T.; Boslego, J.W.; Bhuyan, P.K. 2009: Safety, tolerability and immunogenicity of a recombinant hepatitis B vaccine manufactured by a modified process in healthy young adults. Human Vaccines 5(2): 92-97
Shefner, J.; Cedarbaum, J.M.; Cudkowicz, M.E.; Maragakis, N.; Lee, J.; Jones, D.; Watson, M.L.; Mahoney, K.; Chen, M.; Saikali, K.; Mao, J.; Russell, A.J.; Hansen, R.L.; Malik, F.; Wolff, A.A.; Atassi, N.; Bedlack, R.; Boylan, K.; Bradshaw, D.; Goslin, K.; Heiman Patterson, T.; Jackson, C.; Kasarskis, E.J.; Katz, J.; Levine, T.; Maragakis, N.J.; Pestronk, A.; Simmons, Z. 2012: Safety, tolerability and pharmacodynamics of a skeletal muscle activator in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis: Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases 13(5): 430-438
Saha, N.; Moehrle, J.J.; Zutshi, A.; Sharma, P.; Kaur, P.; Iyer, S.S. 2014: Safety, tolerability and pharmacokinetic profile of single and multiple oral doses of arterolane (RBx11160) maleate in healthy subjects. Journal of Clinical Pharmacology 54(4): 386-393
Li, Q.; Qiao, J.; Deng, J.; Zeng, T.; Zhou, P.; Li, W. 2009: Safety, tolerability and pharmacokinetic study of recombinant human parathyroid hormone [rhPTH (1-84)] in Chinese healthy volunteers. Journal of Huazhong University of Science and Technology. Medical Sciences 29(4): 431-434
Cutler, D.L.; Tendolkar, A.; Grachev, I.D. 2012: Safety, tolerability and pharmacokinetics after single and multiple doses of preladenant (SCH420814) administered in healthy subjects. Journal of Clinical Pharmacy and Therapeutics 37(5): 578-587
Kaste, M.; Murayama, S.; Ford, G.A.; Dippel, D.W.J.; Walters, M.R.; Tatlisumak, T. 2013: Safety, tolerability and pharmacokinetics of MCI-186 in patients with acute ischemic stroke: new formulation and dosing regimen. Cerebrovascular Diseases 36(3): 196-204
Kumagai, Y.; Fujita, T.; Ozaki, M.; Yokota, S.-i.; Maeda, M.; Shida, M.; Otani, Y.; Yamaya, H.; Tsuruta, H. 2009: Safety, tolerability and pharmacokinetics of TAS-108, a novel anti-oestrogen, in healthy post-menopausal Japanese women: a phase i single oral dose study. Basic and Clinical Pharmacology and Toxicology 104(5): 352-359
Van Hartingsveldt, B.; Nnane, I.P.; Bouman-Thio, E.; Loza, M.J.; Piantone, A.; Davis, H.M.; Petty, K.J. 2013: Safety, tolerability and pharmacokinetics of a human anti-interleukin-13 monoclonal antibody (CNTO 5825) in an ascending single-dose first-in-human study. British Journal of Clinical Pharmacology 75(5): 1289-1298
Vachiery, J.-L.; Huez, S.; Gillies, H.; Layton, G.; Hayashi, N.; Gao, X.; Naeije, R. 2011: Safety, tolerability and pharmacokinetics of an intravenous bolus of sildenafil in patients with pulmonary arterial hypertension. British Journal of Clinical Pharmacology 71(2): 289-292
Derks, M.; Anzures-Cabrera, J.; Turnbull, L.; Phelan, M. 2011: Safety, tolerability and pharmacokinetics of dalcetrapib following single and multiple ascending doses in healthy subjects: a randomized, double-blind, placebo-controlled, phase i study. Clinical Drug Investigation 31(5): 325-335
Frey Tirri, B.; Bitzer, J.; Geudelin, B.; Drewe, J. 2010: Safety, tolerability and pharmacokinetics of intravaginal pentamycin. ChemoTherapy 56(3): 190-196
Weller, S.; Jones, L.S.; Lou, Y.; Piscitelli, S.; Peppercorn, A.; Ng-Cashin, J. 2013: Safety, tolerability and pharmacokinetics of orally inhaled zanamivir: a randomized study comparing Rotacap/Rotahaler and Rotadisk/Diskhaler in healthy adults. Antiviral Therapy 18(6): 827-830
Zhao, L.; Yang, X.; Xu, R.; Wu, J.; Gu, S.; Zhang, L.; Gong, P.; Chen, H.; Zeng, F. 2009: Safety, tolerability and pharmacokinetics of phenoprolamine hydrochloride floating sustained-release tablets in healthy Chinese subjects. International Journal of Pharmaceutics 377(1-2): 99-104
Pascoe, S.; Reynolds, C.; Pleskow, W.; Perry, S.; Hmissi, A.; Kaiser, G.; Brookman, L. 2011: Safety, tolerability and pharmacokinetics of single escalating doses of indacaterol, a once-daily beta2-agonist bronchodilator, in subjects with COPD. International Journal of Clinical Pharmacology and Therapeutics 49(2): 153-161
Peeters, P.A.M.; van den Heuvel, M.W.; van Heumen, E.; Passier, P.C.C.M.; Smeets, J.M.W.; van Iersel, T.; Zwiers, A. 2010: Safety, tolerability and pharmacokinetics of sugammadex using single high doses (up to 96 mg/kg) in healthy adult subjects: a randomized, double-blind, crossover, placebo-controlled, single-centre study. Clinical Drug Investigation 30(12): 867-874
Othman, A.A.; Haig, G.; Florian, H.; Locke, C.; Zhang, J.; Dutta, S. 2013: Safety, tolerability and pharmacokinetics of the histamine H3 receptor antagonist, ABT-288, in healthy young adults and elderly volunteers. British Journal of Clinical Pharmacology 75(5): 1299-1311
Paquette, J.-M.; Rufiange, M.; Iovu Niculita, M.; Massicotte, J.; Lefebvre, M.; Colin, P.; Telmat, A.; Ranger, M. 2014: Safety, tolerability and pharmacokinetics of trimebutine 3-thiocarbamoylbenzenesulfonate (GIC-1001) in a randomized phase i integrated design study: single and multiple ascending doses and effect of food in healthy volunteers. Clinical Therapeutics 36(11): 1650-1664
Granel, B.; Daumas, A.él.; Jouve, E.; Harlé, J.-R.; Nguyen, P.-S.éb.; Chabannon, C.; Colavolpe, N.; Reynier, J.-C.; Truillet, R.; Mallet, S.ép.; Baiada, A.; Casanova, D.; Giraudo, L.; Arnaud, L.; Veran, J.; Sabatier, F.; Magalon, G. 2015: Safety, tolerability and potential efficacy of injection of autologous adipose-derived stromal vascular fraction in the fingers of patients with systemic sclerosis: an open-label phase i trial. Annals of the Rheumatic Diseases 74(12): 2175-2182
Chistyakov, A.V.; Rubicsek, O.; Kaplan, B.; Zaaroor, M.; Klein, E. 2010: Safety, tolerability and preliminary evidence for antidepressant efficacy of theta-burst transcranial magnetic stimulation in patients with major depression. International Journal of Neuropsychopharmacology 13(3): 387-393
Oba, Y.; Zaza, T.; Thameem, D.M. 2008: Safety, tolerability and risk benefit analysis of tiotropium in COPD. International Journal of Chronic Obstructive Pulmonary Disease 3(4): 575-584
Gonçalves, A.K.; Cobucci, R.N.; Rodrigues, H.M.; de Melo, A.G.; Giraldo, P.C.és. 2014: Safety, tolerability and side effects of human papillomavirus vaccines: a systematic quantitative review. Brazilian Journal of Infectious Diseases: An Official Publication of the Brazilian Society of Infectious Diseases 18(6): 651-659
Siegel, M.; Garber, M.E.; Spencer, A.G.; Botwick, W.; Kumar, P.; Williams, R.N.; Kozuka, K.; Shreeniwas, R.; Pratha, V.; Adelman, D.C. 2012: Safety, tolerability, and activity of ALV003: results from two phase 1 single, escalating-dose clinical trials. Digestive Diseases and Sciences 57(2): 440-450
Winblad, B.; Andreasen, N.; Minthon, L.; Floesser, A.; Imbert, G.; Dumortier, T.; Maguire, R.P.; Blennow, K.; Lundmark, J.; Staufenbiel, M.; Orgogozo, J.-M.; Graf, A. 2012: Safety, tolerability, and antibody response of active Aβ immunotherapy with CAD106 in patients with Alzheimer's disease: randomised, double-blind, placebo-controlled, first-in-human study. LANCET. Neurology 11(7): 597-604
Alfaro, V.Y.; Goldblatt, D.L.; Valverde, G.R.; Munsell, M.F.; Quinton, L.J.; Walker, A.K.; Dantzer, R.; Varadhachary, A.; Scott, B.L.; Evans, S.E.; Tuvim, M.J.; Dickey, B.F. 2014: Safety, tolerability, and biomarkers of the treatment of mice with aerosolized Toll-like receptor ligands. Frontiers in Pharmacology 5: 8
Parry, G.J.; Rodrigues, C.M.P.; Aranha, M.M.; Hilbert, S.J.; Davey, C.; Kelkar, P.; Low, W.C.; Steer, C.J. 2010: Safety, tolerability, and cerebrospinal fluid penetration of ursodeoxycholic Acid in patients with amyotrophic lateral sclerosis. Clinical Neuropharmacology 33(1): 17-21
Mease, P.J.; Wei, N.; Fudman, E.J.; Kivitz, A.J.; Schechtman, J.; Trapp, R.G.; Hobbs, K.F.; Greenwald, M.; Hou, A.; Bookbinder, S.A.; Graham, G.E.; Wiesenhutter, C.W.; Willis, L.; Ruderman, E.M.; Forstot, J.Z.; Maricic, M.J.; Dao, K.H.; Pritchard, C.H.; Fiske, D.N.; Burch, F.X.; Prupas, H.M.; Anklesaria, P.; Heald, A.E. 2010: Safety, tolerability, and clinical outcomes after intraarticular injection of a recombinant adeno-associated vector containing a tumor necrosis factor antagonist gene: results of a phase 1/2 Study. Journal of Rheumatology 37(4): 692-703
Kunde, S.; Pham, A.; Bonczyk, S.; Crumb, T.; Duba, M.; Conrad, H.; Cloney, D.; Kugathasan, S. 2013: Safety, tolerability, and clinical response after fecal transplantation in children and young adults with ulcerative colitis. Journal of Pediatric Gastroenterology and Nutrition 56(6): 597-601
Czömpöly, T.ás.; Langmár, Z.án.; Bors, M.ár.; Zsákai, C.; Géczy, M.ár.; Kulcsár, G. 2014: Safety, tolerability, and effect on quality of life of a mixture of amino acids and other small molecules in cancer patients. Cancer BioTherapy and Radiopharmaceuticals 29(3): 124-134
Hadley, D.; Anderson, B.S.; Borckardt, J.J.; Arana, A.; Li, X.; Nahas, Z.; George, M.S. 2011: Safety, tolerability, and effectiveness of high doses of adjunctive daily left prefrontal repetitive transcranial magnetic stimulation for treatment-resistant depression in a clinical setting. Journal of Ect 27(1): 18-25
Corey, R.; Naderer, O.J.; O'Riordan, W.D.; Dumont, E.; Jones, L.S.; Kurtinecz, M.; Zhu, J.Z. 2014: Safety, tolerability, and efficacy of GSK1322322 in the treatment of acute bacterial skin and skin structure infections. Antimicrobial Agents and ChemoTherapy 58(11): 6518-6527
Hicks, C.; Clay, P.; Redfield, R.; Lalezari, J.; Liporace, R.; Schneider, S.; Sension, M.; McRae, M.; Laurent, J.-P. 2013: Safety, tolerability, and efficacy of KP-1461 as monotherapy for 124 days in antiretroviral-experienced, HIV type 1-infected subjects. Aids Research and Human Retroviruses 29(2): 250-255
Bramlage, P.; Zemmrich, C.; Ketelhut, R.; Wolf, W.-P.; Fronk, E.-M.; Schmieder, R.E. 2013: Safety, tolerability, and efficacy of a fixed-dose combination of olmesartan 40 mg and hydrochlorothiazide 12.5/25 mg in daily practice. Vascular Health and Risk Management 9: 475-483
Rachlis, A.; Clotet, B.; Baxter, J.; Murphy, R.; Lefebvre, E. 2007: Safety, tolerability, and efficacy of darunavir (TMC114) with low-dose ritonavir in treatment-experienced, hepatitis B or C co-infected patients in POWER 1 and 3. HIV Clinical Trials 8(4): 213-220
Greenwald, B.D.; Dumot, J.A.; Horwhat, J.D.; Lightdale, C.J.; Abrams, J.A. 2010: Safety, tolerability, and efficacy of endoscopic low-pressure liquid nitrogen spray cryotherapy in the esophagus. Diseases of the Esophagus: Official Journal of the International Society for Diseases of the Esophagus 23(1): 13-19
Bell, N.P.; Ramos, J.é L.; Feldman, R.M. 2010: Safety, tolerability, and efficacy of fixed combination therapy with dorzolamide hydrochloride 2% and timolol maleate 0.5% in glaucoma and ocular hypertension. Clinical Ophthalmology 4: 1331-1346
Yuan, N.; Kane, P.; Shelton, K.; Matel, J.; Becker, B.C.; Moss, R.B. 2010: Safety, tolerability, and efficacy of high-frequency chest wall oscillation in pediatric patients with cerebral palsy and neuromuscular diseases: an exploratory randomized controlled trial. Journal of Child Neurology 25(7): 815-821
Hajjaji, I.; Shah, S.; Li, Y.; Prusty, V.; Benabbas, Y.; Home, P.D. 2014: Safety, tolerability, and efficacy of insulin aspart in people with type 2 diabetes, as biphasic insulin aspart or with Basal insulin: findings from the multinational, non-interventional a1chieve study. Diabetes Therapy: Research Treatment and Education of Diabetes and Related Disorders 5(1): 113-126
Findling, R.L.; Pathak, S.; Earley, W.R.; Liu, S.; DelBello, M. 2013: Safety, tolerability, and efficacy of quetiapine in youth with schizophrenia or bipolar i disorder: a 26-week, open-label, continuation study. Journal of Child and Adolescent Psychopharmacology 23(7): 490-501
Squires, K.E.; Bekker, L.-G.; Eron, J.J.; Cheng, B.; Rockstroh, J.K.; Marquez, F.; Kumar, P.; Thompson, M.; Campo, R.E.; Mounzer, K.; Strohmaier, K.M.; Lu, C.; Rodgers, A.; Jackson, B.E.; Wenning, L.A.; Robertson, M.; Nguyen, B.-Y.T.; Sklar, P.; Grinstejn, B.; Martins Netto, E.; Donastorg, Y.; Figueroa, P.; Botes, M.; Miller, S.; Barker, D.; Bedimo, R.; Campo, R.; Casey, K.; Cook, P.; Rieg, G.; Daar, E.; DeJesus, E.; Gathe, J.; Gilliam, B.; Gupta, S.; Goldman, M.; Hagins, D.; Hao, R.; Kadlecik, P.; Kumar, P.; Marquez, F.; Mounzer, K.; Mullane, K.; Myers, R.; Osiyemi, O.; Parks, D.; Perez, G.; Polland, R.; Santiago, S.; Sax, P.; Tandon, R.; Skrik, P.; Squires, K.; Thompson, M.; Yin, M.; Corales, R.; Liporace, R.; Albrecht, H. 2013: Safety, tolerability, and efficacy of raltegravir in a diverse cohort of HIV-infected patients: 48-week results from the REALMRK Study. Aids Research and Human Retroviruses 29(6): 859-870
Alam, M.Y.; Jacobsen, P.L.; Chen, Y.; Serenko, M.; Mahableshwarkar, A.R. 2014: Safety, tolerability, and efficacy of vortioxetine (Lu AA21004) in major depressive disorder: results of an open-label, flexible-dose, 52-week extension study. International Clinical Psychopharmacology 29(1): 36-44
Yoshikawa, K.; Nakazawa, Y.; Katsuyama, Y.; Hirabayashi, K.; Saito, S.; Shigemura, T.; Tanaka, M.; Yanagisawa, R.; Sakashita, K.; Koike, K. 2014: Safety, tolerability, and feasibility of antifungal prophylaxis with micafungin at 2 mg/kg daily in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation. Infection 42(4): 639-647
Yoon, G.; Kim, S.W.; Thuras, P.; Westermeyer, J. 2011: Safety, tolerability, and feasibility of high-dose naltrexone in alcohol dependence: an open-label study. Human Psychopharmacology 26(2): 125-132
Vermeulen, J.N.; Lange, J.M.A.; Tyring, S.K.; Peters, P.H.; Nunez, M.; Poland, G.; Levin, M.J.; Freeman, C.; Chalikonda, I.; Li, J.; Smith, J.G.; Caulfield, M.J.; Stek, J.E.; Chan, I.S.F.; Vessey, R.; Schödel, F.P.; Annunziato, P.W.; Schlienger, K.; Silber, J.L. 2012: Safety, tolerability, and immunogenicity after 1 and 2 doses of zoster vaccine in healthy adults ≥60 years of age. Vaccine 30(5): 904-910
Reisinger, K.S.; Block, S.L.; Collins-Ogle, M.; Marchant, C.; Catlett, M.; Radley, D.; Sings, H.L.; Haupt, R.M.; Garner, E.I.O. 2010: Safety, tolerability, and immunogenicity of gardasil given concomitantly with Menactra and Adacel. Pediatrics 125(6): 1142-1151
Rodriguez, B.; Asmuth, D.M.; Matining, R.M.; Spritzler, J.; Jacobson, J.M.; Mailliard, R.B.; Li, X.-D.; Martinez, A.I.; Tenorio, A.R.; Lori, F.; Lisziewicz, J.; Yesmin, S.; Rinaldo, C.R.; Pollard, R.B. 2013: Safety, tolerability, and immunogenicity of repeated doses of dermavir, a candidate therapeutic HIV vaccine, in HIV-infected patients receiving combination antiretroviral therapy: results of the ACTG 5176 trial. Journal of Acquired Immune Deficiency Syndromes 64(4): 351-359
Nell, A.S.; D'lom, E.; Bouic, P.; Sabaté, M.; Bosser, R.; Picas, J.; Amat, M.è; Churchyard, G.; Cardona, P.-J. 2014: Safety, tolerability, and immunogenicity of the novel antituberculous vaccine RUTI: randomized, placebo-controlled phase Ii clinical trial in patients with latent tuberculosis infection. Plos one 9(2): E89612
Mills, R.; Tyring, S.K.; Levin, M.J.; Parrino, J.; Li, X.; Coll, K.E.; Stek, J.E.; Schlienger, K.; Chan, I.S.F.; Silber, J.L. 2010: Safety, tolerability, and immunogenicity of zoster vaccine in subjects with a history of herpes zoster. Vaccine 28(25): 4204-4209
Wang, J.; Patil, S.P.; Yang, N.; Ko, J.; Lee, J.; Noone, S.; Sampson, H.A.; Li, X.-M. 2010: Safety, tolerability, and immunologic effects of a food allergy herbal formula in food allergic individuals: a randomized, double-blinded, placebo-controlled, dose escalation, phase 1 study. Annals of Allergy Asthma and Immunology: Official Publication of the American College of Allergy Asthma and Immunology 105(1): 75-84
Kieninger, D.M.; Kueper, K.; Steul, K.; Juergens, C.; Ahlers, N.; Baker, S.; Jansen, K.U.; Devlin, C.; Gruber, W.C.; Emini, E.A.; Scott, D.A.; Adelt, T.; Behre, U.; Blume, S.; Burow, H.-M.; Büttner, H.-J.; Clementsen, R.; Dehn, M.; Deigendesch, W.; Dietmair, E.; Distel, D.; Ernst, R.; Freund, R.; Habash, T.; Hubmann, M.; Janssen, U.; Kandzora, J.; Kessler, K.-D.; Knapp, G.; Knecht, R.; Kohl, A.; Laakmann, K.-H.; Landendörfer, W.; Lauf, R.; Lautenbach, P.; Lenz, T.; Leonhardt, E.; Lugauer, S.; Mahdi, S.; Mahlo, P.; Mai, K.-E.; Maruschke, S.; Möllering, C.; Morf, G.; Münzer, S.; Noll, S.; Pauli, C.; Peters, H.-H.; Mohns-Petersen, S.; Raff, W.; Richter, T.; Rossius, H.; Runge, C.; Sander, L.; Schlegel, D.; Soemantri, P.A.; Stechele, V.; St 2010: Safety, tolerability, and immunologic noninferiority of a 13-valent pneumococcal conjugate vaccine compared to a 7-valent pneumococcal conjugate vaccine given with routine pediatric vaccinations in Germany. Vaccine 28(25): 4192-4203
Rose, M.A.; Weigand, B.; Schubert, R.; Schulze, J.; Zielen, S. 2011: Safety, tolerability, and impact on allergic inflammation of autologous E.coli autovaccine in the treatment of house dust mite asthma--a prospective open clinical trial. Bmc Complementary and Alternative Medicine 11: 45
Asmuth, D.M.; Murphy, R.L.; Rosenkranz, S.L.; Lertora, J.J.L.; Kottilil, S.; Cramer, Y.; Chan, E.S.; Schooley, R.T.; Rinaldo, C.R.; Thielman, N.; Li, X.-D.; Wahl, S.M.; Shore, J.; Janik, J.; Lempicki, R.A.; Simpson, Y.; Pollard, R.B. 2010: Safety, tolerability, and mechanisms of antiretroviral activity of pegylated interferon Alfa-2a in HIV-1-monoinfected participants: a phase Ii clinical trial. Journal of Infectious Diseases 201(11): 1686-1696
Lowe, S.L.; Wong, C.J.; Witcher, J.; Gonzales, C.R.; Dickinson, G.L.; Bell, R.L.; Rorick-Kehn, L.; Weller, M.; Stoltz, R.R.; Royalty, J.; Tauscher-Wisniewski, S. 2014: Safety, tolerability, and pharmacokinetic evaluation of single- and multiple-ascending doses of a novel kappa opioid receptor antagonist LY2456302 and drug interaction with ethanol in healthy subjects. Journal of Clinical Pharmacology 54(9): 968-978
Dooley, K.E.; Park, J.-G.; Swindells, S.; Allen, R.; Haas, D.W.; Cramer, Y.; Aweeka, F.; Wiggins, I.; Gupta, A.; Lizak, P.; Qasba, S.; van Heeswijk, R.; Flexner, C.; Sutherland, D.; Free, M.; Chicurel, M.; Tedder, C.W.; Koletar, S.L.; Harber, H.; Luetkemeyer, A.; Dwyer, J.; Hackman, J.; Weiss, A. 2012: Safety, tolerability, and pharmacokinetic interactions of the antituberculous agent TMC207 (bedaquiline) with efavirenz in healthy volunteers: AIDS Clinical Trials Group Study A5267. Journal of Acquired Immune Deficiency Syndromes 59(5): 455-462
Roberts, E.S.; Vanlare, K.A.; Strehlau, G.; Peyrou, M.; Roycroft, L.M.; King, S. 2014: Safety, tolerability, and pharmacokinetics of 6-month daily dosing of an oral formulation of cyclosporine (ATOPICA for cats®) in cats. Journal of Veterinary Pharmacology and Therapeutics 37(2): 161-168
Bozik, M.E.; Mather, J.L.; Kramer, W.G.; Gribkoff, V.K.; Ingersoll, E.W. 2011: Safety, tolerability, and pharmacokinetics of KNS-760704 (dexpramipexole) in healthy adult subjects. Journal of Clinical Pharmacology 51(8): 1177-1185
Ginsberg, A.M.; Laurenzi, M.W.; Rouse, D.J.; Whitney, K.D.; Spigelman, M.K. 2009: Safety, tolerability, and pharmacokinetics of PA-824 in healthy subjects. Antimicrobial Agents and ChemoTherapy 53(9): 3720-3725
O'Loughlin, J.; Millwood, I.Y.; McDonald, H.M.; Price, C.F.; Kaldor, J.M.; Paull, J.R.A. 2010: Safety, tolerability, and pharmacokinetics of SPL7013 gel (VivaGel): a dose ranging, phase i study. Sexually Transmitted Diseases 37(2): 100-104
Li, M.; Shi, A.; Pang, H.; Xue, W.; Li, Y.; Cao, G.; Yan, B.; Dong, F.; Li, K.; Xiao, W.; He, G.; Du, G.; Hu, X. 2014: Safety, tolerability, and pharmacokinetics of a single ascending dose of baicalein chewable tablets in healthy subjects. Journal of Ethnopharmacology 15(6): 210-215
Dietrich, H.; Hu, K.; Ruffin, M.; Song, D.; Bouillaud, E.; Wang, Y.; Hasskarl, J. 2012: Safety, tolerability, and pharmacokinetics of a single dose of pasireotide long-acting release in healthy volunteers: a single-center Phase i study. European Journal of Endocrinology 166(5): 821-828
Choy, G.; Joshi-Hangal, R.; Oganesian, A.; Fine, G.; Rasmussen, S.; Collier, J.; Kissling, J.; Sahai, A.; Azab, M.; Redkar, S. 2012: Safety, tolerability, and pharmacokinetics of amuvatinib from three phase 1 clinical studies in healthy volunteers. Cancer ChemoTherapy and Pharmacology 70(1): 183-190
Peterschmitt, M.J.; Burke, A.; Blankstein, L.; Smith, S.E.; Puga, A.C.; Kramer, W.G.; Harris, J.A.; Mathews, D.; Bonate, P.L. 2011: Safety, tolerability, and pharmacokinetics of eliglustat tartrate (Genz-112638) after single doses, multiple doses, and food in healthy volunteers. Journal of Clinical Pharmacology 51(5): 695-705
Nunes, T.; Rocha, J.é F.; Vaz-da-Silva, M.; Igreja, B.; Wright, L.C.; Falcão, A.íl.; Almeida, L.; Soares-da-Silva, P. 2010: Safety, tolerability, and pharmacokinetics of etamicastat, a novel dopamine-β-hydroxylase inhibitor, in a rising multiple-dose study in young healthy subjects. Drugs in R&d 10(4): 225-242
Cao, G.-Y.; Zhang, J.; Zhang, Y.-Y.; Guo, B.-N.; Yu, J.-C.; Wu, X.-J.; Chen, Y.-C.; Wu, J.-F.; Shi, Y.-G. 2014: Safety, tolerability, and pharmacokinetics of intravenous nemonoxacin in healthy chinese volunteers. Antimicrobial Agents and ChemoTherapy 58(10): 6116-6121
Brennan, B.J.; Davies, B.; Cirrincione-Dall, G.; Morcos, P.N.; Beryozkina, A.; Chappey, C.; Aceves Baldó, P.; Lennon-Chrimes, S.; Rayner, C.R. 2012: Safety, tolerability, and pharmacokinetics of intravenous oseltamivir: single- and multiple-dose phase i studies with healthy volunteers. Antimicrobial Agents and ChemoTherapy 56(9): 4729-4737
Karhu, D.; Gossen, E.R.; Mostert, A.; Cronjé, T.; Fradette, C. 2011: Safety, tolerability, and pharmacokinetics of once-daily trazodone extended-release caplets in healthy subjects. International Journal of Clinical Pharmacology and Therapeutics 49(12): 730-743
Mann, D.; Liu, J.; Chew, M.L.; Bockbrader, H.; Alvey, C.W.; Zegarac, E.; Pellock, J.; Pitman, V.W. 2014: Safety, tolerability, and pharmacokinetics of pregabalin in children with refractory partial seizures: a phase 1, randomized controlled study. Epilepsia 55(12): 1934-1943
Brennan, B.J.; Wang, K.; Blotner, S.; Magnusson, M.O.; Wilkins, J.J.; Martin, P.; Solsky, J.; Nieforth, K.; Wat, C.; Grippo, J.F. 2013: Safety, tolerability, and pharmacokinetics of ribavirin in hepatitis C virus-infected patients with various degrees of renal impairment. Antimicrobial Agents and ChemoTherapy 57(12): 6097-6105
Dooley, K.E.; Sayre, P.; Borland, J.; Purdy, E.; Chen, S.; Song, I.; Peppercorn, A.; Everts, S.; Piscitelli, S.; Flexner, C. 2013: Safety, tolerability, and pharmacokinetics of the HIV integrase inhibitor dolutegravir given twice daily with rifampin or once daily with rifabutin: results of a phase 1 study among healthy subjects. Journal of Acquired Immune Deficiency Syndromes 62(1): 21-27
Haluska, P.; Worden, F.; Olmos, D.; Yin, D.; Schteingart, D.; Batzel, G.N.; Paccagnella, M.L.; de Bono, J.S.; Gualberto, A.; Hammer, G.D. 2010: Safety, tolerability, and pharmacokinetics of the anti-IGF-1R monoclonal antibody figitumumab in patients with refractory adrenocortical carcinoma. Cancer ChemoTherapy and Pharmacology 65(4): 765-773
Uhl, W.; Zühlsdorf, M.; Koernicke, T.; Forssmann, U.; Kovar, A. 2014: Safety, tolerability, and pharmacokinetics of the novel αv-integrin antibody EMD 525797 (DI17E6) in healthy subjects after ascending single intravenous doses. Investigational new Drugs 32(2): 347-354
Konstan, M.W.; Sharma, A.; Moroni-Zentgraf, P.; Wang, F.; Koker, P. 2015: Safety, tolerability, and plasma exposure of tiotropium Respimat® in children and adults with cystic fibrosis. Journal of Aerosol Medicine and Pulmonary Drug Delivery 28(2): 137-144
Montaner, J.; Yeni, P.; Clumeck, N.N.; Fätkenheuer, G.; Gatell, J.; Hay, P.; Seminari, E.; Peeters, M.P.; Schöller-Gyüre, M.; Simonts, M.; Woodfall, B. 2008: Safety, tolerability, and preliminary efficacy of 48 weeks of etravirine therapy in a phase IIb dose-ranging study involving treatment-experienced patients with HIV-1 infection. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 47(7): 969-978
Meini, M.; Moncini, M.; Cecconi, D.; Cellesi, V.; Biasci, L.; Simoni, G.; Ameglio, M.; Pellegrini, M.; Forgione, R.N.; Rucci, P. 2011: Safety, tolerability, and self-rated effects of aripiprazole and ropinirole treatment for cocaine dependence: a pilot study. American Journal on Addictions 20(2): 179-180
Mooney, J.J.; Pagel, P.S.; Kundu, A. 2014: Safety, tolerability, and short-term efficacy of intravenous lidocaine infusions for the treatment of chronic pain in adolescents and young adults: a preliminary report. Pain Medicine 15(5): 820-825
Nel, A.M.; Coplan, P.; van de Wijgert, J.H.; Kapiga, S.H.; von Mollendorf, C.; Geubbels, E.; Vyankandondera, J.; Rees, H.V.; Masenga, G.; Kiwelu, I.; Moyes, J.; Smythe, S.C. 2009: Safety, tolerability, and systemic absorption of dapivirine vaginal microbicide gel in healthy, HIV-negative women. Aids 23(12): 1531-1538
Bush, M.A.; Matthews, J.E.; De Boever, E.H.; Dobbins, R.L.; Hodge, R.J.; Walker, S.E.; Holland, M.C.; Gutierrez, M.; Stewart, M.W. 2009: Safety, tolerability, pharmacodynamics and pharmacokinetics of albiglutide, a long-acting glucagon-like peptide-1 mimetic, in healthy subjects. Diabetes Obesity and Metabolism 11(5): 498-505
Kelleher, D.L.; Mehta, R.S.; Jean-Francois, B.M.; Preece, A.F.; Blowers, J.; Crater, G.D.; Thomas, P. 2012: Safety, tolerability, pharmacodynamics and pharmacokinetics of umeclidinium and vilanterol alone and in combination: a randomized crossover trial. Plos one 7(12): E50716
Okusaka, T.; Ikeda, M.; Fukutomi, A.; Kobayashi, Y.; Shibayama, K.; Takubo, T.; Gansert, J. 2014: Safety, tolerability, pharmacokinetics and antitumor activity of ganitumab, an investigational fully human monoclonal antibody to insulin-like growth factor type 1 receptor, combined with gemcitabine as first-line therapy in patients with metastatic pancreatic cancer: a phase 1b study. Japanese Journal of Clinical Oncology 44(5): 442-447
Seino, Y.; Nakajima, H.; Miyahara, H.; Kurita, T.; Bush, M.A.; Yang, F.; Stewart, M.W. 2009: Safety, tolerability, pharmacokinetics and pharmacodynamics of albiglutide, a long-acting GLP-1-receptor agonist, in Japanese subjects with type 2 diabetes mellitus. Current Medical Research and Opinion 25(12): 3049-3057
Choy, E.H.; Bendit, M.; McAleer, D.; Liu, F.; Feeney, M.; Brett, S.; Zamuner, S.; Campanile, A.; Toso, J. 2013: Safety, tolerability, pharmacokinetics and pharmacodynamics of an anti- oncostatin M monoclonal antibody in rheumatoid arthritis: results from phase Ii randomized, placebo-controlled trials. Arthritis Research and Therapy 15(5): R132
Patat, A.; Parks, V.; Raje, S.; Plotka, A.; Chassard, D.; Le Coz, F. 2009: Safety, tolerability, pharmacokinetics and pharmacodynamics of ascending single and multiple doses of lecozotan in healthy young and elderly subjects. British Journal of Clinical Pharmacology 67(3): 299-308
Teng, R.; Butler, K. 2013: Safety, tolerability, pharmacokinetics and pharmacodynamics of high single-ascending doses of ticagrelor in healthy volunteers. International Journal of Clinical Pharmacology and Therapeutics 51(10): 795-806
Barbour, A.M.; Sarov-Blat, L.; Cai, G.; Fossler, M.J.; Sprecher, D.L.; Graggaber, J.; McGeoch, A.T.; Maison, J.; Cheriyan, J. 2013: Safety, tolerability, pharmacokinetics and pharmacodynamics of losmapimod following a single intravenous or oral dose in healthy volunteers. British Journal of Clinical Pharmacology 76(1): 99-106
Liu, Y.; Shi, S.; Wu, J.; Li, Z.; Zhou, X.; Zeng, F. 2012: Safety, tolerability, pharmacokinetics and pharmacodynamics of recombinant human parathyroid hormone after single- and multiple-dose subcutaneous administration in healthy Chinese volunteers. Basic and Clinical Pharmacology and Toxicology 110(2): 154-161
Sarashina, A.; Koiwai, K.; Seman, L.J.; Yamamura, N.; Taniguchi, A.; Negishi, T.; Sesoko, S.; Woerle, H.J.; Dugi, K.A. 2013: Safety, tolerability, pharmacokinetics and pharmacodynamics of single doses of empagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, in healthy Japanese subjects. Drug Metabolism and Pharmacokinetics 28(3): 213-219
Boss, D.S.; Schwartz, G.K.; Middleton, M.R.; Amakye, D.D.; Swaisland, H.; Midgley, R.S.; Ranson, M.; Danson, S.; Calvert, H.; Plummer, R.; Morris, C.; Carvajal, R.D.; Chirieac, L.R.; Schellens, J.H.M.; Shapiro, G.I. 2010: Safety, tolerability, pharmacokinetics and pharmacodynamics of the oral cyclin-dependent kinase inhibitor AZD5438 when administered at intermittent and continuous dosing schedules in patients with advanced solid tumours. Annals of Oncology: Official Journal of the European Society for Medical Oncology 21(4): 884-894
Galasko, D.R.; Graff-Radford, N.; May, S.; Hendrix, S.; Cottrell, B.A.; Sagi, S.A.; Mather, G.; Laughlin, M.; Zavitz, K.H.; Swabb, E.; Golde, T.E.; Murphy, M.P.; Koo, E.H. 2007: Safety, tolerability, pharmacokinetics, and Abeta levels after short-term administration of R-flurbiprofen in healthy elderly individuals. Alzheimer Disease and Associated Disorders 21(4): 292-299
Wilfret, D.A.; Walker, J.; Adkison, K.K.; Jones, L.A.; Lou, Y.; Gan, J.; Castellino, S.; Moseley, C.L.; Horton, J.; de Serres, M.; Culp, A.; Goljer, I.; Spreen, W. 2013: Safety, tolerability, pharmacokinetics, and antiviral activity of GSK2336805, an inhibitor of hepatitis C virus (HCV) NS5A, in healthy subjects and subjects chronically infected with HCV genotype 1. Antimicrobial Agents and ChemoTherapy 57(10): 5037-5044
Petersen, K.L.; Iyengar, S.; Chappell, A.S.; Lobo, E.D.; Reda, H.; Prucka, W.R.; Verfaille, S.J. 2014: Safety, tolerability, pharmacokinetics, and effects on human experimental pain of the selective ionotropic glutamate receptor 5 (iGluR5) antagonist LY545694 in healthy volunteers. Pain 155(5): 929-936
Abarca, K.; Jung, E.; Fernández, P.; Zhao, L.; Harris, B.; Connor, E.M.; Losonsky, G.A. 2009: Safety, tolerability, pharmacokinetics, and immunogenicity of motavizumab, a humanized, enhanced-potency monoclonal antibody for the prevention of respiratory syncytial virus infection in at-risk children. Pediatric Infectious Disease Journal 28(4): 267-272
Naik, H.; Vakilynejad, M.; Wu, J.; Viswanathan, P.; Dote, N.; Higuchi, T.; Leifke, E. 2012: Safety, tolerability, pharmacokinetics, and pharmacodynamic properties of the GPR40 agonist TAK-875: results from a double-blind, placebo-controlled single oral dose rising study in healthy volunteers. Journal of Clinical Pharmacology 52(7): 1007-1016
Wolin, E.M.; Hu, K.; Hughes, G.; Bouillaud, E.; Giannone, V.; Resendiz, K.Hermosillo. 2013: Safety, tolerability, pharmacokinetics, and pharmacodynamics of a long-acting release (LAR) formulation of pasireotide (SOM230) in patients with gastroenteropancreatic neuroendocrine tumors: results from a randomized, multicenter, open-label, phase I study. Cancer ChemoTherapy and Pharmacology 72(2): 387-395
Iwamoto, K.; Nasu, R.; Yamamura, A.; Kothare, P.A.; Mace, K.; Wolka, A.M.; Linnebjerg, H. 2009: Safety, tolerability, pharmacokinetics, and pharmacodynamics of exenatide once weekly in Japanese patients with type 2 diabetes. Endocrine Journal 56(8): 951-962
Chi, Y.H.; Lee, H.; Paik, S.H.; Lee, J.H.; Yoo, B.W.; Kim, J.H.; Tan, H.K.; Kim, S.L. 2011: Safety, tolerability, pharmacokinetics, and pharmacodynamics of fimasartan following single and repeated oral administration in the fasted and fed states in healthy subjects. American Journal of Cardiovascular Drugs: Drugs Devices and other Interventions 11(5): 335-346
Yamahira, N.; Frost, C.; Fukase, H.; Yu, Z.; Wang, J.; Pursley, J.; LaCreta, F.; Hiraoka, M. 2014: Safety, tolerability, pharmacokinetics, and pharmacodynamics of multiple doses of apixaban in healthy Japanese male subjects. International Journal of Clinical Pharmacology and Therapeutics 52(7): 564-573
Liu, Y.; Yang, C.; Li, Z.; Zhou, J.; Lv, Y.; Zhang, Y.; Zeng, F.; Shi, S. 2014: Safety, tolerability, pharmacokinetics, and pharmacodynamics of recombinant human parathyroid hormone (1-34) in healthy Chinese subjects. Clinical Therapeutics 36(6): 940-952
Hüttner, S.; Graefe-Mody, E.U.; Withopf, B.; Ring, A.; Dugi, K.A. 2008: Safety, tolerability, pharmacokinetics, and pharmacodynamics of single oral doses of Bi 1356, an inhibitor of dipeptidyl peptidase 4, in healthy male volunteers. Journal of Clinical Pharmacology 48(10): 1171-1178
Mistry, P.; Reid, J.; Pouliquen, I.; McHugh, S.; Abberley, L.; DeWall, S.; Taylor, A.; Tong, X.; Rocha Del Cura, M.; McKie, E. 2014: Safety, tolerability, pharmacokinetics, and pharmacodynamics of single-dose antiinterleukin- 18 mAb GSK1070806 in healthy and obese subjects. International Journal of Clinical Pharmacology and Therapeutics 52(10): 867-879
Yu, Y.; Logovinsky, V.; Schuck, E.; Kaplow, J.; Chang, M.-K.; Miyagawa, T.; Wong, N.; Ferry, J. 2014: Safety, tolerability, pharmacokinetics, and pharmacodynamics of the novel γ-secretase modulator, E2212, in healthy human subjects. Journal of Clinical Pharmacology 54(5): 528-536
Boumans, M.J.H.; Houbiers, J.G.A.; Verschueren, P.; Ishikura, H.; Westhovens, R.; Brouwer, E.; Rojkovich, B.; Kelly, S.; den Adel, M.; Isaacs, J.; Jacobs, H.; Gomez-Reino, J.; Holtkamp, G.M.; Hastings, A.; Gerlag, D.M.; Tak, P.P. 2012: Safety, tolerability, pharmacokinetics, pharmacodynamics and efficacy of the monoclonal antibody ASK8007 blocking osteopontin in patients with rheumatoid arthritis: a randomised, placebo controlled, proof-of-concept study. Annals of the Rheumatic Diseases 71(2): 180-185
Trottier, S.; Omar, R.F.; Désormeaux, Aé.; Drouin, J.; Gagnon, M-Thérèse.; Vezina, F.; Guilbert, E.; Mâsse, Bît.; Bergeron, M.G. 2007: Safety, tolerance and acceptability of the Invisible Condom and its vaginal applicator in healthy women and their male sexual partners. Contraception 76(2): 117-125
Kolve, H.; Ahlke, E.; Fegeler, W.; Ritter, J.ör.; Jürgens, H.; Groll, A.H. 2009: Safety, tolerance and outcome of treatment with liposomal amphotericin B in paediatric patients with cancer or undergoing haematopoietic stem cell transplantation. Journal of Antimicrobial ChemoTherapy 64(2): 383-387
Nash, M.S.; Lewis, J.E.; Dyson-Hudson, T.A.; Szlachcic, Y.; Yee, F.; Mendez, A.J.; Spungen, A.M.; Bauman, W.A. 2011: Safety, tolerance, and efficacy of extended-release niacin monotherapy for treating dyslipidemia risks in persons with chronic tetraplegia: a randomized multicenter controlled trial. Archives of Physical Medicine and Rehabilitation 92(3): 399-410
Van Roosmalen, L.; Ritchie Orton, N.; Schneider, L. 2013: Safety, usability, and independence for wheelchair-seated drivers and front-row passengers of private vehicles: a qualitative research study. Journal of Rehabilitation Research and Development 50(2): 239-252
Wang, Y.; Chen, S. 2013: Safety-aware semi-supervised classification. IEEE Transactions on Neural Networks and Learning Systems 24(11): 1763-1772
Pal, A.; Labuza, T.P.; Diez-Gonzalez, F. 2009: Safety-based shelf life model for frankfurters based on time to detect Listeria monocytogenes with initial inoculum below detection limit. Journal of Food Protection 72(9): 1878-1884
Masket, S.; Fram, N.R. 2013: Safety-basket suture for management of malpositioned posterior chamber intraocular lens. Journal of Cataract and Refractive Surgery 39(11): 1633-1635
Jagger, J.; Perry, J. 2013: Safety-engineered devices in 2012: the critical role of healthcare workers in device selection. Infection Control and Hospital Epidemiology 34(6): 615-618
Adams, D.; Elliott, T.S.J. 2011: Safety-engineered needle devices: evaluation prior to introduction is essential. Journal of Hospital Infection 79(2): 174-175
Touchette, D.R.; Masica, A.L.; Dolor, R.J.; Schumock, G.T.; Choi, Y.K.; Kim, Y.; Smith, S.R. 2012: Safety-focused medication therapy management: a randomized controlled trial. Journal of the American Pharmacists Association: Japha 52(5): 603-612
Virgo, K.S.; Little, A.G.; Fedewa, S.A.; Chen, A.Y.; Flanders, W.D.; Ward, E.M. 2011: Safety-net burden hospitals and likelihood of curative-intent surgery for non-small cell lung cancer. Journal of the American College of Surgeons 213(5): 633-643
Jackson, B.E.; Suzuki, S.; Coultas, D.; Su, F.; Lingineni, R.; Singh, K.P.; Bartolucci, A.; Bae, S. 2011: Safety-net facilities and hospitalization rates of chronic obstructive pulmonary disease: a cross-sectional analysis of the 2007 Texas Health Care Information Council inpatient data. International journal of chronic obstructive pulmonary disease 6: 563-571
Zwanziger, J.; Khan, N. 2008: Safety-net hospitals. Medical Care Research and Review: Mcrr 65(4): 478-495
Thompson, C.A. 2009: Safety-net hospitals see more financial good than bad from Medicare Part D. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 66(2): 116-117
Blum, J.D.; Conway, P.H.; VanLare, J.M. 2013: Safety-net hospitals: other hospitals score similarly on patient experience. JAMA Internal Medicine 173(5): 389-391
Katz, M.H. 2011: Safety-net providers and preparation for health reform: staff down, staff up, staff differently. Archives of Internal Medicine 171(15): 1319-1320
Cunningham, P.; Felland, L.; Stark, L. 2012: Safety-net providers in some US communities have increasingly embraced coordinated care models. Health Affairs 31(8): 1698-1707
Grimes, B. 2010: Safety-net technology helps INTEGRIS Health reduce denials. Revenue-Cycle Strategist 7(9): 6-7
Pelayo, S.; Hassler, S.; Bernonville, S.ép.; Aldegheri, J.; Beuscart-Zephir, M.-C. 2013: Safety-oriented usability test of a semi-automated unit dose system: role of task allocation between human and machine. Studies in Health Technology and Informatics 194: 103-109
Hamilton, E.S.B. 1947: Safety-pin in larynx for five weeks. British Medical Journal 2(4513): 16
Tarantino, N.; Goodrum, N.; Armistead, L.P.; Cook, S.L.; Skinner, D.; Toefy, Y. 2014: Safety-related moderators of a parent-based HIV prevention intervention in South Africa. Journal of Family Psychology: Jfp: Journal of the Division of Family Psychology of the American Psychological Association 28(6): 790-799
Marino, M.; Frigo, F.; Bartolomeoli, I.; Maifreni, M. 2011: Safety-related properties of staphylococci isolated from food and food environments. Journal of Applied Microbiology 110(2): 550-561
Giezen, T.J.; Mantel-Teeuwisse, A.K.; Straus, S.M.J.M.; Schellekens, H.; Leufkens, H.G.M.; Egberts, A.C.G. 2008: Safety-related regulatory actions for biologicals approved in the United States and the European Union. JAMA 300(16): 1887-1896
Heemstra, H.E.; Giezen, T.J.; Mantel-Teeuwisse, A.K.; de Vrueh, R.L.A.; Leufkens, H.G.M. 2010: Safety-related regulatory actions for orphan drugs in the US and EU: a cohort study. Drug Safety 33(2): 127-137
Hedtke, K.A.; Kendall, P.C.; Tiwari, S. 2009: Safety-seeking and coping behavior during exposure tasks with anxious youth. Journal of Clinical Child and Adolescent Psychology: the Official Journal for the Society of Clinical Child and Adolescent Psychology American Psychological Association Division 53 38(1): 1-15
Chaix, J.ép.; Ma, E.; Nguyen, A.; Ortiz Collado, M.A.; Rexhaj, S.; Favrod, J.ér.ôm. 2014: Safety-seeking behaviours and verbal auditory hallucinations in schizophrenia. Psychiatry Research 220(1-2): 158-162
Pound, R. 2011: Safety. Create a stronger voice for change. Health Service Journal 121(6286): 28-29
Szabo, J. 2010: Safety. Study: keys to reducing needlestick injuries for residents. Hospitals and Health Networks 84(3): 17 19
Chiu, P.-Y.; Dai, D.-E.; Hsu, H.-P.; Lee, C.; Lin, J.-J.; Kuo, H.-C.; Huang, Y.-C.; Liu, Y.-C.; Tsai, C.-P. 2009: Safety/Tolerability and efficacy of rivastigmine in taiwanese patients with Alzheimer's disease: a prospective post-marketing surveillance study. Clinical Drug Investigation 29(11): 729-738
Bartus, R.T.; Baumann, T.L.; Siffert, J.; Herzog, C.D.; Alterman, R.; Boulis, N.; Turner, D.A.; Stacy, M.; Lang, A.E.; Lozano, A.M.; Olanow, C.W. 2013: Safety/feasibility of targeting the substantia nigra with AAV2-neurturin in Parkinson patients. Neurology 80(18): 1698-1701
Andris, D.A. 2012: Safety: not just a "buzzword" but an "action word" for A.S.P.E.N. JPEN. Journal of Parenteral and Enteral Nutrition 36(2 Suppl): 5s-6s
Eisenhart, C. 1966: Safety: a parallel. Science 153(3732): 122
Kirchner, B. 2009: Safety: addressing inappropriate behavior in the perioperative workplace. AORN Journal 90(2): 177-180
Currie, L. 2011: Safety: principle of nursing practice C. Nursing Standard: 25(30): 35-37
Stichler, J.F. 2008: Safety: priority no. 1. Herd 2(1): 39-43
Hill, J. 2009: Safety: protecting yourself should be your #1 priority. Biomedical Instrumentation and Technology 43(1): 41-42
Bowers, L. 2014: Safewards: a new model of conflict and containment on psychiatric wards. Journal of Psychiatric and Mental Health Nursing 21(6): 499-508
Bowers, L.; Alexander, J.; Bilgin, H.; Botha, M.; Dack, C.; James, K.; Jarrett, M.; Jeffery, D.; Nijman, H.; Owiti, J.A.; Papadopoulos, C.; Ross, J.; Wright, S.; Stewart, D. 2014: Safewards: the empirical basis of the model and a critical appraisal. Journal of Psychiatric and Mental Health Nursing 21(4): 354-364
He, J.; Yang, Y.-N.; Jiang, J.-S.; Feng, Z.-M.; Zhang, P.-C. 2014: Saffloflavonesides a and B, two rearranged derivatives of flavonoid C-glycosides with a furan-tetrahydrofuran ring from Carthamus tinctorius. Organic Letters 16(21): 5714-5717
Park, J.B.; Wang, T.T.Y. 2012: Safflomide increases the expression of adiponectin in vitro and in vivo: potential implication for hypoadiponectemia, visceral obesity, and insulin resistance. Journal of Agricultural and Food Chemistry 60(16): 4048-4052
Wang, C.; He, Y.; Yang, M.; Sun, H.; Zhang, S.; Wang, C. 2013: Safflor yellow B suppresses angiotensin II-mediated human umbilical vein cell injury via regulation of Bcl-2/p22(phox) expression. Toxicology and Applied Pharmacology 273(1): 59-67
Wang, C.; Ma, H.; Zhang, S.; Wang, Y.; Liu, J.; Xiao, X. 2009: Safflor yellow B suppresses pheochromocytoma cell (PC12) injury induced by oxidative stress via antioxidant system and Bcl-2 /Bax pathway. Naunyn-Schmiedeberg's Archives of Pharmacology 380(2): 135-142
Yang, H.; Downs, R.T.; Eichler, C. 2008: Safflorite, (Co,Ni,Fe)As(2), isomorphous with marcasite. Acta Crystallographica. Section E Structure Reports Online 64(Part 9): I62
Higa, R.; White, V.; Martínez, N.; Kurtz, M.; Capobianco, E.; Jawerbaum, A. 2010: Safflower and olive oil dietary treatments rescue aberrant embryonic arachidonic acid and nitric oxide metabolism and prevent diabetic embryopathy in rats. Molecular Human Reproduction 16(4): 286-295
Zhao, G.; Zheng, X-Wei.; Gai, Y.; Chu, W-Jing.; Qin, G-Wei.; Guo, L-He. 2009: Safflower extracts functionally regulate monoamine transporters. Journal of Ethnopharmacology 124(1): 116-124
Fan, S.; Lin, N.; Shan, G.; Zuo, P.; Cui, L. 2014: Safflower yellow for acute ischemic stroke: a systematic review of randomized controlled trials. Complementary Therapies in Medicine 22(2): 354-361
Liu, Y.; Tian, X.; Cui, M.; Zhao, S. 2014: Safflower yellow inhibits angiotensin II-induced adventitial fibroblast proliferation and migration. Journal of Pharmacological Sciences 126(2): 107-114
Kong, D.; Xia, W.; Zhang, Z.; Xiao, L.; Yuan, D.; Liu, Y.; Yang, G. 2013: Safflower yellow injection combined with conventional therapy in treating unstable angina pectoris: a meta-analysis. Journal of Traditional Chinese Medicine 33(5): 553-561
Mora, S.; Manna, M. 2009: Saffman-Taylor instability for generalized Newtonian fluids. Physical Review. E Statistical Nonlinear and Soft Matter Physics 80(1 Part 2): 016308
Mora, S.; Manna, M. 2010: Saffman-Taylor instability of viscoelastic fluids: from viscous fingering to elastic fractures. Physical Review. e Statistical Nonlinear and Soft Matter Physics 81(2 Part 2): 026305
Luque, A.; Brau, F.; Ebert, U. 2008: Saffman-Taylor streamers: mutual finger interaction in spark formation. Physical Review. E Statistical Nonlinear and Soft Matter Physics 78(1 Part 2): 016206
Galama, J.M.D.; Zoll, J.G.; Lanke, K.H.; de Jong, A.S.; Melief, J.; Huitinga, I.; Verbeek, M.M.; van Kuppeveld, F.J.M. 2014: Saffold cardiovirus and multiple sclerosis: no evidence for an association. Annals of Clinical and Translational Neurology 1(8): 618-621
Ren, L.; Gonzalez, R.; Xiao, Y.; Xu, X.; Chen, L.; Vernet, G.; Paranhos-Baccala, G.; Jin, Q.; Wang, J. 2009: Saffold cardiovirus in children with acute gastroenteritis, Beijing, China. Emerging Infectious Diseases 15(9): 1509-1511
Itagaki, T.; Abiko, C.; Aoki, Y.; Ikeda, T.; Mizuta, K.; Noda, M.; Kimura, H.; Matsuzaki, Y. 2011: Saffold cardiovirus infection in children associated with respiratory disease and its similarity to coxsackievirus infection. Pediatric Infectious Disease Journal 30(8): 680-683
Khamrin, P.; Chaimongkol, N.; Nantachit, N.; Okitsu, S.; Ushijima, H.; Maneekarn, N. 2011: Saffold cardioviruses in children with diarrhea, Thailand. Emerging Infectious Diseases 17(6): 1150-1152
Ren, L.; Gonzalez, R.; Xie, Z.; Xiao, Y.; Li, Y.; Liu, C.; Chen, L.; Yang, Q.; Vernet, G.; Paranhos-Baccalà, G.; Jin, Q.; Shen, K.; Wang, J. 2010: Saffold cardioviruses of 3 lineages in children with respiratory tract infections, Beijing, China. Emerging Infectious Diseases 16(7): 1158-1161
Chua, K.B.; Voon, K.; Yu, M.; Ali, W.N.A.W.; Kasri, A.R.; Wang, L.-F. 2011: Saffold virus infection in children, Malaysia, 2009. Emerging Infectious Diseases 17(8): 1562-1564
Himeda, T.; Hosomi, T.; Okuwa, T.; Muraki, Y.; Ohara, Y. 2013: Saffold virus type 3 (SAFV-3) persists in Hela cells. Plos one 8(1): E53194
Zoll, J.; Erkens Hulshof, S.; Lanke, K.; Verduyn Lunel, F.; Melchers, W.J.G.; Schoondermark-van de Ven, E.; Roivainen, M.; Galama, J.M.D.; van Kuppeveld, F.J.M. 2009: Saffold virus, a human Theiler's-like cardiovirus, is ubiquitous and causes infection early in life. Plos Pathogens 5(5): E1000416
Hausenblas, H.A.; Saha, D.; Dubyak, P.J.; Anton, S.D. 2013: Saffron (Crocus sativus L.) and major depressive disorder: a meta-analysis of randomized clinical trials. Journal of Integrative Medicine 11(6): 377-383
Bajerska, J.; Mildner-Szkudlarz, S.; Podgórski, T.; Oszmatek-Pruszyńska, E. 2013: Saffron (Crocus sativus L.) powder as an ingredient of rye bread: an anti-diabetic evaluation. Journal of Medicinal Food 16(9): 847-856
Ghoshooni, H.; Daryaafzoon, M.; Sadeghi-Gharjehdagi, S.; Zardooz, H.; Sahraei, H.; Tehrani, S.P.; Noroozzadeh, A.; Bahrami-Shenasfandi, F.; Kaka, G.H.; Sadraei, S.H. 2011: Saffron (Crocus sativus) ethanolic extract and its constituent, safranal, inhibits morphine-induced place preference in mice. Pakistan Journal of Biological Sciences: Pjbs 14(20): 939-944
Lopresti, A.L.; Drummond, P.D. 2014: Saffron (Crocus sativus) for depression: a systematic review of clinical studies and examination of underlying antidepressant mechanisms of action. Human Psychopharmacology 29(6): 517-527
Bathaie, S.Z.; Miri, H.; Mohagheghi, M.-A.; Mokhtari-Dizaji, M.; Shahbazfar, A.-A.; Hasanzadeh, H. 2013: Saffron Aqueous Extract Inhibits the Chemically-induced Gastric Cancer Progression in the Wistar Albino Rat. Iranian Journal of Basic Medical Sciences 16(1): 27-38
Makri, O.E.; Ferlemi, A-Varvara.; Lamari, F.N.; Georgakopoulos, C.D. 2013: Saffron administration prevents selenite-induced cataractogenesis. Molecular Vision 19: 1188-1197
Bolhassani, A.; Khavari, A.; Bathaie, S.Z. 2014: Saffron and natural carotenoids: Biochemical activities and anti-tumor effects. Biochimica et Biophysica Acta 1845(1): 20-30
Bisti, S.; Maccarone, R.; Falsini, B. 2014: Saffron and retina: neuroprotection and pharmacokinetics. Visual Neuroscience 31(4-5): 355-361
Geromichalos, G.D.; Lamari, F.N.; Papandreou, M.A.; Trafalis, D.T.; Margarity, M.; Papageorgiou, A.; Sinakos, Z. 2012: Saffron as a source of novel acetylcholinesterase inhibitors: molecular docking and in vitro enzymatic studies. Journal of Agricultural and Food Chemistry 60(24): 6131-6138
Berger, F.; Hensel, A.; Nieber, K. 2011: Saffron extract and trans-crocetin inhibit glutamatergic synaptic transmission in rat cortical brain slices. Neuroscience 180: 238-247
Kashani, L.; Raisi, F.; Saroukhani, S.; Sohrabi, H.; Modabbernia, A.; Nasehi, A.-A.; Jamshidi, A.; Ashrafi, M.; Mansouri, P.; Ghaeli, P.; Akhondzadeh, S. 2013: Saffron for treatment of fluoxetine-induced sexual dysfunction in women: randomized double-blind placebo-controlled study. Human Psychopharmacology 28(1): 54-60
Asadi, M.Hossein.; Zafari, F.; Sarveazad, A.; Abbasi, M.; Safa, M.; Koruji, M.; Yari, A.; Alizadeh Miran, R. 2014: Saffron improves epididymal sperm parameters in rats exposed to cadmium. Nephro-Urology Monthly 6(1): E12125
Shemshian, M.; Mousavi, S.H.; Norouzy, A.; Kermani, T.; Moghiman, T.; Sadeghi, A.; Ghayour-Mobarhan, M.; Ferns, G.A. 2014: Saffron in metabolic syndrome: its effects on antibody titers to heat-shock proteins 27, 60, 65 and 70. Journal of Complementary and Integrative Medicine 11(1): 43-49
Schmidt, M.; Betti, G.; Hensel, A. 2007: Saffron in phytotherapy: pharmacology and clinical uses. Wiener Medizinische Wochenschrift 157(13-14): 315-319
Akhondzadeh, S.; Sabet, M.S.; Harirchian, M.H.; Togha, M.; Cheraghmakani, H.; Razeghi, S.; Hejazi, S.S.; Yousefi, M.H.; Alimardani, R.; Jamshidi, A.; Zare, F.; Moradi, A. 2010: Saffron in the treatment of patients with mild to moderate Alzheimer's disease: a 16-week, randomized and placebo-controlled trial. Journal of Clinical Pharmacy and Therapeutics 35(5): 581-588
Rubio-Moraga, A.; Castillo-López, R.; Gómez-Gómez, L.; Ahrazem, O. 2009: Saffron is a monomorphic species as revealed by RAPD, ISSR and microsatellite analyses. Bmc Research Notes 2: 189
Purushothuman, S.; Nandasena, C.; Peoples, C.L.; El Massri, N.; Johnstone, D.M.; Mitrofanis, J.; Stone, J. 2013: Saffron pre-treatment offers neuroprotection to Nigral and retinal dopaminergic cells of MPTP-Treated mice. Journal of Parkinson's Disease 3(1): 77-83
Ziaee, T.; Razavi, B.M.; Hosseinzadeh, H. 2014: Saffron reduced toxic effects of its constituent, safranal, in acute and subacute toxicities in rats. Jundishapur Journal of Natural Pharmaceutical Products 9(1): 3-8
Manoharan, S.; Wani, S.A.; Vasudevan, K.; Manimaran, A.; Prabhakar, M.M.; Karthikeyan, S.; Rajasekaran, D. 2013: Saffron reduction of 7,12-dimethylbenz[a]anthracene-induced hamster buccal pouch carcinogenesis. Asian Pacific Journal of Cancer Prevention: Apjcp 14(2): 951-957
Lech, K.; Witowska-Jarosz, J.; Jarosz, M. 2009: Saffron yellow: characterization of carotenoids by high performance liquid chromatography with electrospray mass spectrometric detection. Journal of Mass Spectrometry: Jms 44(12): 1661-1667
Modabbernia, A.; Akhondzadeh, S. 2013: Saffron, passionflower, valerian and sage for mental health. Psychiatric Clinics of North America 36(1): 85-91
Hosseinzadeh, H. 2014: Saffron: a herbal medicine of third millennium. Jundishapur Journal of Natural Pharmaceutical Products 9(1): 1-2
Amin, A.; Hamza, A.A.; Bajbouj, K.; Ashraf, S.S.; Daoud, S. 2011: Saffron: a potential candidate for a novel anticancer drug against hepatocellular carcinoma. Hepatology 54(3): 857-867
Chazot, P.L. 2007: Safinamide for the treatment of Parkinson's disease, epilepsy and restless legs syndrome. Current Opinion in Investigational Drugs 8(7): 570-579
Schapira, A.H.V. 2010: Safinamide in the treatment of Parkinson's disease. Expert Opinion on PharmacoTherapy 11(13): 2261-2268
Coward, J.; Ambrosini, G.; Musi, E.; Truman, J.-P.; Haimovitz-Friedman, A.; Allegood, J.C.; Wang, E.; Merrill, A.H.; Schwartz, G.K. 2009: Safingol (L-threo-sphinganine) induces autophagy in solid tumor cells through inhibition of PKC and the PI3-kinase pathway. Autophagy 5(2): 184-193
Samarghandian, S.; Borji, A.; Delkhosh, M.B.; Samini, F. 2013: Safranal treatment improves hyperglycemia, hyperlipidemia and oxidative stress in streptozotocin-induced diabetic rats. Journal of Pharmacy and Pharmaceutical Sciences: a Publication of the Canadian Society for Pharmaceutical Sciences Societe Canadienne des Sciences Pharmaceutiques 16(2): 352-362
Geromichalos, G.D.; Papadopoulos, T.; Sahpazidou, D.; Sinakos, Z. 2014: Safranal, a Crocus sativus L constituent suppresses the growth of K-562 cells of chronic myelogenous leukemia. in silico and in vitro study. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association 74: 45-50
Maeda, A.; Kai, K.; Ishii, M.; Ishii, T.; Akagawa, M. 2014: Safranal, a novel protein tyrosine phosphatase 1B inhibitor, activates insulin signaling in C2C12 myotubes and improves glucose tolerance in diabetic KK-Ay mice. Molecular Nutrition and Food Research 58(6): 1177-1189
Fernández-Sánchez, L.; Lax, P.; Esquiva, G.; Martín-Nieto, J.é; Pinilla, I.; Cuenca, N.ás. 2012: Safranal, a saffron constituent, attenuates retinal degeneration in P23H rats. Plos one 7(8): E43074
Rezaee, R.; Hosseinzadeh, H. 2013: Safranal: from an aromatic natural product to a rewarding pharmacological agent. Iranian Journal of Basic Medical Sciences 16(1): 12-26
Conn, H.J. 1923: Safranin and Methyl Green. Science 57(1471): 304-305
Lofrumento, C.; Arci, F.; Carlesi, S.; Ricci, M.; Castellucci, E.; Becucci, M. 2015: Safranin-O dye in the ground state. a study by density functional theory, Raman, SERS and infrared spectroscopy. Spectrochimica Acta. Part a Molecular and Biomolecular Spectroscopy 137: 677-684
Perevoshchikova, I.V.; Sorochkina, A.I.; Zorov, D.B.; Antonenko, Y.N. 2009: Safranine O as a fluorescent probe for mitochondrial membrane potential studied on the single particle level and in suspension. Biochemistry. Biokhimiia 74(6): 663-671
Figueira, T.R.; Melo, D.R.; Vercesi, A.íb.E.; Castilho, R.F. 2012: Safranine as a fluorescent probe for the evaluation of mitochondrial membrane potential in isolated organelles and permeabilized cells. Methods in Molecular Biology 810: 103-117
Yu, C.-S.; Huang, A.-C.; Yang, J.-S.; Yu, C.-C.; Lin, C.-C.; Chung, H.-K.; Huang, Y.-P.; Chueh, F.-S.; Chung, J.-G. 2012: Safrole induces G0/G1 phase arrest via inhibition of cyclin e and provokes apoptosis through endoplasmic reticulum stress and mitochondrion-dependent pathways in human leukemia HL-60 cells. Anticancer Research 32(5): 1671-1679
Yu, F-S.; Yang, J-S.; Yu, C-S.; Lu, C-C.; Chiang, J-H.; Lin, C-W.; Chung, J-G. 2011: Safrole induces apoptosis in human oral cancer HSC-3 cells. Journal of Dental Research 90(2): 168-174
Zhao, Y.; Xin, J.; Sun, C.; Zhao, B.; Zhao, J.; Su, L. 2012: Safrole oxide induced neuronal differentiation of rat bone-marrow mesenchymal stem cells by elevating Hsp70. Gene 509(1): 85-92
Su, L.; Zhang, H.; Zhao, J.; Zhang, S.; Zhang, Y.; Zhao, B.; Miao, J. 2013: Safrole-2',3'-oxide induces atherosclerotic plaque vulnerability in apolipoprotein E-knockout mice. Toxicology Letters 217(2): 129-136
Chiang, S.-y.; Lee, P.-y.; Lai, M.-t.; Shen, L.-c.; Chung, W.-s.; Huang, H.-f.; Wu, K.-y.; Wu, H.-c. 2011: Safrole-2',3'-oxide induces cytotoxic and genotoxic effects in HepG2 cells and in mice. Mutation Research 726(2): 234-241
Fan, M.-J.; Lin, S.-Y.; Yu, C.-C.; Tang, N.-Y.; Ho, H.-C.; Chung, H.-K.; Yang, J.-S.; Huang, Y.-P.; Ip, S.-W.; Chung, J.-G. 2012: Safrole-modulated immune response is mediated through enhancing the CD11b surface marker and stimulating the phagocytosis by macrophages in BALB/c mice. Human and Experimental Toxicology 31(9): 898-904
Xu, J.-P.; Guo, W.-R.; Lin, G.-B. 2012: Safty action of heat shock protein 27 in reperfusion after spinal marrow ischemia. Zhongguo Gu Shang 25(10): 880-882
Walsh, J. 1983: Sag in the market for scientists, engineers. Science 222(4628): 1103
Hatakeyama, M. 2008: SagA of CagA in Helicobacter pylori pathogenesis. Current Opinion in Microbiology 11(1): 30-37
Sun, Y.; Sun, L.; Xing, M.-q.; Liu, C.-s.; Hu, Y.-h. 2013: SagE induces highly effective protective immunity against Streptococcus iniae mainly through an immunogenic domain in the extracellular region. Acta Veterinaria Scandinavica 55: 78
Petrova, O.E.; Sauer, K. 2011: SagS contributes to the motile-sessile switch and acts in concert with BfiSR to enable Pseudomonas aeruginosa biofilm formation. Journal of Bacteriology 193(23): 6614-6628
Molvaer, O.I. 2009: Saga about a cyst. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 129(16): 1669-1670
Reinbach, H. 1946: Saga of industrial nursing in Kansas. Industrial Nursing 5(11): 24-26
Manchikanti, L.; Singh, V.; Hirsch, J.A. 2012: Saga of payment systems of ambulatory surgery centers for interventional techniques: an update. Pain Physician 15(2): 109-130
Morita, M.; Igarashi, Y.; Ito, M.; Chen, Y.-A.; Nagao, C.; Sakaguchi, Y.; Sakate, R.; Masui, T.; Mizuguchi, K. 2012: Sagace: a web-based search engine for biomedical databases in Japan. Bmc Research Notes 5: 604
Nau, J.-Y.; Sagan, F.ço.; Blondin, A. 2009: Sagan (Françoise), Blondin, Palfium and writings. Revue Medicale Suisse 5(226): 2362
Waldrop, M.M. 1988: Sagdeev to step down. Science 241(4865): 528
Deeb, S.J.; El-Baba, C.O.; Hassan, S.B.; Larsson, R.L.; Gali-Muhtasib, H.U. 2011: Sage components enhance cell death through nuclear factor kappa-B signaling. Frontiers in Bioscience 3(2): 410-420
Marchev, A.; Haas, C.; Schulz, S.; Georgiev, V.; Steingroewer, J.; Bley, T.; Pavlov, A. 2014: Sage in vitro cultures: a promising tool for the production of bioactive terpenes and phenolic substances. Biotechnology Letters 36(2): 211-221
Goedert, J. 2007: Sage sets its health I.T. table. Health Data Management 15(6): 54
Sá, C.M.; Ramos, A.A.; Azevedo, M.F.; Lima, C.F.; Fernandes-Ferreira, M.; Pereira-Wilson, C. 2009: Sage tea drinking improves lipid profile and antioxidant defences in humans. International Journal of Molecular Sciences 10(9): 3937-3950
Park, S.-H.; Kim, J.-L.; Kang, M.-K.; Gong, J.-H.; Han, S.-Y.; Shim, J.-H.; Lim, S.S.; Kang, Y.-H. 2012: Sage weed (Salvia plebeia) extract antagonizes foam cell formation and promotes cholesterol efflux in murine macrophages. International Journal of Molecular Medicine 30(5): 1105-1112
Cardon, Z.G.; Stark, J.M.; Herron, P.M.; Rasmussen, J.A. 2013: Sagebrush carrying out hydraulic lift enhances surface soil nitrogen cycling and nitrogen uptake into inflorescences. Proceedings of the National Academy of Sciences of the United States of America 110(47): 18988-18993
Savoiardo, M.; Farina, L.; Chiapparini, L. 2010: Sagging and swelling of the midbrain suggest spontaneous intracranial hypotension rather than a malformation. Brain: a journal of neurology 133(Pt 8): e148; author reply e149
Huang, Y.-M.; Davidsson, L. 2013: Sagging brain development after lumbar puncture agrees with Monro-Kellie hypothesis. Journal of Neurology 260(3): 920-922
Luna, J.; Khanna, I.; Cook, F.J.; Marti, E.M.; Hoppenot, R.G. 2014: Sagging brain masquerading as a pituitary adenoma. Journal of Clinical Endocrinology and Metabolism 99(9): 3043
Venot, M.; Abboud, I.; Duboust, A.; Michel, C.; Suberbielle, C.; Vérine, J.; Flamant, M.; Morelon, E.; Glotz, D.; Peraldi, M.-N. 2011: Calcineurin inhibitor-free monotherapy in human leukocyte antigen–identical live donor renal transplantation. Transplantation 91(3): 330-333
Chaudhuri, Z.; Demer, J.L. 2013: Sagging eye syndrome: connective tissue involution as a cause of horizontal and vertical strabismus in older patients. JAMA Ophthalmology 131(5): 619-625
Espín, L.; Kumar, S. 2014: Sagging of evaporating droplets of colloidal suspensions on inclined substrates. Langmuir: the Acs Journal of Surfaces and Colloids 30(40): 11966-11974
Ezure, T.; Hosoi, J.; Amano, S.; Tsuchiya, T. 2009: Sagging of the cheek is related to skin elasticity, fat mass and mimetic muscle function. Skin Research and Technology: Official Journal of International Society for Bioengineering and the Skin and International Society for Digital Imaging of Skin and International Society for Skin Imaging 15(3): 299-305
Jeong, Y.Mi.; Shin, M.Jin.; Lee, S.Hoon.; Chung, H.Won. 2013: Sagging posterior layer thoracolumbar fascia: can it be the cause or result of adjacent segment diseases?. Journal of Spinal Disorders and Techniques 26(4): E124-E129
Pimentel, G.D.; Moreto, F.; Takahashi, M.M.; Portero-McLellan, K.C.; Burini, R.C. 2011: Sagital abdominal diameter, but not waist circumference is strongly associated with glycemia, triacilglycerols and HDL-C levels in overweight adults. Nutricion Hospitalaria 26(5): 1125-1129
Yu, Q.; Pan, X.-g.; Qian, Y.-f.; Fan, L.-f. 2009: Sagital position of glenoid fossa in Angle Class Ii malocclusion with mandibular retrusion. Shanghai Kou Qiang Yi Xue 18(1): 5-9
Sasao, Y.; Kojima, A.; Torii, Y.; Morioka, S.; Fujii, A.; Aoki, H. 2016: Sagittal Alignment of Spine and Spinal Cord for Upper Cervical Irreducible Atlantoaxial Kyphosis in Elderly Patients. Clinical Spine Surgery 29(6): E303-E308
Kasemeier-Kulesa, J.C.; Lefcort, F.; Kulesa, P.M. 2007: Sagittal Explant Culture for 3D Confocal Time-Lapse Analysis of Chick Peripheral Nervous System Formation. Csh Protocols 2007: Pdb.Prot 4791
Sakima, H.; Isa, K.; Goya, Y.; Ohya, Y. 2012: Sagittal MR black blood imaging revealing ACA dissection. Internal Medicine 51(9): 1145
Padua, D.A.; Distefano, L.J. 2009: Sagittal Plane Knee Biomechanics and Vertical Ground Reaction Forces Are Modified Following ACL Injury Prevention Programs: A Systematic Review. Sports Health 1(2): 165-173
Karia, S.J.; Kassamali, R.H. 2012: Sagittal T2 weighted magnetic resonance image of the lumbar spine. Bmj 345: E6689
Gletsu-Miller, N.; Kahn, H.S.; Gasevic, D.; Liang, Z.; Frediani, J.K.; Torres, W.E.; Ziegler, T.R.; Phillips, L.S.; Lin, E. 2013: Sagittal abdominal diameter and visceral adiposity: correlates of beta-cell function and dysglycemia in severely obese women. Obesity Surgery 23(7): 874-881
Vasques, A.Carolina.Junqueira.; Souza, Jé.Roberto.Matos.; Yamanaka, A.; de Oliveira, M.da.Saúde.; Novaes, F.Satake.; Pareja, Jé.Carlos.; Geloneze, B. 2013: Sagittal abdominal diameter as a marker for epicardial adipose tissue in premenopausal women. Metabolism, Clinical and Experimental 62(7): 1032-1036
Petersson, H.; Daryani, A.; Risérus, U. 2007: Sagittal abdominal diameter as a marker of inflammation and insulin resistance among immigrant women from the Middle East and native Swedish women: a cross-sectional study. Cardiovascular diabetology 6: 10
Pajunen, P.; Rissanen, H.; Laaksonen, M.A.; Heliövaara, M.; Reunanen, A.; Knekt, P. 2013: Sagittal abdominal diameter as a new predictor for incident diabetes. Diabetes Care 36(2): 283-288
Risérus, U.; de Faire, U.; Berglund, L.; Hellénius, M.-L. 2010: Sagittal abdominal diameter as a screening tool in clinical research: cutoffs for cardiometabolic risk. Journal of Obesity 2010
Clerc, D.; Blaser, B.; Demartines, N.; Christoforidis, D. 2015: Sagittal abdominal diameter is a better predictor than body mass index for duration of laparoscopic left colectomy. World Journal of Surgery 39(3): 769-775
Dahlén, E.M.; Bjarnegård, N.; Länne, T.; Nystrom, F.H.; Ostgren, C.J. 2013: Sagittal abdominal diameter is a more independent measure compared with waist circumference to predict arterial stiffness in subjects with type 2 diabetes--a prospective observational cohort study. Cardiovascular Diabetology 12: 55
Yim, J.Y.; Kim, D.; Lim, S.H.; Park, M.J.; Choi, S.H.; Lee, C.H.; Kim, S.S.; Cho, S.-H. 2010: Sagittal abdominal diameter is a strong anthropometric measure of visceral adipose tissue in the Asian general population. Diabetes Care 33(12): 2665-2670
Lee, M.J.; Shin, D.H.; Kim, S.J.; Yoo, D.E.; Ko, K.I.; Koo, H.M.; Kim, C.H.; Doh, F.M.; Oh, H.J.; Park, J.T.; Han, S.H.; Yoo, T.-H.; Choi, K.H.; Kang, S.-W. 2013: Sagittal abdominal diameter is an independent predictor of all-cause and cardiovascular mortality in incident peritoneal dialysis patients. Plos one 8(10): E77082
Sasso, R.C.; Metcalf, N.H.; Hipp, J.A.; Wharton, N.D.; Anderson, P.A. 2011: Sagittal alignment after Bryan cervical arthroplasty. Spine 36(13): 991-996
Watkins, R.G.; Hanna, R.; Chang, D.; Watkins, R.G. 2014: Sagittal alignment after lumbar interbody fusion: comparing anterior, lateral, and transforaminal approaches. Journal of Spinal Disorders and Techniques 27(5): 253-256
Guérin, P.; Obeid, I.; Gille, O.; Bourghli, A.; Luc, S.ép.; Pointillart, V.; Vital, J.-M. 2012: Sagittal alignment after single cervical disc arthroplasty. Journal of Spinal Disorders and Techniques 25(1): 10-16
Park, M.S.; Kelly, M.P.; Lee, D.-H.; Min, W.-K.; Rahman, R.'K.K.; Riew, K.D. 2014: Sagittal alignment as a predictor of clinical adjacent segment pathology requiring surgery after anterior cervical arthrodesis. Spine Journal: Official Journal of the North American Spine Society 14(7): 1228-1234
Djurasovic, M.O.; Carreon, L.Y.; Glassman, S.D.; Dimar, J.R.; Puno, R.M.; Johnson, J.R. 2008: Sagittal alignment as a risk factor for adjacent level degeneration: a case-control study. Orthopedics 31(6): 546
Aizawa, T.; Sato, T.; Ozawa, H.; Morozumi, N.; Matsumoto, F.; Sasaki, H.; Hoshikawa, T.; Kawahara, C.; Kokubun, S.; Itoi, E. 2008: Sagittal alignment changes after thoracic laminectomy in adults. Journal of Neurosurgery. Spine 8(6): 510-516
Yanbin, Z.; Yu, S.; Zhongqiang, C.; Zhongjun, L. 2011: Sagittal alignment comparison of Bryan disc arthroplasty with ProDisc-C arthroplasty: a prospective, randomized controlled clinical trial. Journal of Spinal Disorders and Techniques 24(6): 381-385
Berjano, P.; Damilano, M.; Lamartina, C. 2012: Sagittal alignment correction and reconstruction of lumbar post-traumatic kyphosis via MIS lateral approach. European Spine Journal: Official Publication of the European Spine Society the European Spinal Deformity Society and the European Section of the Cervical Spine Research Society 21(12): 2718-2720
Charles, Y.P.; Meyer, N.; Steib, J-P. 2008: Sagittal alignment correction of the thoracolumbar junction in idiopathic scoliosis by in situ bending technique. Studies in Health Technology and Informatics 140: 72-78
Zhu, Z.; Xu, L.; Zhu, F.; Jiang, L.; Wang, Z.; Liu, Z.; Qian, B.-p.; Qiu, Y. 2014: Sagittal alignment of spine and pelvis in asymptomatic adults: norms in Chinese populations. Spine 39(1): E1-E6
Ilharreborde, B.; Vidal, C.; Skalli, W.; Mazda, K. 2013: Sagittal alignment of the cervical spine in adolescent idiopathic scoliosis treated by posteromedial translation. European Spine Journal: Official Publication of the European Spine Society the European Spinal Deformity Society and the European Section of the Cervical Spine Research Society 22(2): 330-337
Terauchi, M.; Hatayama, K.; Yanagisawa, S.; Saito, K.; Takagishi, K. 2011: Sagittal alignment of the knee and its relationship to noncontact anterior cruciate ligament injuries. American Journal of Sports Medicine 39(5): 1090-1094
Sugama, R.; Minoda, Y.; Kobayashi, A.; Iwaki, H.; Ikebuchi, M.; Hashimoto, Y.; Takaoka, K.; Nakamura, H. 2011: Sagittal alignment of the lower extremity while standing in female. Knee Surgery Sports Traumatology Arthroscopy: Official Journal of the Esska 19(1): 74-79
Sevinc, O.; Is, M.; Barut, C.; Ozdemir, S.T.; Ayoglu, F. 2007: Sagittal alignment of the lumbar spine in a Turkish population. Neurosciences 12(3): 221-225
Mukai, Y.; Hosono, N.; Sakaura, H.; Fujii, R.; Iwasaki, M.; Fuchiya, T.; Fujiwara, K.; Fuji, T.; Yoshikawa, H. 2007: Sagittal alignment of the subaxial cervical spine after C1-C2 transarticular screw fixation in rheumatoid arthritis. Journal of Spinal Disorders and Techniques 20(6): 436-441
Levine, H.B.; Bosco, J.A. 2007: Sagittal and coronal biomechanics of the knee: a rationale for corrective measures. Bulletin of the Nyu Hospital for Joint Diseases 65(1): 87-95
Novak, A.C.; Brouwer, B. 2011: Sagittal and frontal lower limb joint moments during stair ascent and descent in young and older adults. Gait and Posture 33(1): 54-60
McMillan, A.G.; Pulver, A.M.E.; Collier, D.N.; Williams, D.S.B. 2010: Sagittal and frontal plane joint mechanics throughout the stance phase of walking in adolescents who are obese. Gait and Posture 32(2): 263-268
Estrada-Molina, A.; Campos-García, M.; Díaz-Uribe, R. 2013: Sagittal and meridional radii of curvature for a surface with symmetry of revolution by using a null-screen testing method. Applied Optics 52(4): 625-634
Cabrera, L.de.Castro.; Retamoso, L.Borges.; Mei, R.Magnoler.Sampaio.; Tanaka, O. 2013: Sagittal and vertical aspects of Class II division 1 subjects according to the respiratory pattern. Dental Press Journal of Orthodontics 18(2): 30-35
Medawar, C. 2006: Sagittal and vertical dentoalveolar compensation in hyperdivergent malocclusion: control using the Straight Wire Integrated in Normal Growth (SWING) system. L' Orthodontie Francaise 77(4): 439-449
Farronato, G.; Giannini, L.; Galbiati, G.; Maspero, C. 2011: Sagittal and vertical effects of rapid maxillary expansion in Class I, II, and IIi occlusions. Angle Orthodontist 81(2): 298-303
Crismani, A.G.; Celar, A.G.; Burstone, C.J.; Bernhart, T.G.; Bantleon, H.-P.; Mittlboeck, M. 2007: Sagittal and vertical load-deflection and permanent deformation of transpalatal arches connected with palatal implants: an in-vitro study. American Journal of Orthodontics and Dentofacial Orthopedics: Official Publication of the American Association of Orthodontists its Constituent Societies and the American Board of Orthodontics 131(6): 742-752
Bretos, J.L.G.ça.; Pereira, M.D.; Gomes, H.C.; Toyama Hino, C.; Ferreira, L.M. 2007: Sagittal and vertical maxillary effects after surgically assisted rapid maxillary expansion (SARME) using Haas and Hyrax expanders. Journal of Craniofacial Surgery 18(6): 1322-1326
Wu, J.Y.C.; Hägg, U.; Pancherz, H.; Wong, R.W.K.; McGrath, C. 2010: Sagittal and vertical occlusal cephalometric analyses of Pancherz: Norms for Chinese children. American Journal of Orthodontics and Dentofacial Orthopedics: Official Publication of the American Association of Orthodontists its Constituent Societies and the American Board of Orthodontics 137(6): 816-824
Denny, M.; McGowan, R.S. 2012: Sagittal area of the vocal tract in young female children. Folia Phoniatrica et Logopaedica: Official Organ of the International Association of Logopedics and Phoniatrics 64(6): 297-303
Lippold, C.; Segatto, E.; Végh, A.ás.; Drerup, B.; Moiseenko, T.; Danesh, G. 2010: Sagittal back contour and craniofacial morphology in preadolescents. European Spine Journal: Official Publication of the European Spine Society the European Spinal Deformity Society and the European Section of the Cervical Spine Research Society 19(3): 427-434
Lenke, L.G. 2014: Sagittal balance. Journal of Neurosurgery. Spine 20(5): 512; Discussion 513-4
Baghdadi, Y.M.K.; Larson, A.N.; Dekutoski, M.B.; Cui, Q.; Sebastian, A.S.; Armitage, B.M.; Nassr, A. 2014: Sagittal balance and spinopelvic parameters after lateral lumbar interbody fusion for degenerative scoliosis: a case-control study. Spine 39(3): E166-E173
Charles, Y.Philippe.; Bouchaïb, J.; Walter, A.; Schuller, Sébastien.; Sauleau, E.André.; Steib, J-Paul. 2012: Sagittal balance correction of idiopathic scoliosis using the in situ contouring technique. European Spine Journal: Official Publication of the European Spine Society the European Spinal Deformity Society and the European Section of the Cervical Spine Research Society 21(10): 1950-1956
La Maida, G.A.; Zottarelli, L.; Mineo, G.V.; Misaggi, B. 2013: Sagittal balance in adolescent idiopathic scoliosis: radiographic study of spino-pelvic compensation after surgery. European Spine Journal: Official Publication of the European Spine Society the European Spinal Deformity Society and the European Section of the Cervical Spine Research Society 22(Suppl 6): S859-S867
Glard, Y.; Pomero, V.; Collignon, P.; Skalli, W.; Jouve, J.-L.; Bollini, G.ér. 2008: Sagittal balance in scoliosis associated with Marfan syndrome: a stereoradiographic three-dimensional analysis. Journal of Children's Orthopaedics 2(2): 113-118
Rabin, D.; Bertagnoli, R.; Wharton, N.; Pickett, G.E.; Duggal, N. 2009: Sagittal balance influences range of motion: an in vivo study with the ProDisc-C. Spine Journal: Official Journal of the North American Spine Society 9(2): 128-133
Faundez, A.; Roussouly, P.; Le Huec, J.C. 2011: Sagittal balance of the spine: a therapeutic revolution. Revue Medicale Suisse 7(322): 2470-2474
Aebi, M. 2011: Sagittal balance of the spine: consequences for the treatment of the degenerative spine. European Spine Journal: Official Publication of the European Spine Society the European Spinal Deformity Society and the European Section of the Cervical Spine Research Society 20(Suppl 5): 555
Schmidt, C.; Liljenqvist, U.; Lerner, T.; Schulte, T.L.; Bullmann, V. 2011: Sagittal balance of thoracic lordoscoliosis: anterior dual rod instrumentation versus posterior pedicle screw fixation. European Spine Journal: Official Publication of the European Spine Society the European Spinal Deformity Society and the European Section of the Cervical Spine Research Society 20(7): 1118-1126
Villard, J.; Ringel, F.; Meyer, B. 2014: Sagittal balance, a useful tool for neurosurgeons?. Advances and Technical Standards in Neurosurgery 41: 23-45
Anakwenze, O.A.; Auerbach, J.D.; Milby, A.H.; Lonner, B.S.; Balderston, R.A. 2009: Sagittal cervical alignment after cervical disc arthroplasty and anterior cervical discectomy and fusion: results of a prospective, randomized, controlled trial. Spine 34(19): 2001-2007
Letti, H.C.B.; Rizzatto, S.M.D.; de Menezes, L.M.; Reale, C.S.; de Lima, E.M.; Martinelli, F.L. 2013: Sagittal changes in lower incisors by the use of lingual arch. Dental Press Journal of Orthodontics 18(3): 29-34
Chen, X.; Wang, H.; Cai, Y.; Zhu, Q.; Zhu, J. 2014: Sagittal component alignment is less reliable than coronal component alignment in a Chinese population undergoing navigated TKA. Journal of Orthopaedic Surgery and Research 9: 51
Luo, L.; Selvanathan, S.K. 2014: Sagittal computed tomogram of the cervicothoracic spine. Bmj 349: G4795
Gibson, L.M.; Blankenstein, T.N. 2014: Sagittal computed tomogram of the neck with bone windows. Bmj 349: G4444
Rostom, M. 2014: Sagittal computed tomography angiogram of the abdomen with contrast. Bmj 349: G4909
Saini, A.K.; Afolayan, J. 2013: Sagittal computed tomography of the ankle. Bmj 346: F1613
Shelmerdine, S.C. 2012: Sagittal computed tomography of the sellar region. Bmj 345: E6769
Harnet, J-Cl.; Lombardi, T.; Lutz, J-Ch.; Meyer, P.; Kahn, J-L. 2007: Sagittal craniofacial growth evaluated on children dry skulls using V2 and V3 canal openings as references. Surgical and Radiologic Anatomy: Sra 29(7): 589-594
Kaiser, G.Louis.; Oesch, Vérie. 2009: Sagittal craniosynostosis combined with ossified cephalhematoma--a tricky and demanding puzzle. Child's Nervous System: Chns: Official Journal of the International Society for Pediatric Neurosurgery 25(1): 103-110
Nakahara, H.; Matsuda, S.; Okazaki, K.; Tashiro, Y.; Iwamoto, Y. 2012: Sagittal cutting error changes femoral anteroposterior sizing in total knee arthroplasty. Clinical Orthopaedics and Related Research 470(12): 3560-3565
Lee, S.-H.; Kim, K.-T.; Suk, K.-S.; Lee, J.-H.; Seo, E.-M.; Huh, D.-S. 2011: Sagittal decompensation after corrective osteotomy for lumbar degenerative kyphosis: classification and risk factors. Spine 36(8): E538-E544
Diebo, B.G.; Henry, J.; Lafage, V.; Berjano, P. 2015: Sagittal deformities of the spine: factors influencing the outcomes and complications. European Spine Journal: Official Publication of the European Spine Society the European Spinal Deformity Society and the European Section of the Cervical Spine Research Society 24(Suppl 1): S3-15
Akbar, M.; Wiedenhöfer, B. 2011: Sagittal deformity. Basic principles of surgical strategies. Der Orthopade 40(8): 661-671
Fang, J.-h.; Jia, L.-s.; Zhou, X.-h.; Chen, X.-s.; Zhang, Y. 2008: Sagittal diameters measurements on MR of the cervical spinal cord in normal subjects. Zhonghua Wai Ke Za Zhi 46(21): 1642-1644
Roach, J.M.; Pfau, T.; Bryars, J.; Unt, V.; Channon, S.B.; Weller, R. 2014: Sagittal distal limb kinematics inside the hoof capsule captured using high-speed fluoroscopy in walking and trotting horses. Veterinary Journal 202(1): 94-98
Kaya Bicer, E.; Servien, E.; Lustig, S.; Demey, G.; Ait Si Selmi, T.; Neyret, P. 2010: Sagittal flexion angle of the femoral component in unicompartmental knee arthroplasty: is it same for both medial and lateral UKAs?. Knee Surgery Sports Traumatology Arthroscopy: Official Journal of the Esska 18(7): 928-933
Nisawa, A.; Yoneda, Y.; Ueno, G.; Murakami, H.; Okajima, Y.; Yamamoto, K.; Senba, Y.; Uesugi, K.; Tanaka, Y.; Yamamoto, M.; Goto, S.; Ishikawa, T. 2013: Sagittal focusing of synchrotron radiation X-rays using a winged crystal. Journal of Synchrotron Radiation 20(Part 2): 219-225
Hananouchi, T. 2015: Sagittal gap balancing with the concept of a single radius femoral component in posterior cruciate sacrificing total knee arthroplasty with patient-specific instrumentation. International Orthopaedics 39(4): 659-665
Zemann, W.; Mossböck, R.; Kärcher, H.; Kozelj, V. 2007: Sagittal growth of the facial skeleton of 6-year-old children with a complete unilateral cleft of lip, alveolus and palate treated with two different protocols. Journal of Cranio-Maxillo-Facial Surgery: Official Publication of the European Association for Cranio-Maxillo-Facial Surgery 35(8): 343-349
Sataa, S.; Ramzi, M.; Zouheir, F.; Said, B.M.; Mohamed, C.; Yassine, N.; Ali, H. 2008: Sagittal incomplete hypospadiac anterior duplication of the urethra. La Tunisie Medicale 86(12): 1105
Rey, J.; Fischer, M.S.; Böttcher, P. 2014: Sagittal joint instability in the cranial cruciate ligament insufficient canine stifle. Caudal slippage of the femur and not cranial tibial subluxation. Tierarztliche Praxis. Ausgabe K Kleintiere/Heimtiere 42(3): 151-156
Yeow, C.H.; Lee, P.V.S.; Goh, J.C.H. 2010: Sagittal knee joint kinematics and energetics in response to different landing heights and techniques. Knee 17(2): 127-131
Chouteau, J.; Lerat, J.Luc.; Testa, R.; Moyen, B.; Banks, S.A.; Scott, B.A. 2009: Sagittal laxity after posterior cruciate ligament-retaining mobile-bearing total knee arthroplasty. Journal of Arthroplasty 24(5): 710-715
Woods, M.G. 2008: Sagittal mandibular changes with overbite correction in subjects with different mandibular growth directions: late mixed-dentition treatment effects. American Journal of Orthodontics and Dentofacial Orthopedics: Official Publication of the American Association of Orthodontists its Constituent Societies and the American Board of Orthodontics 133(3): 388-394
Jena, A.K.; Singh, S.P.; Utreja, A.K. 2010: Sagittal mandibular development effects on the dimensions of the awake pharyngeal airway passage. Angle Orthodontist 80(6): 1061-1067
De Oliveira, J.úl.C.és.S.; Garcia, I.R.; de Melo, W.M.; de Matos Barbosa, S.; Rabêlo, P.M.S.; Bastos, E.G.ãe. 2014: Sagittal mandibular osteotomy for removal of intraosseous lesion. Journal of Craniofacial Surgery 25(3): E237-E239
Zemann, W.; Kärcher, H.; Drevenšek, M.; Koželj, V. 2011: Sagittal maxillary growth in children with unilateral cleft of the lip, alveolus and palate at the age of 10 years: an intercentre comparison. Journal of Cranio-Maxillo-Facial Surgery: Official Publication of the European Association for Cranio-Maxillo-Facial Surgery 39(7): 469-474
Chen, Z.-Q.; Qian, Y.-F.; Wang, G.-M.; Shen, G. 2009: Sagittal maxillary growth in patients with unoperated isolated cleft palate. Cleft Palate-Craniofacial Journal: Official Publication of the American Cleft Palate-Craniofacial Association 46(6): 664-667
Chen, Z.-Q.; Wu, J.; Chen, R.-J. 2012: Sagittal maxillary growth pattern in unilateral cleft lip and palate patients with unrepaired cleft palate. Journal of Craniofacial Surgery 23(2): 491-493
Schlesinger, A.E.; Crowe, J.E. 2011: Sagittal orientation of ingested coins in the esophagus in children. AJR. American Journal of Roentgenology 196(3): 670-672
Pećina, M.; Ivković, A.; Hudetz, D.; Smoljanović, T.; Janković, S. 2010: Sagittal osteotomy of the patella after Morscher. International Orthopaedics 34(2): 297-303
Le Huec, J.C.; Demezon, H.; Aunoble, S. 2015: Sagittal parameters of global cervical balance using EOS imaging: normative values from a prospective cohort of asymptomatic volunteers. European Spine Journal: Official Publication of the European Spine Society the European Spinal Deformity Society and the European Section of the Cervical Spine Research Society 24(1): 63-71
Mac-Thiong, J.-M.; Roussouly, P.; Berthonnaud, E.; Guigui, P. 2010: Sagittal parameters of global spinal balance: normative values from a prospective cohort of seven hundred nine Caucasian asymptomatic adults. Spine 35(22): E1193-E1198
Faundez, A.A.; Le Huec, J.Charles. 2013: Sagittal plane analysis. Journal of Neurosurgery. Spine 19(6): 795-796
Liu, T.; Hai, Y. 2014: Sagittal plane analysis of selective posterior thoracic spinal fusion in adolescent idiopathic scoliosis: a comparison study of all pedicle screw and hybrid instrumentation. Journal of Spinal Disorders and Techniques 27(5): 277-282
Li, W.-S.; Li, G.; Chen, Z.-Q.; Wood, K.B. 2010: Sagittal plane analysis of the spine and pelvis in adult idiopathic scoliosis. Chinese Medical Journal 123(21): 2978-2982
Chandrasekaran, S.; Scarvell, J.M.; Buirski, G.; Woods, K.R.; Smith, P.N. 2012: Sagittal plane articulation of the contralateral knee of subjects with posterior cruciate ligament deficiency: an observational study. Journal of Orthopaedic Surgery and Research 7: 12
Winter, D.A. 1987: Sagittal plane balance and posture in human walking. IEEE Engineering in Medicine and Biology Magazine: the Quarterly Magazine of the Engineering in Medicine and Biology Society 6(3): 8-11
Manson, T.T.; Khanuja, H.S.; Jacobs, M.A.; Hungerford, M.W. 2009: Sagittal plane balancing in the total knee arthroplasty. Journal of Surgical Orthopaedic Advances 18(2): 83-92
Haris Phuah, A.; Schache, A.G.; Crossley, K.M.; Wrigley, T.V.; Creaby, M.W. 2010: Sagittal plane bending moments acting on the lower leg during running. Gait and Posture 31(2): 218-222
Brantingham, J.W.; Lee Gilbert, J.; Shaik, J.; Globe, G. 2006: Sagittal plane blockage of the foot, ankle and hallux and foot alignment-prevalence and association with low back pain. Journal of Chiropractic Medicine 5(4): 123-127
Ali, N.; Robertson, D.G.E.; Rouhi, G. 2014: Sagittal plane body kinematics and kinetics during single-leg landing from increasing vertical heights and horizontal distances: implications for risk of non-contact ACL injury. Knee 21(1): 38-46
Schwab, F.; Lafage, V.; Patel, A.; Farcy, J.-P. 2009: Sagittal plane considerations and the pelvis in the adult patient. Spine 34(17): 1828-1833
Kanayama, M. 2013: Sagittal plane correction in pedicle subtraction osteotomy using the Xia 3 SUK Direct Vertebral Rotation System: technical note. Journal of Neurosurgery. Spine 19(4): 507-514
McCarthy, J.J.; Davidson, R.S.; Ast, M.P.; Cavorsi, G.M.; Swick, J. 2011: Sagittal plane deformity during femoral lengthening. Orthopedics 34(10): E602-E604
Streubel, P.N.; Glasgow, D.; Wong, A.; Barei, D.P.; Ricci, W.M.; Gardner, M.J. 2011: Sagittal plane deformity in bicondylar tibial plateau fractures. Journal of Orthopaedic Trauma 25(9): 560-565
Joseph, S.A.; Moreno, A.P.; Brandoff, J.; Casden, A.C.; Kuflik, P.; Neuwirth, M.G. 2009: Sagittal plane deformity in the adult patient. Journal of the American Academy of Orthopaedic Surgeons 17(6): 378-388
Roussouly, P.; Nnadi, C. 2010: Sagittal plane deformity: an overview of interpretation and management. European Spine Journal: Official Publication of the European Spine Society the European Spinal Deformity Society and the European Section of the Cervical Spine Research Society 19(11): 1824-1836
Narkbunnam, R.; Chareancholvanich, K.; Hanroongroj, T. 2015: Sagittal plane evaluation of patellofemoral movement in patellofemoral pain patients with no evidence of maltracking. Knee Surgery Sports Traumatology Arthroscopy: Official Journal of the Esska 23(4): 986-990
Eitzen, I.; Fernandes, L.; Nordsletten, L.; Risberg, M.Arna. 2012: Sagittal plane gait characteristics in hip osteoarthritis patients with mild to moderate symptoms compared to healthy controls: a cross-sectional study. Bmc Musculoskeletal Disorders 13: 258
Hobbs, S.J.; Clayton, H.M. 2013: Sagittal plane ground reaction forces, centre of pressure and centre of mass in trotting horses. Veterinary Journal 198 Suppl. 1: E14-E19
Foucher, K.C.; Schlink, B.R.; Shakoor, N.; Wimmer, M.A. 2012: Sagittal plane hip motion reversals during walking are associated with disease severity and poorer function in subjects with hip osteoarthritis. Journal of Biomechanics 45(8): 1360-1365
Straudi, S.; Manca, M.; Aiello, E.; Ferraresi, G.; Cavazza, S.; Basaglia, N. 2009: Sagittal plane kinematic analysis of the six-minute walk test: a classification of hemiplegic gait. European Journal of Physical and Rehabilitation Medicine 45(3): 341-347
Rendos, N.K.; Harrison, B.C.; Dicharry, J.M.; Sauer, L.D.; Hart, J.M. 2013: Sagittal plane kinematics during the transition run in triathletes. Journal of Science and Medicine in Sport 16(3): 259-265
Tibesku, C.O.; Daniilidis, K.; Vieth, V.; Skwara, A.; Heindel, W.; Fuchs-Winkelmann, S. 2011: Sagittal plane kinematics of fixed- and mobile-bearing total knee replacements. Knee Surgery Sports Traumatology Arthroscopy: Official Journal of the Esska 19(9): 1488-1495
Gatt, A.; Chockalingam, N.; Falzon, O. 2013: Sagittal plane kinematics of passive dorsiflexion of the foot in adolescent athletes. Journal of the American Podiatric Medical Association 103(5): 394-399
Zheng, L.; Jahn, J.; Vasavada, A.N. 2012: Sagittal plane kinematics of the adult hyoid bone. Journal of Biomechanics 45(3): 531-536
Gatt, A.; Chockalingam, N.; Chevalier, T.L. 2011: Sagittal plane kinematics of the foot during passive ankle dorsiflexion. Prosthetics and Orthotics International 35(4): 425-431
Hart, J.M.; Ko, J.-W.K.; Konold, T.; Pietrosimone, B.; Pietrosimione, B. 2010: Sagittal plane knee joint moments following anterior cruciate ligament injury and reconstruction: a systematic review. Clinical Biomechanics 25(4): 277-283
Na, K.-H.; Harms, J.ür.; Ha, K.-Y.; Choi, N.-Y. 2007: Sagittal plane lumbar responses after anterior selective thoracic fusion for main thoracic adolescent idiopathic scoliosis. Asian Spine Journal 1(2): 80-87
Sealey, R.J.; Myerson, M.S.; Molloy, A.; Gamba, C.; Jeng, C.; Kalesan, B. 2009: Sagittal plane motion of the hindfoot following ankle arthrodesis: a prospective analysis. Foot and Ankle International 30(3): 187-196
Rusaw, D.; Ramstrand, N. 2010: Sagittal plane position of the functional joint centre of prosthetic foot/ankle mechanisms. Clinical Biomechanics 25(7): 713-720
Teng, H.-L.; Powers, C.M. 2014: Sagittal plane trunk posture influences patellofemoral joint stress during running. Journal of Orthopaedic and Sports Physical Therapy 44(10): 785-792
Park, M.S.; Mesfin, A.; Stoker, G.E.; Song, K.-S.; Kennedy, C.; Riew, K.D. 2014: Sagittal range of motion after extensive cervical fusion. Spine Journal: Official Journal of the North American Spine Society 14(2): 338-343
Schwab, F.J.; Patel, A.; Shaffrey, C.I.; Smith, J.S.; Farcy, J-Pierre.; Boachie-Adjei, O.; Hostin, R.A.; Hart, R.A.; Akbarnia, B.A.; Burton, D.C.; Bess, S.; Lafage, V. 2012: Sagittal realignment failures following pedicle subtraction osteotomy surgery: are we doing enough?: Clinical article. Journal of Neurosurgery. Spine 16(6): 539-546
Kimura, Y.; Ishibashi, Y.; Tsuda, E.; Fukuda, A.; Tsukada, H. 2009: Sagittal realignment osteotomy for increased posterior tibial slope after opening-wedge high tibial osteotomy: a case report. Sports Medicine Arthroscopy Rehabilitation Therapy and Technology: Smartt 1(1): 26
Rousseau, M.-A.; Lazennec, J.-Y.; Tassin, J.-L.; Fort, D. 2014: Sagittal rebalancing of the pelvis and the thoracic spine after pedicle subtraction osteotomy at the lumbar level. Journal of Spinal Disorders and Techniques 27(3): 166-173
Del Piñal, F.; García-Bernal, F.J.; Studer, A.; Regalado, J.; Ayala, H.; Cagigal, L. 2009: Sagittal rotational malunions of the distal radius: the role of pure derotational osteotomy. Journal of Hand Surgery European Volume 34(2): 160-165
Cho, D.-Y.; Shin, M.-H.; Hur, J.-W.; Ryu, K.-S.; Park, C.-K. 2013: Sagittal sacropelvic morphology and balance in patients with sacroiliac joint pain following lumbar fusion surgery. Journal of Korean Neurosurgical Society 54(3): 201-206
Faldini, C.; Pagkrati, S.; Leonetti, D.; Miscione, M.T.; Giannini, S. 2011: Sagittal segmental alignment as predictor of adjacent-level degeneration after a cloward procedure. Clinical Orthopaedics and Related Research 469(3): 674-681
Madrazo Delgado, M.; Redondo Calvo, F.J.; Gil Trujillo, S.; Castillo, J.L.; Calvo García, M.; Bernal García, G. 2008: Sagittal sinus thrombosis as a rare cause of postpartum headache: a case report. Revista Espanola de Anestesiologia y Reanimacion 55(7): 442-446
Wani, N.A.; Kosar, T.; Pala, N.A.; Qureshi, U.A. 2010: Sagittal sinus thrombosis due to L-asparaginase. Journal of Pediatric Neurosciences 5(1): 32-35
D'Angelo-Donovan, D.; Guarino, M.J. 2012: Sagittal sinus thrombosis while on tamoxifen requiring craniectomy. Delaware Medical Journal 84(1): 31-32
Weber, J.; Vida, M.; Greiner, K. 2013: Sagittal sinus thrombosis with malignant brain oedema: pathophysiology of cortical veins after decompressive craniectomy. Acta Neurochirurgica 155(4): 651-653
Tripathi, M.; D'Souza, M.; Jain, J.; Kumari, R.; Guliani, S.; Pandey, S.K.; Sharma, R.; Mondal, A. 2011: Sagittal sinus tumor thrombosis in a case of NHL demonstrated on F-18 FDG PET/CT. Clinical Nuclear Medicine 36(3): 252-254
Tschechne, S.; Müller, B.; Dibbets, J. 2008: Sagittal space relations in the maxilla during molar eruption. Journal of Orofacial Orthopedics 69(2): 94-98
Endo, K.; Suzuki, H.; Tanaka, H.; Kang, Y.; Yamamoto, K. 2010: Sagittal spinal alignment in patients with lumbar disc herniation. European Spine Journal: Official Publication of the European Spine Society the European Spinal Deformity Society and the European Section of the Cervical Spine Research Society 19(3): 435-438
Winter, R.B.; Lonstein, J.E.; Denis, F. 2009: Sagittal spinal alignment: the true measurement, norms, and description of correction for thoracic kyphosis. Journal of Spinal Disorders and Techniques 22(5): 311-314
López-Miñarro, P.A.; Muyor, J.é M.; Alacid, F. 2011: Sagittal spinal and pelvic postures of highly-trained young canoeists. Journal of Human Kinetics 29: 41-48
Videbaek, T.S.; Bünger, C.E.; Henriksen, M.; Neils, E.; Christensen, F.B. 2011: Sagittal spinal balance after lumbar spinal fusion: the impact of anterior column support results from a randomized clinical trial with an eight- to thirteen-year radiographic follow-up. Spine 36(3): 183-191
Muyor, J.é M.; Sánchez-Sánchez, E.ía.; Sanz-Rivas, D.; López-Miñarro, P.A. 2013: Sagittal spinal morphology in highly trained adolescent tennis players. Journal of Sports Science and Medicine 12(3): 588-593
Klineberg, E.; Schwab, F.; Smith, J.S.; Gupta, M.C.; Lafage, V.; Bess, S. 2013: Sagittal spinal pelvic alignment. Neurosurgery Clinics of North America 24(2): 157-162
Kuo, Y.-L.; Tully, E.A.; Galea, M.P. 2009: Sagittal spinal posture after Pilates-based exercise in healthy older adults. Spine 34(10): 1046-1051
Lafage, V.; Smith, J.S.; Bess, S.; Schwab, F.J.; Ames, C.P.; Klineberg, E.; Arlet, V.; Hostin, R.; Burton, D.C.; Shaffrey, C.I. 2012: Sagittal spino-pelvic alignment failures following three column thoracic osteotomy for adult spinal deformity. European Spine Journal: Official Publication of the European Spine Society the European Spinal Deformity Society and the European Section of the Cervical Spine Research Society 21(4): 698-704
Le Huec, J.C.; Roussouly, P. 2011: Sagittal spino-pelvic balance is a crucial analysis for normal and degenerative spine. European Spine Journal: Official Publication of the European Spine Society the European Spinal Deformity Society and the European Section of the Cervical Spine Research Society 20(Suppl 5): 556-557
Schuller, S.éb.; Charles, Y.P.; Steib, J.-P. 2011: Sagittal spinopelvic alignment and body mass index in patients with degenerative spondylolisthesis. European Spine Journal: Official Publication of the European Spine Society the European Spinal Deformity Society and the European Section of the Cervical Spine Research Society 20(5): 713-719
Zhu, Z.; Sha, S.; Liu, Z.; Sun, X.; Jiang, L.; Yan, H.; Qian, B.; Qiu, Y. 2014: Sagittal spinopelvic alignment in adolescent thoracic scoliosis secondary to Chiari i malformation: a comparison between the left and the right curves. European Spine Journal: Official Publication of the European Spine Society the European Spinal Deformity Society and the European Section of the Cervical Spine Research Society 23(1): 226-233
Jiang, L.; Qiu, Y.; Xu, L.; Liu, Z.; Wang, Z.; Sha, S.; Zhu, Z. 2014: Sagittal spinopelvic alignment in adolescents associated with Scheuermann's kyphosis: a comparison with normal population. European Spine Journal: Official Publication of the European Spine Society the European Spinal Deformity Society and the European Section of the Cervical Spine Research Society 23(7): 1420-1426
Oh, J.Keun.; Smith, J.S.; Shaffrey, C.I.; Lafage, V.; Schwab, F.; Ames, C.P.; Matsumoto, M.; Baik, J.Sam.; Ha, Y. 2014: Sagittal spinopelvic malalignment in Parkinson disease: prevalence and associations with disease severity. Spine 39(14): E833-E841
Karikari, I.O.; Mehta, A.I.; Solakoglu, C.; Bagley, C.A.; Ain, M.C.; Gottfried, O.N. 2012: Sagittal spinopelvic parameters in children with achondroplasia: identification of 2 distinct groups. Journal of Neurosurgery. Spine 17(1): 57-60
Kahnberg, K-Erik.; Kashani, H.; Owman-Moll, P. 2007: Sagittal split advancement osteotomy: comparison of the tendency to relapse after two different methods of rigid fixation. Scandinavian Journal of Plastic and Reconstructive Surgery and Hand Surgery 41(4): 167-172
Schendel, S.A. 2010: Sagittal split genioplasty: a new technique. Journal of Oral and Maxillofacial Surgery: Official Journal of the American Association of Oral and Maxillofacial Surgeons 68(4): 931-934
Greig, A.V.H.; Kapadia, H.; Grayson, B.H.; McCarthy, J.G. 2012: Sagittal split osteotomy in a previously distracted mandible. Plastic and Reconstructive Surgery 130(1): 226e-227e
Longo, B.; Nicolotti, M.; Ferri, G.; Belli, E.; Santanelli, F. 2013: Sagittal split osteotomy of the fibula for modeling the new mandibular angle. Journal of Craniofacial Surgery 24(1): 71-74
Kim, J.-W.; Lee, C.-H.; Kwon, T.-G. 2014: Sagittal split osteotomy on the previously reconstructed mandible with fibula free flap. Journal of Craniofacial Surgery 25(5): 1833-1835
Dolphens, M.; Cagnie, B.; Coorevits, P.; Vanderstraeten, G.; Cardon, G.; Dʼhooge, R.; Danneels, L. 2012: Sagittal standing posture and its association with spinal pain: a school-based epidemiological study of 1196 Flemish adolescents before age at peak height velocity. Spine 37(19): 1657-1666
Araújo, Fábio.; Lucas, R.; Alegrete, N.; Azevedo, A.; Barros, H. 2014: Sagittal standing posture, back pain, and quality of life among adults from the general population: a sex-specific association. Spine 39(13): E782-E794
McHenry, B.D.; Exten, E.L.; Long, J.; Law, B.; Marks, R.M.; Harris, G. 2015: Sagittal subtalar and talocrural joint assessment with weight-bearing fluoroscopy during barefoot ambulation. Foot and Ankle International 36(4): 430-435
Buchmann, E.J.; Libhaber, E. 2008: Sagittal suture overlap in cephalopelvic disproportion: blinded and non-participant assessment. Acta Obstetricia et Gynecologica Scandinavica 87(7): 731-737
Masand, M. 2010: Sagittal synostosis. BMJ Case Reports
Piatt, J.H. 2010: Sagittal synostosis and ossified scalp hematoma: cause or consequence?. Journal of Neurosurgery. Pediatrics 6(1): 29-32
Currarino, G. 2007: Sagittal synostosis in X-linked hypophosphatemic rickets and related diseases. Pediatric Radiology 37(8): 805-812
Murray, D.J.; Kelleher, M.O.; McGillivary, A.; Allcutt, D.; Earley, M.J. 2007: Sagittal synostosis: a review of 53 cases of sagittal suturectomy in one unit. Journal of Plastic Reconstructive and Aesthetic Surgery: Jpras 60(9): 991-997
Kohan, E.; Wexler, A.; Cahan, L.; Kawamoto, H.K.; Katchikian, H.; Bradley, J.P. 2008: Sagittal synostotic twins: reverse pi procedure for scaphocephaly correction gives superior result compared to endoscopic repair followed by helmet therapy. Journal of Craniofacial Surgery 19(6): 1453-1458
Nouira, F.; Sarrai, N.; Ghorbel, S.; Khemakhem, R.; Chariag, W.; Jlidi, S.; Chaouachi, B. 2011: Sagittal uretral duplication in boy. La Tunisie Medicale 89(11): 867-868
Ichiba, A.; Kido, H.; Tokuyama, F.; Makuya, K.; Oda, K. 2014: Sagittal view of the tibial attachment of the anterior cruciate ligament on magnetic resonance imaging and the relationship between anterior cruciate ligament size and the physical characteristics of patients. Journal of Orthopaedic Science: Official Journal of the Japanese Orthopaedic Association 19(1): 97-103
Hanson, E.H.; Mishra, R.K.; Chang, D.S.; Perkins, T.G.; Bonifield, D.R.; Tandy, R.D.; Cartwright, P.E.; Peoples, R.R.; Orrison, W.W. 2010: Sagittal whole-spine magnetic resonance imaging in 750 consecutive outpatients: accurate determination of the number of lumbar vertebral bodies. Journal of Neurosurgery. Spine 12(1): 47-55
Larsen, H.J.; Sørensen, H.B.; Artmann, L.; Christensen, I.J.; Kjaer, I. 2010: Sagittal, vertical and transversal dimensions of the maxillary complex in patients with ectopic maxillary canines. Orthodontics and Craniofacial Research 13(1): 34-39
Blackburn, J.T.; Padua, D.A. 2009: Sagittal-plane trunk position, landing forces, and quadriceps electromyographic activity. Journal of Athletic Training 44(2): 174-179
Tsai, H.-Y.; Lee, M.-H.; Chen, H.-C.; Chen, H.-C.; Guh, J.-Y. 2015: Sagittally malrotated kidney: a case series of two patients. Surgical and Radiologic Anatomy: Sra 37(5): 551-553
Arditty, H.J.; Leèfovre, H.C. 1981: Sagnac effect in fiber gyroscopes. Optics Letters 6(8): 401-403
Huang, A.; Whitaker, N.; Avramopoulos, H.; French, P.; Houh, H.; Chuang, I. 1994: Sagnac fiber logic gates and their possible applications: a system perspective. Applied Optics 33(26): 6254-6267
Refael, G.; Heo, J.; Bockrath, M. 2007: Sagnac interference in carbon nanotube loops. Physical Review Letters 98(24): 246803
Lee, C.-W.; Wang, R.; Yeh, P.; Cheng, W.-H. 2006: Sagnac interferometer based flat-top birefringent interleaver. Optics Express 14(11): 4636-4643
Shiokawa, N.; Mizuno, Y.; Tsuchiya, H.; Tokunaga, E. 2012: Sagnac interferometer for photothermal deflection spectroscopy. Optics Letters 37(13): 2655-2657
Kråkenes, K.; Bløtekjaer, K. 1989: Sagnac interferometer for underwater sound detection: noise properties. Optics Letters 14(20): 1152-1154
Jones, P.H.; Rashid, M.; Makita, M.; Maragò, O.M. 2009: Sagnac interferometer method for synthesis of fractional polarization vortices. Optics Letters 34(17): 2560-2562
Bortolozzo, U.; Residori, S.; Rubin, J.L.; Huignard, J.P. 2011: Sagnac interferometer with adaptive nonlinear detection. Optics Letters 36(4): 520-522
Garvey, D.W.; Li, Q.; Kuzyk, M.G.; Dirk, C.W.; Martinez, S. 1996: Sagnac interferometric intensity-dependent refractive-index measurements of polymer optical fiber. Optics Letters 21(2): 104-106
Roither, S.; Verhoef, A.J.; Mücke, O.D.; Reider, G.A.; Pugžlys, A.; Baltuška, A. 2012: Sagnac interferometric multipass loop amplifier. Optics Express 20(22): 25121-25129
Kim, D.-H.; Kang, J. 2004: Sagnac loop interferometer based on polarization maintaining photonic crystal fiber with reduced temperature sensitivity. Optics Express 12(19): 4490-4495
Zhang, Y.; Yang, S.; Guan, H.; Lim, A.E.-J.; Lo, G.-Q.; Magill, P.; Baehr-Jones, T.; Hochberg, M. 2014: Sagnac loop mirror and micro-ring based laser cavity for silicon-on-insulator. Optics Express 22(15): 17872-17879
Hariharan, P. 1975: Sagnac or Michelson-Sagnac interferometer?. Applied Optics 14(10)
Bogdanski, J.; Ahrens, J.; Bourennane, M. 2009: Sagnac secret sharing over telecom fiber networks. Optics Express 17(2): 1055-1063
Rønnekleiv, E. 1997: Sagnac sensor for location of a disturbance. Applied Optics 36(10): 2076-2083
Tay, J.W.; Taylor, M.A.; Bowen, W.P. 2009: Sagnac-interferometer-based characterization of spatial light modulators. Applied Optics 48(12): 2236-2242
Tselikov, A.; Blake, J. 1998: Sagnac-interferometer-based fresnel flow probe. Applied Optics 37(28): 6690-6694
Ng, T.T.; Gosal, D.; Lamas-Linares, A.ía.; Kurtsiefer, C. 2011: Sagnac-loop phase shifter with polarization-independent operation. Review of Scientific Instruments 82(1): 013106
Fomitchov, P.A.; Kromine, A.K.; Krishnaswamy, S.; Achenbach, J.D. 2000: Sagnac-type fiber-optic array sensor for detection of bulk ultrasonic waves. IEEE Transactions on Ultrasonics Ferroelectrics and Frequency Control 47(3): 584-590
Linggang, S.; Phang, L.Y.; Wasoh, M.H.; Abd-Aziz, S. 2012: Sago pith residue as an alternative cheap substrate for fermentable sugars production. Applied Biochemistry and Biotechnology 167(1): 122-131
Yang, X.; Barton, H.J.; Wan, Z.; Li, Q.; Ma, Z.; Li, M.; Zhang, D.; Wei, J. 2013: Sago-type palms were an important plant food prior to rice in southern subtropical China. Plos one 8(5): E63148
Klar, U.; Hoffmann, J.; Giurescu, M. 2008: Sagopilone (ZK-EPO): from a natural product to a fully synthetic clinical development candidate. Expert Opinion on Investigational Drugs 17(11): 1735-1748
Hoffmann, J.; Fichtner, I.; Lemm, M.; Lienau, P.; Hess-Stumpp, H.; Rotgeri, A.; Hofmann, B.; Klar, U. 2009: Sagopilone crosses the blood-brain barrier in vivo to inhibit brain tumor growth and metastases. Neuro-Oncology 11(2): 158-166
Strube, A.; Hoffmann, J.; Stepina, E.; Hauff, P.; Klar, U.; Käkönen, S.-M. 2009: Sagopilone inhibits breast cancer bone metastasis and bone destruction due to simultaneous inhibition of both tumor growth and bone resorption. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 15(11): 3751-3759
Galmarini, C.M. 2009: Sagopilone, a microtubule stabilizer for the potential treatment of cancer. Current Opinion in Investigational Drugs 10(12): 1359-1371
Martínez-Ripoll, Mín. 2012: Sagrario Martínez-Carrera (1925-2011). Acta Crystallographica. Section B Structural Science 68(Pt 2): 213-214
Duplantie, A.ée. 2010: Saguenay-Lac-Saint-Jean, Genetic tests. a pilot project to screen for four recessive genes during pregnancy. Importance of support from the nurse. Perspective Infirmiere: Revue Officielle de l'Ordre des Infirmieres et Infirmiers du Quebec 7(1): 32-34
Toksen, E.; Boxshall, G.A.; Altinozek, S. 2012: Sagum posteli Delamare-Deboutteville and Nunes-Ruivo, 1954 (Copepoda: Siphonostomatoida: Lernanthropidae) parasitic on Epinephelus aeneus (Geoffroy Saint-Hilaire) in Turkish waters, with a key to the species of Sagum Wilson, 1913. Systematic Parasitology 82(1): 71-80
Saha, M.V.; Davis, R.E.; Hondula, D.M. 2014: Saha et al. respond to "Mortality displacement after heat waves". American Journal of Epidemiology 179(12): 1407-1408
Reeves, H.M. 2006: Sahagún's "Florentine codex," a little known Aztecan natural history of the Valley of Mexico. Archives of Natural History 33(2): 302-321
Yalta, K.; Sivri, N.; Yetkin, E. 2011: Sahaja yoga: a unique adjunctive approach for the management of cardiac arrhythmias?. International Journal of Cardiology 152(1): 99-100
Nikita, E.; Mattingly, D.; Lahr, M.M.ón. 2012: Sahara: Barrier or corridor? Nonmetric cranial traits and biological affinities of North African late Holocene populations. American Journal of Physical Anthropology 147(2): 280-292
Mallone, S.; Stafoggia, M.; Faustini, A.; Gobbi, G.Paolo.; Marconi, A.; Forastiere, F. 2011: Saharan dust and associations between particulate matter and daily mortality in Rome, Italy. Environmental Health Perspectives 119(10): 1409-1414
Matassoni, L.; Pratesi, G.; Centioli, D.; Cadoni, F.; Lucarelli, F.; Nava, S.; Malesani, P. 2011: Saharan dust contribution to PM₁₀, PM₂.₅ and PM₁ in urban and suburban areas of Rome: a comparison between single-particle SEM-EDS analysis and whole-sample PIXE analysis. Journal of Environmental Monitoring: Jem 13(3): 732-742
Gallisai, R.; Peters, F.; Volpe, G.; Basart, S.; Baldasano, Jé.Maria. 2014: Saharan dust deposition may affect phytoplankton growth in the Mediterranean sea at ecological time scales. Plos one 9(10): E110762
Dadvand, P.; Basagaña, X.; Figueras, F.; Amoly, E.; Tobias, A.; de Nazelle, A.; Querol, X.; Sunyer, J.; Nieuwenhuijsen, M.J. 2011: Saharan dust episodes and pregnancy. Journal of Environmental Monitoring: Jem 13(11): 3222-3228
Matassoni, L.; Pratesi, G.; Centioli, D.; Cadoni, F.; Malesani, P.; Caricchia, A.M.; di Bucchianico, A.D.M. 2009: Saharan dust episodes in Italy: influence on PM10 daily limit value (DLV) exceedances and the related synoptic. Journal of Environmental Monitoring: Jem 11(9): 1586-1594
De Longueville, F.; Henry, S.; Ozer, P. 2009: Saharan dust pollution: implications for the Sahel? [corrected. Epidemiology 20(5): 780
Flavell, G. 1947: Saharan surgeon. Health Horizon 1947: 40-45
Walsh, J. 1984: Sahel will Suffer even if Rains Come: with potential population explosion, no Green Revolution, drought is only part of the problem confronting the region. Science 224(4648): 467-471
Ceesay, S.J.; Bojang, K.A.; Nwakanma, D.; Conway, D.J.; Koita, O.A.; Doumbia, S.O.; Ndiaye, D.; Coulibaly, T.F.; Diakité, M.; Traoré, S.F.; Coulibaly, M.; Ndiaye, J.-L.; Sarr, O.; Gaye, O.; Konaté, L.; Sy, N.; Faye, B.; Faye, O.; Sogoba, N.; Jawara, M.; Dao, A.; Poudiougou, B.; Diawara, S.; Okebe, J.; Sangaré, L.; Abubakar, I.; Sissako, A.; Diarra, A.; Kéita, M.; Kandeh, B.; Long, C.A.; Fairhurst, R.M.; Duraisingh, M.; Perry, R.; Muskavitch, M.A.T.; Valim, C.; Volkman, S.K.; Wirth, D.F.; Krogstad, D.J. 2012: Sahel, savana, riverine and urban malaria in West Africa: Similar control policies with different outcomes. Acta Tropica 121(3): 166-174
Wade, N. 1974: Sahelian drought: no victory for Western aid. Science 185(4147): 234-237
Eckerström, M.; Skoogh, J.; Rolstad, S.; Göthlin, M.; Steineck, G.; Johansson, B.; Wallin, A. 2013: Sahlgrenska Academy Self-reported Cognitive Impairment Questionnaire (SASCI-Q)--a research tool discriminating between subjectively cognitively impaired patients and healthy controls. International Psychogeriatrics 25(3): 420-430
Biörserud, C.; Nielsen, C.; Staalesen, T.; Elander, A.; Olbers, T.; Olsén, M.Fagevik. 2013: Sahlgrenska Excess Skin Questionnaire (SESQ): a reliable questionnaire to assess the experience of excessive skin after weight loss. Journal of Plastic Surgery and Hand Surgery 47(1): 50-59
Boycott, A.E. 1912: Sahli's Haemoglobinometer. Proceedings of the Royal Society of Medicine 5(Pathol Sect): 43-45
Boycott, A.E. 1912: Sahli's Hæmoglobinometer. Proceedings of the Royal Society of Medicine 5(Pathol Sect): 43-45
Sahraoui, F.; Robert, P.; Goldstein, M.L.; Khotyaintsev, Y.V. 2013: Sahraoui et al. reply. Physical Review Letters 111(14): 149002
Komiya, K.; Ishii, H.; Ohama, M.; Uchida, M.; Tsubone, T.; Iwashita, T.; Miyajima, H.; Okabe, E.; Matsumoto, T.; Matsumoto, B.; Kadota, J-ichi. 2012: Sai-rei-to-induced lung injury: a case report and brief review of the literature. Internal Medicine 51(24): 3421-3425
Maurer, B.T. 2013: Said and done: when the present is all we have left. Jaapa: Official Journal of the American Academy of Physician Assistants 26(2): 65
Ayres, C.G. 2009: Said another way. Nurses' role in cancer control. Nursing Forum 44(1): 64-67
Gugerty, L. 2008: Said another way. Nursing care: a lost art. Nursing Forum 43(3): 160-161
West, E. 2009: Said another way. the real cost of higher education. Nursing Forum 44(1): 68-69
Goodman, W.M.; Lamers, A. 2010: Said another way: asking the right questions regarding the effectiveness of simulations. Nursing Forum 45(4): 246-252
Tzeng, H.-M.; Yin, C.-Y. 2007: Said another way: seeing the nursing profession from a different perspective: nurstry? Why not!. Nursing Forum 42(4): 185-188
Lavin, R.P.; Dreyfus, M.; Slepski, L.; Kasper, C.E. 2007: Said another way: subject matter experts: facts or fiction?. Nursing Forum 42(4): 189-195
Kilcullen, N.M. 2007: Said another way: the impact of mentorship on clinical learning. Nursing Forum 42(2): 95-104
Mizoguchi, K.; Ikeda, R.; Shoji, H.; Tanaka, Y.; Jin, X-Long.; Kase, Y.; Takeda, S.; Maruyama, W.; Tabira, T. 2009: Saikokaryukotsuboreito, a herbal medicine, prevents chronic stress-induced anxiety in rats: comparison with diazepam. Journal of Natural Medicines 63(1): 69-74
Ohta, Y.; Kongo-Nishimura, M.; Hayashi, T.; Kitagawa, A.; Matsura, T.; Yamada, K. 2007: Saikokeishito Extract Exerts a Therapeutic Effect on alpha-Naphthylisothiocyanate-Induced Liver Injury in Rats through Attenuation of Enhanced Neutrophil Infiltration and Oxidative Stress in the Liver Tissue. Journal of Clinical Biochemistry and Nutrition 40(1): 31-41
Zhu, J.; Luo, C.; Wang, P.; He, Q.; Zhou, J.; Peng, H. 2013: Saikosaponin a mediates the inflammatory response by inhibiting the MAPK and NF-κB pathways in LPS-stimulated RAW 264.7 cells. Experimental and Therapeutic Medicine 5(5): 1345-1350
Wang, X.; Wang, Q.; Burczynski, F.J.; Kong, W.; Gong, Y. 2013: Saikosaponin a of Bupleurum chinense (Chaihu) elevates bone morphogenetic protein 4 (BMP-4) during hepatic stellate cell activation. Phytomedicine: International Journal of PhytoTherapy and Phytopharmacology 20(14): 1330-1335
Lee, T.H.; Chang, J.; Kim, B.M. 2014: Saikosaponin C inhibits lipopolysaccharide-induced apoptosis by suppressing caspase-3 activation and subsequent degradation of focal adhesion kinase in human umbilical vein endothelial cells. Biochemical and Biophysical Research Communications 445(3): 615-621
Li, Z.-Y.; Jiang, Y.-M.; Liu, Y.-M.; Guo, Z.; Shen, S.-N.; Liu, X.-M.; Pan, R.-L. 2014: Saikosaponin D acts against corticosterone-induced apoptosis via regulation of mitochondrial GR translocation and a GR-dependent pathway. Progress in Neuro-Psychopharmacology and Biological Psychiatry 53: 80-89
Chen, L.; Zhang, F.; Kong, D.; Zhu, X.; Chen, W.; Wang, A.; Zheng, S. 2013: Saikosaponin D disrupts platelet-derived growth factor-β receptor/p38 pathway leading to mitochondrial apoptosis in human LO2 hepatocyte cells: a potential mechanism of hepatotoxicity. Chemico-Biological Interactions 206(1): 76-82
Chen, M.F.; Huang, C.C.; Liu, P.S.; Chen, C.H.; Shiu, L.Y. 2013: Saikosaponin a and saikosaponin d inhibit proliferation and migratory activity of rat HSC-T6 cells. Journal of Medicinal Food 16(9): 793-800
Sun, Y.; Cai, T.-T.; Zhou, X.-B.; Xu, Q. 2009: Saikosaponin a inhibits the proliferation and activation of T cells through cell cycle arrest and induction of apoptosis. International Immunopharmacology 9(7-8): 978-983
Yu, Y.-H.; Xie, W.; Bao, Y.; Li, H.-M.; Hu, S.-J.; Xing, J.-L. 2012: Saikosaponin a mediates the anticonvulsant properties in the HNC models of AE and SE by inhibiting NMDA receptor current and persistent sodium current. Plos one 7(11): E50694
Liu, A.; Tanaka, N.; Sun, L.; Guo, B.; Kim, J.-H.; Krausz, K.W.; Fang, Z.; Jiang, C.; Yang, J.; Gonzalez, F.J. 2014: Saikosaponin d protects against acetaminophen-induced hepatotoxicity by inhibiting NF-κB and STAT3 signaling. Chemico-Biological Interactions 223: 80-86
Zhang, B.-Z.; Guo, X.-T.; Chen, J.-W.; Zhao, Y.; Cong, X.; Jiang, Z.-L.; Cao, R.-F.; Cui, K.; Gao, S.-S.; Tian, W.-R. 2014: Saikosaponin-D attenuates heat stress-induced oxidative damage in LLC-PK1 cells by increasing the expression of anti-oxidant enzymes and HSP72. American Journal of Chinese Medicine 42(5): 1261-1277
Wang, B.-F.; Wang, X.-J.; Kang, H.-F.; Bai, M.-H.; Guan, H.-T.; Wang, Z.-W.; Zan, Y.; Song, L.-Q.; Min, W.-L.; Lin, S.; Cheng, Y.-A. 2014: Saikosaponin-D enhances radiosensitivity of hepatoma cells under hypoxic conditions by inhibiting hypoxia-inducible factor-1α. Cellular Physiology and Biochemistry: International Journal of Experimental Cellular Physiology Biochemistry and Pharmacology 33(1): 37-51
Wong, V.Kam.Wai.; Zhang, M.Miao.; Zhou, H.; Lam, K.Yin.Ching.; Chan, P.Ling.; Law, C.Ka.Man.; Yue, P.Ying.Kit.; Liu, L. 2013: Saikosaponin-d Enhances the Anticancer Potency of TNF-α via Overcoming Its Undesirable Response of Activating NF-Kappa B Signalling in Cancer Cells. Evidence-Based Complementary and Alternative Medicine: Ecam 2013: 745295
Ying, Z.-L.; Li, X.-J.; Dang, H.; Wang, F.; Xu, X.-Y. 2014: Saikosaponin-d affects the differentiation, maturation and function of monocyte-derived dendritic cells. Experimental and Therapeutic Medicine 7(5): 1354-1358
Wang, B.-F.; Dai, Z.-J.; Wang, X.-J.; Bai, M.-H.; Lin, S.; Ma, H.-B.; Wang, Y.-L.; Song, L.-Q.; Ma, X.-L.; Zan, Y.; Min, W.-L.; Cheng, Y.-A. 2013: Saikosaponin-d increases the radiosensitivity of smmc-7721 hepatocellular carcinoma cells by adjusting the g0/g1 and g2/m checkpoints of the cell cycle. Bmc Complementary and Alternative Medicine 13: 263
Liu, R.-Y.; Li, J.-P. 2014: Saikosaponin-d inhibits proliferation of human undifferentiated thyroid carcinoma cells through induction of apoptosis and cell cycle arrest. European Review for Medical and Pharmacological Sciences 18(17): 2435-2443
Hao, Y.; Piao, X.; Piao, X. 2012: Saikosaponin-d inhibits β-conglycinin induced activation of rat basophilic leukemia-2H3 cells. International Immunopharmacology 13(3): 257-263
Wu, G.-C.; Wu, H.; Fan, L.-Y.; Pan, H.-F. 2011: Saikosaponins: a potential treatment option for systemic lupus erythematosus. Irish Journal of Medical Science 180(1): 259-261
Yao, M.; Yang, J.; Cao, L.; Zhang, L.; Qu, S.; Gao, H. 2014: Saikosaponin‑d inhibits proliferation of DU145 human prostate cancer cells by inducing apoptosis and arresting the cell cycle at G0/G1 phase. Molecular Medicine Reports 10(1): 365-372
He, S.; Lu, G.; Hou, H.; Zhao, Z.; Zhu, Z.; Lu, X.; Chen, J.; Wang, Z. 2014: Saikosaponin‑d suppresses the expression of cyclooxygenase‑2 through the phospho‑signal transducer and activator of transcription 3/hypoxia‑inducible factor‑1α pathway in hepatocellular carcinoma cells. Molecular Medicine Reports 10(5): 2556-2562
Shrubb, R. 2010: Sail away. Mental Health Today 2010: 14-15
Nicol, P.; Young, M. 2007: Sail training: an innovative approach to graduate nurse preceptor development. Journal for Nurses in Staff Development: Jnsd: Official Journal of the National Nursing Staff Development Organization 23(6): 298-302